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Abstract 
Endogenous analgesia (EA) is modulated through multiple central inhibitory 
and facilitatory mechanisms to limit perception of pain. Evidence suggests that 
these EA mechanisms can be activated through the phenomena of conditioned 
pain modulation (CPM) and manipulation induced pain modulation (MIPM). 
These forms of natural analgesia appear to share similar neurophysiological 
mechanisms, although with some individual variations. Although the 
immediate effects of MIPM in musculoskeletal pain have been established (e.g. 
in conditions such as lateral epicondylalgia (LE)), there is still a limited 
understanding about exactly how MIPM exerts its analgesic effect. The overall 
objective of this research was to determine whether, in individuals with LE,  
CPM and MIPM analgesia are associated and the extent to which the analgesic 
responses of each were augmented when combined with other interventions.  
A series of four experimental studies (one reliability study and three main 
studies) were included in this thesis. LE was used as the clinical model of 
musculoskeletal pain where there is already evidence for the MIPM having an 
effect. This facilitated valid comparisons of the analgesia produced by CPM 
and MIPM. The protocols for CPM and MIPM assessment were identified with 
reference to existing literature. For CPM the analgesic response was induced 
with a noxious cold pressor test (CPT) whereas the MIPM analgesic response 
was induced by a pain-free oscillatory cervical lateral glide (CLG) technique. 
Analgesic responses were primarily measured using pressure pain threshold 
(PPT) at local and distant sites by a single investigator. PPT was assessed at 
baseline, during, and post CPT for CPM and CLG for MIPM. For MIPM, 
secondary outcome measures of pain free grip (PFG) and upper limb 
neurodynamic test with radial nerve bias (ULNDT-RN) were also measured 
pre and post CLG.   
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An initial reliability study (N=11 and N=10) was conducted to establish the 
reliability of repeated PPT measures at the wrist and elbow (Study 1, Chapter 
3). It also aimed to assess the pattern of CPM analgesia over a one hour period 
to calculate the time required for PPT to return to baseline value. This was 
important to determine the washout period between the CPM and MIPM 
assessment protocols applied in Studies 2 - 4. The data from this study were 
also used to calculate the minimal sample size required for each main study. 
For the wrist test site only, the PPT test-retest protocol was conducted 
followed by the CPM assessment protocol with a 10 minute rest period in 
between in a single testing session. For the elbow test site, the PPT test-retest 
protocol was conducted on a separate session. In the PPT test-retest protocol, 
PPT was measured at baseline, at 1 minute, at 2 minutes and at 5 minutes over 
the wrist and elbow test sites over 2 days. In the CPM assessment protocol, 
PPT measures were obtained over the wrist test site only at baseline pre CPT, 
at 1 minute during CPT, and at 1 minute, 5 minutes, 15 minutes, 30 minutes, 
45 minutes, and 60 minutes post CPT. The study demonstrated an excellent 
reliability for PPT at the wrist and elbow test sites with intra-class correlation 
coefficients (ICCs) of 0.991 and 0.986, respectively. Linear mixed model 
analysis showed that the CPM analgesic effect returned to baseline value after 
5 minutes post immersion. The PPT data from the elbow test site (i.e. effect 
size difference) were included in the sample size calculation.  
Next, a quasi-experimental single-group repeated measures study (N=70) was 
conducted with the main aim to determine the association between CPM and 
MIPM analgesia in people with LE (Study 2, Chapter 4). A secondary aim was 
to determine whether there was a difference in the level of MIPM analgesia 
between CPM responders and non-responders, defined as those individuals 
who had a post-stimulus increase in PPT greater than the standard error of the 
mean for the sample. The CPM assessment protocol was applied first, followed 
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by the MIPM assessment protocol in a single session with a 15 minute rest 
period in between. PPT measures were collected from the wrist and elbow of 
the symptomatic LE side pre, during, and post the cold pressor test (CPT) for 
CPM and at the same time-points for the cervical lateral glide (CLG) 
mobilisation for MIPM. Pre and post CLG, PFG and ULNDT-RN were also 
assessed. Participants were assigned post hoc into two CPM groups: 
responders (n=62) and non-responders (n=8), using a previously calculated 
literature based cut-off value of meaningful CPM effect. Linear mixed models 
were used to analyse the differences in CPM and MIPM analgesic responses, 
with participants showing a significant increase in PPT, PFG and ULNDT 
measures (i.e. higher levels of analgesia) both during and post CPT and CLG 
(p<0.001 for all). There were significant moderate and positive partial 
correlations (r: 0.40–0.54, p<0.001) between CPM and MIPM analgesia 
(measured by PPT) over different time points measured at the two test sites. 
Univariate regression analysis showed that CPM analgesia significantly 
predicted MIPM analgesia (adjusted R2: 73%-85%, p<0.001). CPM responders 
demonstrated significantly higher levels of analgesia during (wrist: p=0.033, 
elbow: p=0.021) and post (wrist: p=0.017, elbow: p= 0.014) MIPM compared to 
CPM non-responders, although with no significant between-group differences 
in PFG (p=0.083) and ULNDT-RN (p=0.653). The association between CPM 
and MIPM analgesia suggests that the two forms of EA are related and may 
potentially be mediated by similar underlying neurophysiological 
mechanisms.  These study findings laid the foundations for the subsequent 
two studies (Studies 3 and 4), where the EA systems were manipulated using 
psychological and physical interventions.  
For Study 3 (Chapter 5), a randomised between-group controlled trial (N=68) 
was conducted to evaluate the influence of an enhanced research assistant / 
participant empathetic interaction on CPM and MIPM analgesia in 
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participants with LE. Participants were randomly allocated to either the 
enhanced empathetic or the neutral interaction group (n=34 each group). All 
participants were initially evaluated for CPM and MIPM analgesia (using the 
same assessment protocols applied in Study 2) in a single session prior to the 
main test session. For 15 minutes at the start of the main test session and in the 
15 minute rest between CPM and MIPM protocols, participants received either 
enhanced empathetic and positive or neutral (business-like) interactions from 
a professionally trained role play actor, who performed the role of a research 
assistant (RA). All CPM and MIPM assessment was completed in a neutral 
manner by the main investigator, who only entered the research room for 
these aspects of the study. At the end of the session, participants were asked 
to complete the Consultation and Relational Empathy (CARE) measure to rate 
the overall interaction they experienced with the RA. The RA was similarly 
asked to evaluate the quality of the interactions they conveyed using a quality 
of session scale. The enhanced empathetic interaction group reported 
significantly higher CARE measure scores (p<0.001) than those reported by the 
neutral interaction group, signifying a clear distinction in participant 
perception between both types of interaction. Linear mixed models were used 
to assess any differences in CPM and MIPM responses between interaction 
groups. Participants in both groups showed a significant increase in all PPT 
measures for both CPM and MIPM and in MIPM secondary outcome 
measures (p<0.001 for all). However, the enhanced empathetic interaction 
group demonstrated significantly higher levels of analgesia than the neutral 
interaction group during (wrist: p<0.001, elbow: p<0.001) and post CPM (wrist 
p=0.002, elbow: p=0.002) and post MIPM (wrist p=0.004, elbow: p<0.001) test 
sites. There were no significant differences between groups in PFG (p=0.398) 
and ULNDT-RN (p=0.668) measures. The correlation data also suggested that 
enhanced empathetic interaction positively influences CPM and MIPM 
analgesic responses to a similar extent in people with LE. 
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Finally, in Study 4 (Chapter 6), a randomised between-group controlled trial 
(N=68) was conducted to establish the immediate effect of two different 
aerobic exercise intensities on CPM and MIPM analgesia in participants with 
LE. As with the psychological study, this study secondarily investigated the 
association between CPM/MIPM analgesia and aerobic exercise induced 
analgesia (EIA). Participants were randomly allocated to one of two aerobic 
exercise intensity groups, moderate and high (n=34 per group). These aerobic 
exercise intensities were determined based on individual age-related target 
heart rate (HR): the moderate group exercised at 50% of maximum HR while 
the high group exercised at 75% maximum HR. A cycle ergometer with linked 
HR monitor was used. Each participant was required to complete two 15 
minute cycling sessions at either moderate or high intensity depending on 
group allocation, on two separate days with a three day rest in between. 
Immediately after each aerobic exercise session, all participants were 
individually assessed for either CPM or MIPM in a random order. CPM and 
MIPM protocol followed the same methodology used in Study 2. Data were 
analysed using linear mixed models, partial correlations, and univariate 
regression. Participants in both groups showed a significant increase in all PPT 
measures for CPM and MIPM at both test sites and at both time-points during 
and post (all p<0.001) as well as for PFG (p<0.001), and ULNDT-RN (p<0.001). 
There were also significant differences in EIA between the exercise groups, as 
measured by the change in PPT from pre to post aerobic exercise (p<0.001 for 
all). However, the high aerobic intensity group demonstrated significantly 
higher levels of analgesia in all PPT measures for CPM and MIPM at the wrist 
(p<0.001) and elbow (p<0.001), and for ULNDT-RN (p<0.001), although not for 
PFG (p=0.052). There were significant large and positive partial correlations 
between EIA and CPM (r: 0.90–0.93, p<0.001) and between EIA and MIPM 
analgesia (r: 0.68–0.86, p<0.001) over different time points measured at both 
test sites.  EIA was a significant predictor of both CPM analgesia (adjusted R2: 
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92%-95%) and MIPM analgesia (adjusted R2: 73%-93%). The study showed that 
an acute bout of high intensity aerobic exercise significantly enhanced the 
analgesic effect of CPM and MIPM in a patient population with LE. The 
correlational results also may suggest that aerobic exercise, CPM and MIPM 
activate similar descending inhibitory mechanisms to mediate their analgesic 
effects.  
The above studies found that CPM and MIPM have similar patterns of 
analgesic responses that are significantly associated and comparably 
manipulated by an enhanced empathetic interaction and by aerobic exercise 
interventions. These findings show that CPM and MIPM provide sufficient 
stimulus for activation of endogenous descending pain inhibitory systems and 
so may share similar neuro-physiological mechanisms. There may also be an 
overlap with EIA. The results highlight the potential utility of CPM in 
forecasting MIPM outcomes. This may improve our knowledge about the 
nature of MIPM analgesia and therefore guide clinical practice towards more 
effective treatment. The final two studies show that enhanced empathetic 
interaction and aerobic exercise both potentiate the CPM and MIPM analgesic 
effects in a patient population with LE. This suggests that, in a clinical setting, 
analgesia may be enhanced by ensuring that a patient has a positive and 
empathetic experience when visiting a clinician and adding an aerobic element 
before other physical interventions.  
It must be noted that these investigations did not attempt to investigate the 
analgesic effects of CPM and MIPM analgesia over a longer follow-up period 
and for optimal clinical value this needs to be studied. Follow-up studies with 
other chronic pain conditions would also clarify whether these finding can be 
more widely applied. In addition, given the evidence regarding the likely 
involvement of serotonergic and noradrenergic systems in the endogenous 
descending inhibitory pathways in CPM and MIPM analgesia, it is anticipated 
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that the CPM and MIPM analgesia might be further enhanced using a 
pharmacological intervention that accesses the same pain modulatory systems 
(e.g. duloxetine). Further research in these areas and future animal studies 
evaluating the mechanisms of both forms of analgesia in a similar manner are 
recommended.     
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 Introduction  
The overall objective of this thesis was to improve our understanding of two 
important forms of endogenous analgesia (EA): that induced by conditioned 
pain modulation (CPM) and by manipulation induced pain modulation 
(MIPM). Secondarily, the aim was to determine whether these analgesic 
responses were associated, and whether they were similarly influenced by 
psychological and physical interventions designed to manipulate the analgesic 
responses.  
MIPM encompasses the pain relieving effects of manual therapy interventions 
applied by the clinician to improve range of movement, reduce resistance, and 
decrease pain (Schmid et al. 2008). It has been effectively used in the treatment 
of various musculoskeletal conditions such as knee osteoarthritis (OA) (Moss, 
Sluka & Wright 2007), hip OA (MacDonald et al. 2006), low back pain (LBP) 
(Childs et al. 2004), neck pain (Garcia et al. 2016; Hidalgo et al. 2017) and lateral 
epicondylalgia (LE) (Vicenzino et al. 2001). Evidence from recent systematic 
reviews supports the effectiveness of manual therapy for reducing pain (Voogt 
et al. 2015) and improving clinical outcomes in several musculoskeletal 
conditions (Clar et al. 2014; Coulter et al. 2018; Heiser, O'Brien & Schwartz 
2013; Martins et al. 2016; Xu et al. 2015). It has been hypothesised that MIPM 
exerts its analgesia by activating endogenous descending inhibitory 
mechanisms (Wright 1995), in which serotonergic and noradrenergic systems 
are likely to be key players (Skyba et al. 2003). 
CPM is commonly described as ‘pain inhibits pain’ (Lebars, Dickenson & 
Besson 1979). Growing evidence suggests that CPM is a reliable measure of 
EA and potentially a predictive tool for pain related therapeutic outcomes 
(Kennedy et al. 2016). CPM assessment typically involves application of a 
measurable noxious test stimulus before and during and/or after a painful 
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conditioning stimulus applied remotely. CPM can be evoked using a range of 
different painful conditioning stimuli including heat, cold, electrical, 
ischaemic and others (Yarnitsky 2015). There is also compelling evidence from 
animal (Bannister et al. 2017; Bannister et al. 2015) and human (Niesters et al. 
2014; Yarnitsky et al. 2012) studies that CPM-induced analgesia is mediated 
via supra-spinal descending mechanisms involving serotonergic and 
noradrenergic systems. It is therefore suggested that CPM and MIPM 
analgesia may share common neurophysiological mechanisms. This raises 
queries as to whether they stimulate the same or different systems, whether 
individuals who respond well to CPM will also show a good response to 
MIPM, and whether their analgesic effects are positively enhanced when 
combined with additional interventions that may influence response. 
Chapter 2 considers the salient aspects of literature pertaining to CPM and 
MIPM analgesia and evidence of centrally mediated descending 
neurophysiological mechanisms, relevant methodological considerations, and 
factors influencing analgesic responses. This chapter particularly considers the 
evidence for shared descending pain inhibitory mechanisms that potentially 
mediate both forms of EA.   
The thesis then describes a series of experimental studies (Figure 1.1) that 
evaluate the analgesia associated with CPM and MIPM using well-established 
assessment protocols. Both CPM and MIPM assessment protocols used 
pressure pain threshold (PPT) as the main outcome measure to quantify the 
immediate analgesic responses elicited during each test protocol. It was 
important therefore to conduct an initial reliability study (Study 1, Chapter 3) 
to ensure that repeated PPT measures were not influenced by random errors 
that could potentially pose a threat to the studies’ validity (Fitzmaurice 2002). 
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In the subsequent investigations (Studies 2 and 3) CPM and MIPM assessment 
protocols were applied in a single session. An additional aim of the first study 
was therefore to determine the duration of a measurable CPM effect to assist 
in determining test order for CPM and MIPM as well as the time required for 
suitable rest period between protocols in order to ensure no confounding 
carry-over effects. In addition, the data from the first study were essential to 
calculate the minimum sample size required in subsequent studies. 
Chapter 4 (Study 2) describes a quasi-experimental one-group study (N=70) 
investigating the association between CPM and MIPM analgesia in a sample 
population with LE. The study also compared the levels of MIPM analgesia 
between those who exhibited a CPM response (CPM responders) and those 
who did not exhibit CPM response (CPM non-responders).  
In the subsequent two studies (Studies 3 and 4), both CPM and MIPM 
analgesia were manipulated using two experimental paradigms which aimed 
to enhance descending pain modulation. Chapter 5 (Study 3) reports on a 
randomised between-group controlled trial (N=68) comparing the effect of 
enhanced empathetic or neutral interactions on CPM and MIPM analgesia in 
participants with LE (Study 3). In Chapter 6 (Study 4), a randomised between-
groups controlled trial (N=68) was carried out to evaluate the influence of 
moderate versus high intensity aerobic exercise on CPM and MIPM analgesia 
also in a patient population with LE.  This study also assessed whether there 
was an association between CPM/MIPM analgesia and aerobic exercise-
induced analgesia (EIA).  
Chapter 7 (the final chapter) outlines the overall findings of the studies 
included in this thesis, addresses areas for future research and summarises the 
original contribution to knowledge offered by this work.
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Figure 1.1  Methodologies and main aims of the studies. CPM: Conditioned Pain Modulation, MIPM: Manipulation Induced Pain Modulation, LE: Lateral 
Epicondylalgia, CPT: Cold Pressor Test, PPT: Pressure Pain Threshold, CLG: Cervical Lateral Glide, PFG: Pain Free Grip, ULNDT-RN: Upper Limb 
Neurodynamic Test-Radial Nerve bias, EIA: Exercise-induced Analgesia. 
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 Background 
 Central Pain Modulation  
Our understanding about the neurophysiological mechanisms of pain 
modulation is relatively well established and is known to involve the 
interaction between multiple cortical and spinal pathways. Peripheral 
nociceptive signals are primarily transmitted via nociceptive afferent neurons 
(i.e. A and C fibres) to the spinal cord dorsal horn (Millan 2002).  Myelinated 
A  fibres convey immediate and well-localised pain whereas unmyelinated C 
fibres transmit dull aching and more diffuse pain (Yam et al. 2018). These 
nociceptive neurons form synapses with second order neurones in the spinal 
cord to transmit nociceptive stimuli to the brain for processing. This process 
leads to activation of multiple neural structures and networks to modulate 
nociception (Millan 2002; Yam et al. 2018). The descending modulation 
systems exert inhibitory or facilitatory effects on the incoming nociceptive 
signals at the dorsal horn of the spinal cord to attenuate or augment perception 
of pain, respectively (Heinricher et al. 2009; Ossipov, Dussor & Porreca 2010). 
The net influence of descending modulation on the dorsal horn is mediated by 
the equilibrium of inhibition and facilitation (Calvino & Grilo 2006). 
The periaqueductal gray (PAG) region in the brain is believed to play a central 
role in modulation of pain at the spinal cord dorsal horn via relays in the 
rostral ventromedial medulla (RVM) (Kwon et al. 2014), which in turn 
provides direct descending projections to the spinal cord dorsal horn (Porreca, 
Ossipov & Gebhart 2002). Evidence suggests that PAG-RVM system pain 
modulation is ‘bidirectional’, since controlling both pain facilitation and 
inhibition is a major part of its function (Ossipov, Morimura & Porreca 2014). 
RVM bidirectional modulation is mainly orchestrated via two types of pain 
modulatory neurons (Fields, Heinricher & Mason 1991): ON-cells and OFF-
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cells that are thought to activate descending nociceptive facilitation and 
inhibition, respectively (Carlson et al. 2007). It has also been found that 
descending modulation of pain is mediated in the spinal cord dorsal horn 
through release of the neurotransmitters serotonin (5-hydroxytryptamine; 5-
HT) (Klintschar 2012; Ossipov, Morimura & Porreca 2014) and noradrenaline 
(NA) (Cui et al. 1999). Depending on the type of spinal receptors activated, 5-
HT can induce excitatory or inhibitory effects (Cui et al. 1999) via presynaptic 
or postsynaptic mechanisms (Kwon et al. 2014). Activation of serotonergic 5-
HT2 and 5-HT3 receptors mediates pain facilitation, while activation of 5-HT7 
and 5-HT2A receptors induces inhibition (Bannister & Dickenson 2017). NA 
has also been shown to be both a facilitatory and inhibitory neurotransmitter 
(Bannister & Dickenson 2017). NA can facilitate nociception through 
activation of spinal α1-adrenergic receptors (Budai, Harasawa & Fields 1998) 
but can also induce pain inhibition via activation of spinal α2-adrenergic 
receptors (α2- AR) (Pertovaara 2006). The NA pathway can also facilitate pain 
inhibition by inhibiting presynaptic release of excitatory neurotransmitters 
from the central terminals of primary nociceptors and by supressing 
postsynaptic spinal pain-relay neurons (Pertovaara 2006).  
Research has also shown that several cortical centres, the so called “pain 
matrix” (Apkarian et al. 2005), are activated in response to nociceptive stimuli 
(Mazzola et al. 2012). This matrix interacts with the PAG-RVM system to 
influence pain modulation (Heinricher et al. 2009). For example: the primary 
(S1) and secondary (S2) somatosensory cortices are involved in the sensory 
discrimination of pain (Lithwick, Lev & Binshtok 2013); the amygdala is 
involved in pain related to negative emotions and memories (Li et al. 2013); 
the anterior cingulate cortex (ACC) is involved in affective and attentional 
elements of pain (Peyron, Laurent & Garcia-Larrea 2000) as well as empathy 
(Lamm, Decety & Singer 2011) and social (exclusion) pain (Yanagisawa et al. 
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2011). The insula, which plays a role in the emotional experience of pain, 
works with the ACC in feeling empathy for another’s pain (Lamm, Decety & 
Singer 2011), and with somatosensory cortices in the sensory discrimination 
component of pain (Peyron, Laurent & Garcia-Larrea 2000). The insula may 
also have a role in the coping element of pain (Lithwick, Lev & Binshtok 2013). 
The prefrontal cortex (PFC) is involved in the emotional component and the 
cognitive assessment of pain (Lithwick, Lev & Binshtok 2013). Pain processing 
therefore involves multiple cortical areas that interact to determine whether 
the nociceptive stimulus is painful or not, and the degree of pain that is 
experienced.   
 Conditioned Pain Modulation  
Central pain modulation encompasses multiple pain inhibitory and 
facilitatory mechanisms that modulate the perception of noxious stimuli. The 
outputs of the central pain pathways responsible for pain inhibition are 
broadly termed endogenous analgesia (EA).  
One of the most widely investigated EA mechanisms is generally termed 
diffuse noxious inhibitory control (DNIC). This is the widely recognized 
concept that pain inhibits pain (Reinert, Treede & Bromm 2000). The term was 
first coined by Lebars, Dickenson and Besson (1979) during their early 
experiments on animals. They observed that inhibition of spinal cord dorsal 
horn neurons and trigeminal nuclei neurons occurred in response to distantly 
applied nociceptive stimuli in sedated rats. In 1989, Talbot, Duncan and 
Bushnell showed that a DNIC-like mechanism was also present in humans. 
Research has since referred to this mechanism using a range of different terms, 
such as DNIC, DNIC-like, pain-evoked hypoalgesia, counter-irritation, 
heterotopic noxious counter-stimulation. For consistency, Yarnitsky and 
colleagues (2010) recommended the use of Conditioned Pain Modulation 
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(CPM) as a term to distinctly define the DNIC phenomenon in humans and to 
limit the use of DNIC to describe a specific lower brainstem 
neurophysiological mechanism in animal research. Therefore, in the following 
section, for clarity the term DNIC will refer to the EA phenomenon in animals 
while CPM will be used to describe the human EA phenomena.  
 Neurophysiology 
There is considerably more literature that explore the neurophysiology of 
DNIC than CPM.  DNIC involves a cortically influenced spinal-bulbo-spinal 
neural circuit acting through inhibition of wide dynamic range (WDR) 
neurons in the spinal dorsal horn (Lebars, Dickenson & Besson 1979). A 
noxious conditioning stimulus is transmitted via Aδ and C fibres to the spinal 
WDR neurons that send supra-spinal input to the subnucleus reticularis 
dorsalis (SRD) in the caudal medulla (Lewis, Rice & McNair 2012). The SRD 
directs a diffused descending inhibition via the dorsolateral funiculi to the 
dorsal horn of the spinal cord to inhibit WDR neurons across multiple spinal 
levels (Lewis, Rice & McNair 2012; Villanueva, Bouhassira & LeBars 1996), 
which in turn inhibits the painful stimulus. 
It has been shown that DNIC exerts its hypoalgesic effect on pain via an 
opioidergic central pathway. Willer, Lebars and Debroucker (1990) used 
naloxone hydrochloride to investigate the involvement of the opioidergic 
system in DNIC among 9 healthy participants using electrical stimuli as a test 
stimulus. The stimuli were applied distally on the right sural nerve, with 
noxious hot water bath immersion of the non-dominant hand used as a 
conditioning stimulus. Two minutes post hot water immersion, there was a 
complete inhibition of the RIII reflex in the biceps femoris that took 6-9 
minutes to return to its pre-testing level. Participants were then randomly 
allocated into either a naloxone or saline group. Five minutes post intravenous 
9 
 
injection of naloxone, the analgesic effects were totally blocked. These anti-
analgesic effects continued till 50 minutes post injection.  Saline injection, 
however, produced no such blocking of DNIC-induced analgesia. These 
observations were similar to study findings with rats (Lebars et al. 1981), 
where DNIC was reduced after the naloxone administration. However, 
several studies reported that CPM is partially affected (Sprenger, Bingel & 
Buchel 2011) or completely unaffected (Edwards, Ness & Fillingim 2004; 
Hermans et al. 2018; Peters et al. 1992) by naloxone suggesting non-opioid pain 
mechanism.  Collectively, these data suggest the findings of the involvement 
of the endogenous opioid system in the expression of DNIC analgesia are 
mixed.  
It has also been postulated that DNIC exerts its effect via rostral brainstem 
networks (Villanueva 2009) mediated by serotoninergic (Bannister et al. 2017) 
and noradrenergic (Bannister et al. 2015) descending neurons. The RVM, 
including the nucleus raphe magnus (NRM) serotonergic cells, receives direct 
inputs from the PAG and then sends inhibitory signals downwards to WDR 
neurons (in laminae I, II, V) in the spinal dorsal horn (Calvino & Grilo 2006), 
where WDR neuron inhibition is mediated by neurons releasing the 
neurotransmitters 5-HT (Liu et al. 2007) and NA (Pertovaara 2006). 5-HT may 
induce an inhibitory effect on pain through direct action on the second order 
neurons (Radhakrishnan et al. 2003).  It can also facilitate spinal interneurons 
release of several inhibitory mediators, which may inhibit release of glutamate 
from the primary afferent neurons, and consequently lead to pain inhibition 
(Yoshimura & Furue 2006). The NA inhibitory mechanisms have been outlined 
above (see central pain modulation).   
Recent pharmacological studies on animals provide evidence for the 
important role of serotoninergic and noradrenergic inhibitory pathways in 
DNIC. Bannister et al. (2015) investigated the DNIC effect in naïve (n=12), 
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sham ligated (n=6) and spinal nerve ligated (SNL) (n=18) rats. DNIC was 
measured through application of von Frey filaments on the hind paw during 
ipsilateral noxious ear pinch. The resulting neuronal action potentials were 
recorded for 5 seconds before and during ear pinch, with maximum reduction 
in WDR neuronal firing representing the DNIC effect. The naïve and sham-
operated (control) rats were then injected with spinal atipamezole (an α2-
adrenergic receptors (AR) antagonist) or subcutaneous yohimbine (an α2-AR 
antagonist) to block the action of α2-AR. The SNL animals (n=18) were injected 
with ondansetron (a 5-HT3 receptor antagonist) to block the 5-HT3 descending 
facilitatory effect. The DNIC effect was assessed at baseline and after drug 
administration. At baseline (pre-injection), the control groups showed a 
significant reduction in neuronal response indicating an efficient DNIC effect, 
but it was absent in the SNL group. While the DNIC effect was abolished after 
injecting the control with atipamezole or yohimbine, it was restored in SNL 
rats in response to topical ondansetron injection, to a degree similar to that 
observed in the control.  The authors then attempted to augment the inhibitory 
noradrenergic control in the SNL rats through intrathecal reboxetine (a 
norepinephrine reuptake inhibitor, NRI) or systemic tapentadol (an NRI and 
a -opioid receptor (MOR) agonist) administration. The DNIC effect was re-
established after intrathecal reboxetine or systemic tapentadol administration. 
The authors concluded that the DNIC effect was potentially mediated by α2 -
AR (noradrenergic) mechanisms. 
In another experiment, Bannister et al. (2017) investigated the function of 5-
HT in DNIC expression in  sedated naïve (control) and SNL rats using the 
same DNIC protocol they applied in their original study (Bannister et al. 2015). 
The DNIC effect was recorded pre and post administration of the following 
drugs: single application of selective serotonin reuptake inhibitors (SSRIs) 
citalopram or fluoxetine, or joint application of SSRI plus 5-HT7 receptor 
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antagonist SB269970, or SSRI plus α2-AR antagonist atipamezole. Pre drug 
administration, DNIC effect was observed in control, but not in SNL rats. In 
contrast to systematic application, following spinal administration of SNL 
animals with SSRIs citalopram or fluoxetine the DNIC effect was restored. 
When the same animals were then injected with 5-HT7 receptor antagonist 
SB269970, the restored DNIC effect was abolished. Joint application of SSRI 
plus the α2-AR antagonist atipamezole produced no DNIC effect (i.e. no 
significant inhibition of WDR firing). The authors suggested that serotonergic 
5-HT7 receptors were involved in mediating the (inhibitory) effect of DNIC in 
SNL rats after spinal SSRI application. They also proposed that the inhibitory 
effect of DNIC was mediated through α2-AR mechanisms. These findings 
from animal studies suggest the involvement of serotonergic and 
noradrenergic mechanisms in the pain modulation of DNIC in animal models. 
Similar to DNIC in animals, there is robust pharmacological evidence that 
CPM in humans exerts its action via serotoninergic and noradrenergic 
inhibitory pathways. Duloxetine, a selective 5-HT and NA reuptake inhibitor, 
produces its analgesic effects by inhibiting the re-uptake of 5-HT and NA in 
the descending pain inhibitory neurons, thereby increasing the concentration 
of NA and 5-HT available to inhibit nociceptive transmission in the spinal cord 
(Iyengar et al. 2004). Yarnitsky et al. (2012) examined the relationship between 
CPM effect and duloxetine efficacy in thirty diabetic neuropathy patients. 
CPM was measured using contact heat and von Frey filament as test stimuli 
and hot water immersion as a conditioning stimulus. Participants received one 
week of placebo, followed by one week of 30mg/day duloxetine, and then 4 
weeks of 60 mg/day. Overall, pain scores during contact heat significantly 
improved with duloxetine. However, when the results of individual 
participants were analysed, patients with less efficient CPM showed a better 
improvement with the drug than those patients with efficient CPM, who 
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showed no benefit from duloxetine. The authors proposed that duloxetine 
produced its effect among patients with inefficient CPM through reinstating 
the descending inhibitory control mechanism which was intact among those 
with efficient CPM.   
Another study by Niesters et al. (2014) investigated the effect of Tapentadol, a 
combined MOR agonist and NRI, on CPM in diabetic polyneuropathy (DPN) 
patients.  To induce CPM, heat pain applied on the non-dominant forearm was 
used as the measurable test stimulus and cold water immersion of the foot and 
lower leg was used as the conditioning stimulus. Patients were randomly 
allocated to Tapentadol therapy or placebo for 4 weeks. CPM was measured 
at baseline and on the last day of week 4.  Pain scores were monitored on a 
weekly basis over 4 weeks. At baseline, no CPM effect was detected in either 
group. After 4 weeks, both groups showed a significant CPM effect, with a 
greater pain relief (i.e. reduction in pain scores) and greater CPM effect 
reported for those receiving Tapentadol. The authors concluded that 
Tapentadol restored CPM effect through stimulation of descending inhibitory 
systems, in which the noradrenergic system plays a key role.  
It has been proposed that CPM in humans is mediated by autonomic 
cardiovascular mechanisms. Chalaye et al. (2013) demonstrated that CPM 
effect was positively associated with blood pressure increase in response to 
the cold pressor test (CPT) in healthy pain free individuals. A similar finding 
was also reported in patients with fibromyalgia (FM) (Chalaye et al. 2014), 
indicating that a baroreceptor mechanism is possibly involved in producing 
the CPM response.   
Recent human imaging research demonstrated that CPM expression is 
influenced by several higher cortical centres (Brock et al. 2012; Piche, 
Arsenault & Rainville 2009; Sprenger, Bingel & Buchel 2011) such as S1, PFC, 
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and ACC (Knudsen et al. 2018), thalamus, insula, S2, medulla, and the 
amygdala (Sprenger, Bingel & Buchel 2011). La Cesa et al. (2014) examined the 
association between the cold pressor test (CPT) and PAG activation among 
twelve healthy participants using functional magnetic resonance imaging 
(fMRI).  The CPT was applied to the left hand while the participants were lying 
flat in the fMRI machine. In response to the CPT, fMRI revealed a prominent 
co-activation of PAG bilaterally and other central neural structures, including: 
bilateral, middle and superior frontal gyrus, ACC and thalamus, left insula, 
right inferior frontal gyrus, and left inferior temporal gyrus. These results 
indicate that several cortical structures are involved in the perception of cold 
pressor pain and in mediating the CPM-induced hypoalgesia.    
 CPM Efficiency  
CPM testing typically involves application of a painful ‘test stimulus’, during 
or after a distant painful ‘conditioning stimulus’ (Nir & Yarnitsky 2015). CPM 
effect is defined as the difference between the ‘test stimulus’ values before and 
during or after the ‘conditioning stimulus’ application. Many studies have 
demonstrated that a normal response involves a reduction in the painfulness 
of the test stimulus following application of the conditioning stimulus 
(Bouhassira et al. 2003; Graven-Nielsen et al. 2002; Reinert, Treede & Bromm 
2000). In the case of pressure pain threshold (PPT), a positive CPM response is 
represented by an increase in the PPT measure. It is proposed that this reflects 
a normally efficient CPM. 
Lewis, Rice and McNair (2012), in their systematic review and meta-analysis, 
concluded that several chronic pain conditions are associated with an 
inefficient CPM response. Patients with irritable bowel syndrome (IBS) 
demonstrated an increased heat pain (test stimulus) sensitivity in the hand in 
response to foot cold water immersion (conditioning stimulus) (King et al. 
14 
 
2009). A similar response was observed in FM patients (Julien et al. 2005). In 
these cases, it is almost a reverse response of hyperalgesia rather than 
analgesia following the conditioning stimulus. Less efficient CPM was also 
highly correlated with more reports of past pain experience in pain-free 
healthy individuals (Edwards, Fillingim & Ness 2003). Yarnitsky (2015) 
acknowledges that the less efficient CPM seen in chronic pain conditions 
appears to imply a dysfunctional pain modulation system. However, he also 
proposes that that the less efficient CPM in chronic pain syndromes is instead 
the by-product of a pain modulatory system that is already working optimally, 
meaning that no further increase in CPM can be demonstrated (Yarnitsky 
2015).  
2.4.1. Protocols for testing CPM   
The CPM literature has described different CPM testing protocols (Pud, 
Granovsky & Yarnitsky 2009). Test stimulus modalities can include contact 
heat, mechanically-induced pressure, electrical stimulation, chemical stimuli 
(Nir & Yarnitsky 2015; Yarnitsky 2015) or ischemic pain (Fujii, Motohashi & 
Umino 2006). Different pain measurement parameters have also been used 
such as pain threshold, rating of supra-threshold pain and rating of temporal 
summation pain (Pud, Granovsky & Yarnitsky 2009). With respect to 
conditioning stimuli, these may include contact heat, or the most frequently 
used cold water immersion, the so called cold pressor test (CPT), or hot water 
immersion (Nir & Yarnitsky 2015; Pud, Granovsky & Yarnitsky 2009; 
Yarnitsky 2015). The most pronounced analgesic effect was observed in CPM 
paradigms using cold water immersion pain (or cold pressor test) to inhibit a 
test stimulus of PPT (Oono et al. 2011) and therefore this protocol was used in 
the current research. The test stimulus can be applied alone and then 
concurrently with the conditioning stimulus (parallel protocol), or directly 
after the conditioning stimulus ends (sequential protocol). The test stimulus is 
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applied at an anatomically distant site from the conditioning stimulus, 
preferably using one upper and lower limb site (ipsilateral or contralateral), 
though using only upper limb sites is acceptable and may be more practical 
(Yarnitsky 2015). 
Lewis et al. (2012) have shown that CPM testing is a reliable measure for EA 
function using the CPT as the conditioning stimulus and PPT as the test 
stimulus. In their systematic review, Kennedy et al. (2016) have also shown 
that CPM using CPT and PPT is reliable, with a good (ICC: 0.6 – 0.75) to 
excellent (ICC: >0.75) inter-session reliability that was reported in 50% of 
studies. They concluded that the reliability of measuring CPM response is 
primarily determined by methods of CPM testing, stimulation parameters, 
and study population.  
2.4.2. Cognitive and psychological influences and CPM 
There is evidence to suggest that manipulation of cognitive elements can 
modify CPM effect. Nir et al. (2012) investigated the effect of expectancy 
reassurance on CPM in 48 healthy men. Participants were randomly allocated 
into four groups. Group 1 and 2 represented placebo and nocebo groups, 
respectively. Group 3 and 4 served as controls (for groups 1 and 2) and 
received no cognitive manipulation. Contact-heat applied to the dominant 
forearm was used as a test stimulus, and hot water immersion applied to the 
non-dominant (left) hand was used as a conditioning stimulus. Both placebo 
and nocebo groups had an anaesthetic cream applied to the left hand. The 
placebo group was informed that the cream would reduce the conditioning 
stimulus heat pain but the nocebo group was informed that the cream would 
increase the heat pain. Group 3 and 4 underwent the same protocol as groups 
1 and 2 but without cognitive manipulation.   CPM response was evaluated 
before and post cognitive manipulation. Compared to other groups, the 
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placebo group showed a significant reduction in the conditioning stimulus 
pain, and therefore a CPM effect. In contrast, the nocebo group significantly 
demonstrated an increase in the conditioning stimulus pain so no CPM effect 
and a hyperalgesic response. It therefore appears that CPM analgesic effect is 
influenced by the perceived painfulness of the conditioning stimulus pain 
instead of its actual pain intensity. This also suggests that CPM effect is open 
to manipulation of the person’s expectations. 
Cormier, Piche and Rainville (2013) likewise examined the influence of 
expectations on CPM anti-nociceptive effect among 64 healthy volunteers. In 
this study, CPM was assessed using electrical stimulations of the right sural 
nerve as a test stimulus and a noxious cold pack applied on the contralateral 
forearm as a conditioning stimulus. The participants were equally allocated 
into 4 groups: control, expectation, hyperalgesia, or hypoalgesia. The control 
group received simple instructions. The expectation group were asked to rate 
the extent that they thought the intensity of electrical stimulus pain would be 
increased or decreased in response to cold pack application. The hyperalgesia 
group was clearly instructed that the conditioning cold pack would increase 
the electrical test stimulus pain whilst the hypoalgesia group was informed 
that the cold pack would reduce the electrical stimulation pain. A priori 
expectations were significantly correlated with the extent of CPM analgesia 
produced. Compared to all other groups, the hyperalgesia group 
demonstrated a significant increase in test stimulus pain in response to the 
suggestion of increased pain. The hypoalgesia group CPM analgesia was 
comparable to that observed in expectation and control groups. Thus the 
verbally initiated expectations via suggestions was only and significantly 
different in the hyperalgesia groups.  The lack of power could explain these 
study findings. Therefore, this study highlights the influence of cognitive 
17 
 
manipulation by suggestion on CPM responses that still require further 
research to fully uncover. 
Gougeon et al. (2016) also studied the role of empathy in influencing CPM 
during three experimental conditions: pain condition, self-observation 
condition, and spouse-observation condition. In the pain condition 
participants were video recorded while immersing their forearm in a cold 
water bath (7°C). They were asked to rate their pain and unpleasantness levels 
2 minutes post immersion on 0-100 scale. The participants were then randomly 
assigned into either self- or spouse-condition on two separate days. In the self-
observation condition, the forearm was immersed in a warm water bath (20°C) 
(not likely to directly induce CPM) for 2 minutes while watching themselves 
in the film recorded on the first day. In addition to rating their average pain 
and unpleasantness levels, pain rating during seeing themselves in pain in the 
video was recorded. In the spouse-observation condition, participants 
observed the video of their spouse’s pain experience while immersing their 
forearm in warm water. Again, the participants rated the average pain and 
unpleasantness levels of themselves and of the person they watched in the 
video. Both self-observation and spouse-observation conditions showed a 
significant CPM effect, even in the absence of a painful conditioning stimulus. 
Amongst the female participants only, high empathy responses correlated 
with greater CPM effect.  
Several studies have investigated the association between psychological traits 
and CPM response, although the results are inconsistent. Weissman-Fogel, 
Sprecher and Pud (2008) found a significant correlation between 
catastrophizing personality and reduced CPM in healthy individuals. Similar 
findings were reported by Goodin et al. (2009) that catastrophizing coexisted 
with inefficient CPM. In another study, Goodin et al. (2013) found a strong 
correlation between higher reports of optimism and more efficient CPM.  
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However, Nahman-Averbuch et al. (2016b) demonstrated no significant 
correlation between anxiety and catastrophizing levels and CPM effect. They 
also found that other factors such as novelty seeking and reward dependence 
had no influence on CPM, but harm avoidance trait was strongly correlated 
with reduced CPM effect. Granot et al. (2008) also investigated the effect of the 
personality traits of anxiety and catastrophizing on CPM-induced analgesia. 
They found no effect of anxiety and catastrophizing levels on the magnitude 
of CPM analgesia induced. These studies therefore showed inconsistent 
findings on the influence of personality traits on CPM efficiency.  
Nahman-Averbuch et al. (2016a) have recently conducted a thorough meta-
analysis using 37 studies to explore the association between CPM and 
personality factors of anxiety, depression and catastrophizing in both pain and 
pain free participants. The primary analysis showed no significant 
associations between CPM and these psychological factors but the secondary 
analysis interestingly found a specific correlation between test stimuli used in 
CPM testing and individual psychological factors. Pressure stimulus was 
associated with anxiety, heat stimulus with depression, and electrical stimulus 
with pain catastrophizing. The authors attributed this modality-specific 
correlation to the multifaceted nature of CPM, in which several mechanisms 
mediate its effect, such as noradrenergic and serotonergic, cortical, and 
autonomic systems.   
2.4.3. Aerobic exercise and CPM   
The effect of exercise on reducing pain is widely understood. The 
phenomenon was originally investigated by Black et al. (1979) and it has been 
described in both animals and humans (Koltyn 2000). Exercise has been also 
been shown to be an effective modality in the management of pain in several 
chronic conditions, such as FM (Busch et al. 2007), chronic neck pain, OA, RA, 
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and chronic low back pain (CLBP) (Geneen et al. 2017). Moreover, exercise has 
been shown to be effective in preventing recurrences of CLBP (Choi et al. 2010) 
and limiting the development of chronic musculoskeletal pain conditions 
(Landmark et al. 2013).    
The inhibitory effect of exercise on pain perception is called exercise induced 
analgesia (EIA) (Koltyn 2002). EIA has been observed in response to several 
types of exercise, including aerobic exercise (Hoffman et al. 2007), isometric 
exercise (Kosek & Lundberg 2003) and resistance exercise (Focht & Koltyn 
2009). EIA is associated with reduced pain sensitivity which is usually 
assessed by PPT (Naugle et al. 2014), cold (Ruble et al. 2005), heat (Staud, 
Robinson & Price 2005; Vaegter et al. 2018), electrical stimuli (Vaegter et al. 
2018) or temporal summation of late thermal sensations (Vierck et al. 2001). 
EIA has been observed at local and remote sites (Naugle, Fillingim & Riley 
2012), with more pronounced analgesia measured at the local sites (Vaegter, 
Handberg & Graven-Nielsen 2014). 
Several mechanisms have been proposed to explain EIA. The endogenous 
opioid analgesia system is the most investigated mechanism that explains the 
widespread EIA following exercise (Naugle, Fillingim & Riley 2012; Vaegter 
et al. 2018). Research demonstrated elevated plasma levels of β-endorphin 
following aerobic exercise in healthy individuals (Rahkila et al. 1988; Rahkila 
et al. 1987). Research studies have presented mixed findings on the effect of 
naloxone on EIA as it blocked (Haier, Quaid & Mills 1981) and did not block 
EIA (Droste et al. 1991), indicating that other non-opioid mechanisms may also 
be involved in EIA.  
Serum levels of 5-HT were also shown to be elevated in response to exercise 
in healthy active, compared to inactive, participants (Steinberg et al. 1998), and 
in patients with CLBP (Sokunbi, Watt & Moore 2007) and FM (Valim et al. 
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2013). Further, high intensity aerobic exercise was also found to increase 
serum levels of NA (Bahr et al. 1991). These data suggest that exercise activates 
serotonergic and noradrenergic mechanisms to produce analgesia.   
Similar to CPM, EIA has been shown to be associated with cardiovascular and 
blood pressure responses (Koltyn & Umeda 2006). Pain perception was 
negatively correlated with blood pressure following exercise in a sample of 
healthy men and women (Koltyn et al. 2001). Exercise may initiate a 
baroreceptor mechanism that activates central pain inhibitory pathways 
(Dworkin et al. 1994) suggesting a potential mechanism for EIA.  
Another possible mechanism modulating EIA is an endocannabinoid 
mechanism (Dietrich & McDaniel 2004). In a study by Koltyn et al. (2014), EIA 
measured by PPT was positively associated with a significant elevation in 
circulating endocannabinoids. In the same study, a reduction in thermal heat 
temporal summation following exercise was significantly associated with an 
increase in endocannabinoids plasma levels. Endocannabinoids exert an 
inhibitory feedback mechanism that limits the release of glutamate at synapses 
transmitting nociceptive signals (Piomelli 2003). 
The intensity level for aerobic exercise required to induce EIA is still unclear. 
A number of previous studies have shown strong hypoalgesic responses after 
both moderate and high intensity aerobic exercise (Naugle et al. 2014; Vaegter, 
Handberg & Graven-Nielsen 2016). Naugle et al. (2014) compared the acute 
hypoalgesic effects of stationary cycling at 70% VO2max and 50% VO2max 
among 27 healthy volunteers. Both intensities of aerobic exercise induced 
significant hypoalgesic effects, with a greater hypoalgesia effect after cycling 
at 70% VO2max. However, other studies reported a significant EIA after high, 
but not moderate, intensity aerobic exercise (Hoffman et al. 2004; Vaegter, 
Handberg & Graven-Nielsen 2014). Therefore, the evidence is inconsistent 
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regarding the exact aerobic exercise intensity necessary to induce significant 
EIA.   
The influence of aerobic exercise on chronic pain is also still unclear. In their 
systematic review, Cunha et al. (2016) reported that the positive hypoalgesic 
effect of exercise was consistent in some chronic pain conditions (e.g. 
rheumatoid arthritis and knee osteoarthritis), but it was unspecified in others 
(e.g. FM, temporomandibular disorders, painful DPN). This inconsistency in 
pain responses may be attributed to intact EA pathways in some but not all 
chronic pain states (Vaegter, Handberg & Graven-Nielsen 2016). The authors 
(Cunha et al. (2016)) concluded that further investigations are required to 
clearly identify the effect of aerobic exercise EIA in chronic pain conditions. 
This project therefore explored the effect of aerobic exercise in a patient 
population with chronic lateral epicondylalgia (LE) that has not been 
previously investigated. 
It has been shown in healthy pain-free individuals that acute bouts of aerobic 
exercise positively influence CPM analgesia (Meeus et al. 2015; Naugle, 
Fillingim & Riley 2012) and that greater CPM efficiency is more likely to be 
associated with higher levels of EIA (Lemley, Hunter & Bement 2015; Vaegter, 
Handberg & Graven-Nielsen 2016). Vaegter et al. (2015) examined the 
hypoalgesic effects of 15 minutes of bicycling exercise at an intensity of 75% 
VO2max and cold immersion/CPT among active and inactive healthy 
participants. While the active group showed higher levels of EIA and more 
efficient CPM effect, as measured by PPT than the inactive group, the extent 
of analgesia induced by CPM and aerobic exercise in both groups was 
positively correlated. The association between enhanced CPM effect and 
increased physical activity level is further supported by Flood et al. (2017), 
who demonstrated greater CPM analgesia among athletes compared to non-
athletes.  In this investigation, the influence of 15 minutes stationary cycling at 
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75% of maximum heart rate (HRmax) and 50% HRmax, which has previously 
elicited strong EIA levels (Naugle et al. 2014), on CPM analgesia was 
investigated in people with LE.  
 Manipulation Induced Pain Modulation  
Manipulation induced Pain Modulation (MIPM) is a form of EA associated 
with manual therapy treatments. Wright (1995) has suggested that MIPM is a 
multifactorial phenomenon exerting its analgesic effect through several 
neurophysiological mechanisms.  He has proposed that manipulative therapy 
induces analgesia through facilitation of chemical changes within the 
environment of peripheral nociceptors, stimulation of peripheral joint repair, 
activation of neuro-segmental pain modulation systems, and stimulation of 
descending endogenous anti-nociceptive pathways and non-specific placebo 
effects. Similarly, Bialosky et al. (2009) also presented a broad model 
demonstrating the potential multisystem features of the manipulative therapy 
effect. They have hypothesized that manual therapy may trigger different 
neurophysiological responses, including hypoalgesia, neuromuscular reflex 
responses, autonomic, endocrine, and placebo responses mediated by 
peripheral, spinal, and supraspinal systems. Similar to the model originally 
proposed by Wright (1995), they suggested that the interplay between these 
mechanisms is what produces the manual therapy effect, rather than it being 
induced by an individual system in isolation.  
PPT has been used to measure the analgesic effects of spinal and peripheral 
joint mobilisation and manipulation, with increased PPT values denoting a 
reduction in the perceived pain at the test location, or hypoalgesia. Voogt et 
al. (2015) have recently conducted a systematic review to study MIPM effects. 
Of the 13 randomized studies included in their analysis, 10 demonstrated a 
significant increase in PPT post manual therapy suggesting a clear MIPM 
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effect. Three studies also used PPT to objectively detect both local and remote 
analgesic changes post manual therapy treatment. However, the authors 
(Voogt et al. 2015) reported that thermal pain threshold (TPT) demonstrated 
no significant effects for manual therapy treatments.  
2.5.1. Evidence of central pain modulatory mechanisms 
There is evidence to suggest that descending pain inhibitory systems (central 
mechanisms) likely play a fundamental role in mediating the analgesic effect 
of MIPM (Vicenzino et al. 1995). It has been proposed that manual therapy 
activates afferent neuronal inputs that stimulate the central nervous system to 
inhibit pain through descending modulation (Souvlis, Vicenzino & Wright 
2004). It is thought that the midbrain PAG has an important function in 
controlling the effects of descending analgesia in both animals (Reynolds 1969) 
and humans (Hosobuchi, Adams & Linchitz 1977). Reynolds (1969) elicited a 
strong analgesic effect in rats through direct electrical stimulation of midbrain 
PAG that was enough to perform laparotomy surgery without anaesthesia. 
Stimulation of the dorsal PAG in rats was associated with mechanical 
hypoalgesia, sympathetic excitation and increased muscle activity (Lovick 
1991). In a human study, Hosobuchi, Adams and Linchitz (1977) showed that 
stimulation of the central grey area in people with intractable pain was 
associated with analgesia. In the view of these findings, the PAG may 
potentially play a role in mediating the analgesic effects of manual therapy in 
humans (Sterling, Jull & Wright 2001; Wright 1995).  
 Widespread effect of MIPM  
2.6.1. Animal research  
Animal studies have shown that manual therapy induces widespread effects 
in areas beyond the mobilised joint or spinal segment, suggesting a central 
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mechanism (Sluka et al. 2006; Sluka & Wright 2001). Sluka and Wright (2001) 
showed that knee joint mobilisation decreased experimentally induced ankle 
and foot hyperalgesia induced by joint inflammation. They investigated the 
anti-hyperalgesic effect of ipsilateral knee joint mobilisation, in the form of a 
grade III end range knee extension associated with anterior to posterior tibial 
translation, on ankle joint inflammatory dynamic hyperalgesia induced by 
intra-joint capsaicin injection in 31 superficially sedated rats. There were three 
intervention groups: 3-minue mobilisation group received 3 repetitions of 1-
minute mobilisation with 30 second rest intervals in between, 9-minute 
mobilisation group received three repetitions of 3-minute mobilisation and 15-
minute mobilisation group received three 5-minute mobilisations with 30-
seccond rest intervals in between. Two control groups were also included: the 
first group received the same manual contact and manipulative treatment that 
was used in the 9-minute mobilisation group but without gliding movements 
being made, and the second control group received the same treatment as the 
first control but without a manual contact being applied. Mechanical 
withdrawal thresholds were measured using von Frey filaments applied to the 
sole of the foot at baseline, at 30 minutes, 1 hour, and 2 hours post induction 
of inflammatory hyperalgesia into the left ankle joint, and at 5, 10, 15, 30, 45 
minutes and 1 hour after knee mobilisation. Secondary hypoalgesia appeared 
within 2 hours, and lasted for 4 hours, post capsaicin injection. In comparison 
with the control groups, the 9-minute and 15-minute mobilisation groups 
showed elevated mechanical withdrawal thresholds relative to baseline 
readings, which continued for 30 minutes post-mobilisation. There was a 
complete anti-hyperalgesic effect of 9 minutes and 15 minutes after ipsilateral 
knee mobilisations on foot and ankle joint hyperalgesia secondary to capsaicin 
injection.  This distant anti-nociceptive effect of proximal joint mobilisation is 
possibly mediated by supra-spinal mechanisms.  
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In another animal study, Sluka et al. (2006) investigated the effect of joint 
mobilisation on experimentally induced hyperalgesia after joint and muscle 
inflammation in rats. The rats were first randomly assigned into mobilisation 
and non-mobilisation control groups. Bilateral inflammatory hyperalgesia 
was elicited in both groups by injecting one gastrocnemius muscle or one knee 
joint with 3% carrageenan and 3% kaolin/carrageenan, respectively.  The knee 
joint on the ipsi-lateral side of injection was mobilised with a Maitland grade 
III extension combined with an antero-posterior (AP) tibial glide for three 
minutes with a 30-second rest in between. Mechanical withdrawal threshold 
of the paw was established at baseline prior to inflammatory injection, at 1, 2, 
and 4 weeks post-inflammation, and then at 15, 30, 45, and 60 minutes post 
knee mobilisation. The study found that mechanical withdrawal thresholds 
were bilaterally reduced 1, 2, and 4 weeks post knee or muscle inflammation. 
After knee joint mobilisation over the same period, there was a bilateral 
elevation in mechanical withdrawal thresholds in rats with muscle 
inflammation. The mechanical withdrawal thresholds, however, were only 
elevated after inflamed knee joint mobilisation at 4 weeks, and no change was 
observed at 1 or 2 weeks. It was therefore hypothesised that unilateral knee 
joint mobilisation induced bilateral hypoalgesic effects by triggering central 
EA systems.  
 Human research 
Similar to animal studies, human studies have shown that manual therapy 
produced widespread effects observed at distant body areas (de Camargo et 
al. 2011; Fernandez-Carnero, Fernandez-de-las-Penas & Cleland 2008). Moss, 
Sluka and Wright (2007) examined the initial effect of a large amplitude AP 
knee joint mobilisation on pain and function among 38 participants with knee 
osteoarthritis.  In the experimental condition, 3 sets of 3 minutes of knee 
mobilisation were applied with 30 second rest intervals in between. The 
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placebo condition received manual contact similar to that used in the 
mobilisation condition but without a gliding action occurring. The control 
condition received no treatment or manual contact. PPT was measured over 
the most tender point at the medial aspect of the treated knee and over the 
medial aspect of the heel on the same side.  Compared to placebo and control 
conditions, the experimental condition showed an immediate and significant 
increase in PPT measurements both locally at the knee and at a distant 
ipsilateral heel site. The remote anti-nociception effect induced by knee 
mobilisation, indicated by the immediate increase in PPT at the heel, could 
potentially be mediated by central mechanisms.    
Fernandez-Carnero, Fernandez-de-las-Penas and Cleland (2008) investigated 
the immediate effect of a single cervical upslope manipulation (thrust) C5-6 
level on PPT, TPT and pain free grip (PFG) in subjects with LE. The effect of 
cervical manipulation was compared to manual contact only without a thrust. 
The study found a significant increase in PPT bilaterally and ipsilateral PFG 
on the symptomatic side with no effect on TPT. In a more recent study, de 
Camargo et al. (2011) applied the C5-6 technique in patients with mechanical 
cervical pain and found a significant increase in PPT over the deltoid muscles 
on both sides. These findings support the hypothesis that manual therapy 
induces widespread effects that may be mediated by descending inhibitory 
pathways.   
 Concurrent MIPM and sympathetic excitation  
Several studies have investigated the correlation between MIPM and 
sympathetic excitation, which again suggests activation of central pathways 
(Chiu & Wright 1996; Sterling, Jull & Wright 2001; Vicenzino, Collins & Wright 
1996; Vicenzino et al. 1995). Sterling, Jull and Wright (2001) investigated the 
associated effects of cervical mobilisation on pain, sympathetic, and motor 
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responses among 30 participants with an insidious onset of cervical pain. 
Three conditions were investigated: a grade III unilateral PA C5/6 
mobilisation, a placebo manual contact over C5/6, and a control condition 
without manual contact. The cervical mobilisation condition, compared with 
placebo and the control condition, exhibited an elevated PPT over the 
mobilised C5/6 segment, an immediate hypoalgesic effect represented by 
reduced resting subjective pain rating (visual analogue scale, VAS), a 
significantly elevated skin conductance (SC) denoting a selective sympathetic 
effect, and decrease in superficial cervical flexors electro-myography (EMG) 
signals, likely suggesting an improved deep neck flexors activity, during the 
cranio-cervical flexion test.  The concurrent effect of mobilisation-induced 
hypoalgesia, sympatho-excitation and improved motor function may support 
the hypothesis that MIPM is mediated by descending neuronal systems 
controlled by the PAG.  
In patients with chronic LE, Vicenzino et al. (1998b) examined the link between 
the immediate analgesia post mobilisation and centrally-driven 
sympathoexcitation. The participants received three treatment conditions: a 
grade III oscillatory cervical lateral glide (C5/6) mobilisation, a placebo 
condition where manual contact at the C5/6 segment was provided without 
gliding movements, and a control condition with no manual contact. The 
cervical mobilisation condition achieved a greater improvement in PPT, pain 
free range of movement in the upper limb neurodynamic test (radial nerve 
biased) (ULNDT-RN), PFG, SC, and blood flux of the skin over the lateral 
elbow than the placebo or control conditions. The skin temperature and blood 
flux of the glabrous skin of the hand reduced while TPT had no significant 
change. This study showed that cervical mobilisation induced analgesia at the 
elbow together with sympathoexcitation changes such as an increase in SC in 
the upper limb. In a similar study, Vicenzino et al. (1998a) showed that 
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analgesia and sympatho-excitation effects, such as increased heart rate, 
respiratory rate and blood pressure, and motor responses, were 
simultaneously induced in response to cervical spine mobilisation. This close 
association between the MIPM and sympatho-excitation responses suggests a 
role for EA systems (similar to DNIC/CPM) in producing manual therapy 
analgesia.  
Similar to spinal manual therapy, a peripheral mobilisation with movement 
technique was used to produce concurrent hypoalgesic and sympatho-
excitatory effects in people with LE. Paungmali et al. (2003) investigated the 
effect of a mobilisation with movement technique on pain and sympathetic 
system responses among 24 participants with chronic LE. The experimental 
condition received 10 repetitions of Mulligan’s manual lateral glide and 
gripping a hand dynamometer, with a 15 second rest in between. The placebo 
condition had only a manual contact over the elbow without gliding, but with 
pain-free gripping movements. The control condition received no manual 
contact, but only pain-free gripping. Compared to placebo and control 
conditions, the treatment condition showed a significant increase in PPT, PFG, 
heart rate, and blood pressure, but without a significant change in thermal 
pain threshold (TPT). All skin sympathetic nervous system (SNS) measures of 
conductance, blood flux, and temperature were stimulated in response to 
elbow mobilisation only. These findings demonstrated that peripheral 
mobilisation induced pain inhibition was associated with sympatho-
excitation, comparable to that observed with spinal manipulation.   
2.6.2. Imaging studies and joint mobilisation 
 Animal research  
fMRI studies in animals show central nervous system changes in response to 
joint mobilisation. Malisza et al. (2003b) used lumbar spinal cord fMRI to study 
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the effect of subcutaneous and intra-joint capsaicin injection on the spinal cord 
neuronal activity, and the effect of joint mobilisation on these neural responses 
post-hyperalgesia induction in anaesthetized rats. Capsaicin was injected into 
the plantar aspect of the right hind-paw or into the lateral right ankle joint. 
Three experimental groups were included. The first was right hind-paw 
injection without joint mobilisation, the second was right ankle joint injection 
without joint mobilisation, and the third was right ankle joint injection with 9-
minute mobilisation post-injection.  In the second group, a light touch 
stimulation was applied to the plantar surface of the right hind-paw 4 hours 
post injection using a nylon tip. The third group received light touch 
stimulation 2 hours post-ankle injection and immediately post joint 
mobilisation. Knee joint mobilisation ipsilateral to the injection site, in the form 
of rhythmical flexion and end range extension associated with AP tibial 
translation was applied for 3 minutes, and repeated 3 times with one-minute 
rest in between. fMRI detected a noticeable neural activation in spinal cord 
segments S2-L3 in response to capsaicin-induced hyperalgesia in the hindpaw 
and ankle, with a greater activation found in the ankle injection groups, 
specifically in the ipsilateral spinal dorsal horn area. fMRI showed a decrease 
in the amount of activation in the spinal cord neural activation after knee joint 
mobilisation. This fMRI study shows that knee joint mobilisation reduces the 
neuronal activity in spinal cord areas activated by capsaicin-induced 
hyperalgesia in an animal model. 
These central nervous system changes were further examined by Malisza et al. 
(2003a). They replicated their previously described spinal cord fMRI study, 
but with using fMRI to investigate the effect of hyperalgesia induced by 
capsaicin injection on cortical responses, and the effect of ipsilateral knee joint 
mobilisation on these brain changes after induction of hyperalgesia in 
anaesthetized rats. In all injected animals, fMRI detected an obvious activation 
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of several cortical regions involved in the pain experienced in response to 
capsaicin-induced hyperalgesia, specifically the bilateral anterior cingulate 
and frontal cortices, and the contralateral sensory motor cortex, with a more 
substantial activation reported post subcutaneous capsaicin hind-paw 
injection. Similar brain regions were activated in response to mechanical 
allodynia and secondary hyperalgesia induced post capsaicin intra-articular 
joint injection. Compared to other groups, the knee mobilisation group 
showed tendencies toward decreased activation of the brain regions involved 
in pain processing in response to knee mobilisation.  These fMRI studies 
suggest that manual therapy analgesia is modulated via central anti-
nociceptive pathways.  
 Human research  
Imaging studies in humans have started to investigate potential central 
nervous system changes controlling the pain inhibitory effects of MIPM 
analgesia. More recently, alterations in cortical excitability responses have 
been visualised in fMRI in response to non-painful pressure in pain free 
subjects (Mansour et al. 2018). fMRI detected cortical activation of medial parts 
of the postcentral gyrus (S1) bilaterally, S2, posterior parts of the insular cortex, 
different parts of the cingulate cortex, and the cerebellum during a centrally 
applied PA glide over the lumbar spine vertebrae (L1, L3, and L5) in 10 healthy 
volunteers (Meier et al. 2014). Sparks et al. (2013) also used brain fMRI to detect 
brain activity changes in response to mechanical pain made by von Frey 
filaments application to the cuticle of the index finger, and the effect of a 
thoracic thrust manipulation on these cerebral responses in 10 healthy 
participants. During the fMRI scanning, temporal summation of pain was 
produced by von Frey filaments application at a frequency of 1 Hz for a period 
of 15 seconds, with 15 seconds rest intervals in between, in blocks of 10 cycles 
(5 minutes). This was followed by a mid-thoracic thrust application in the 
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supine position. The participants were then immediately re-scanned using 
fMRI concurrently with von Frey filament stimulations. An 11-point numeric 
pain rating scale was used immediately post-mechanical stimulations, pre and 
post thoracic manipulation. The cortical hemodynamic change pre and post 
thoracic manipulation was measured by blood oxygenation level-dependent 
fMRI. The results showed a reduction in cerebral activity levels in the pain 
neuro-matrix (i.e. cortical structures, including S1, S2, insula, and ACC) post 
thoracic manipulation, that was correlated to a significant decrease in 
perceived pain ratings. Despite the absence of a control group, this fMRI study 
presented evidence suggesting involvement of central endogenous pathways 
in pain inhibition post-thoracic manipulation.    
Gay et al. (2014) also investigated the immediate change in functional cortical 
connectivity in response to three types of manual therapy in an experimentally 
induced low back pain model. After completing an exercise injury protocol to 
produce acute low back pain, a sample of previously healthy volunteers were 
randomly allocated into three manual therapy experimental conditions: 
chiropractic spinal manipulation (thrust), spinal mobilisation (non-thrust), or 
therapeutic touch. Participants then underwent a resting state fMRI scan prior 
to intervention. Following manual therapy interventions, participants 
underwent a second resting state fMRI. All three manual therapy 
interventions equally resulted in reduction in low back pain. Additionally, all 
manual therapy interventions were associated with immediate changes in 
functional cortical connectivity, including a reduction in functional 
connectivity between S1 and posterior insular cortex and an increase in 
functional connectivity between posterior cingulate and anterior insular 
cortices, and affective and descending pain modulatory areas (insular cortex 
and PAG). These immediate changes in functional cortical connectivity after 
manual therapy may explain the neurophysiological mechanism of MIPM 
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analgesia. Further research is required to investigate these functional cortical 
changes in patients with pain conditions.  
2.6.3. Pharmacological Studies  
 Human research 
Evidence from pharmacological studies suggests that opioid analgesia is not 
likely to be involved in manual therapy analgesia in humans (Paungmali et al. 
2004; Vicenzino et al. 2000; Zusman, Edwards & Donaghy 1989) and in animals 
(Skyba et al. 2003). It was shown that systemic administration of naloxone did 
not antagonise the immediate analgesia induced by spinal manual therapy 
analgesia (Vicenzino et al. 2000). Similarly, in their randomised control trial, 
Paungmali et al. (2004) examined the effect of intravenous injection of 
naloxone on a Mulligan mobilisation with movement technique among 18 
individuals with LE. In comparison to placebo (saline injection) and control 
(cannula insertion without injection), naloxone did not reverse the analgesic 
effect of peripheral mobilisation of the elbow. These research findings indicate 
that opioid analgesia is unlikely to be a neurophysiological mechanism 
explaining MIPM analgesia. They support the notion that MIPM analgesia is 
potentially mediated by non-opioid mechanisms.  
 Animal research  
Skyba and colleagues (2003) used a rat model of inflammatory pain to 
demonstrate the important role of descending inhibitory pathways in 
producing the initial effects of mobilisation induced analgesia. They aimed to 
define the types of spinal neurotransmitters involved in the manual therapy 
pain relieving effect in anaesthetized rats. Capsaicin injection into the ankle 
was used to establish hyperalgesia in the ankle and foot region. Optimal 
hyperalgesia was established after 2 hours.  After induction of hyperalgesia, 
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knee joint mobilisation in the form of flexion and end range extension 
associated with AP tibial translation was applied for 3 minutes, and repeated 
three times with 1 minute rest in between. In different groups of rats, 
bicuculline, naloxone, yohimbine and methysergide, were spinally 
administered to block spinal γ-aminobutyric acid (GABA) receptors, opioid 
receptors, α2-adrenergic receptors (α2-AR) and 5-HT1/2 receptors, 
respectively.  Mechanical withdrawal thresholds of the hindpaw plantar 
surface were assessed using von Frey filaments at baseline and 2 hours post 
capsaicin injection, and at 15, 30, 45 and 60 minutes post knee mobilisation. 
Capsaicin induced a reduction in mechanical withdrawal threshold. This effect 
was reversed by mobilisation of the knee joint, demonstrating a significant 
analgesic or anti-hyperalgesic effect. Intrathecal administration of the α2-AR 
antagonist, yohimbine and the 5-HT receptor antagonist, methysergide 
partially blocked and completely blocked this analgesic effect.  Blocking 
GABA and opioid receptors produced no effect on the analgesia induced by 
knee mobilisation. In a further experiment, 5HT1A, 5-HT2A, and 5-HT3 
receptors antagonists were given, namely NAN-190, ketanserin, and MDL-
72222, respectively. The findings from this experiment showed that blockade 
of the 5-HT1A receptor completely abolished the analgesic effect of manual 
therapy. They concluded that segmental pain modulation mechanisms 
involving GABA and the opioid systems do not contribute to the analgesic 
effect of manual therapy. They also concluded that spinal serotonergic and 
noradrenergic receptors linked to descending serotonergic and noradrenergic 
neurons play a key role in mediating manipulation-induced analgesia.   
These data from human and animal research provide evidence that manual 
therapy activates central endogenous pathways, which are non-opioid, to 
mediate its immediate pain relieving effects. The evidence also suggests that 
MIPM can be widespread, as indicated by increasing PPT at distant body 
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regions, and occurring concurrently with sympatho-excitation responses. In 
addition, pharmacological studies have further helped explain the 
neurophysiological analgesic effects of MIPM, through which MIPM activates 
central pain inhibitory mechanisms, where the PAG potentially has a central 
role, involving serotonergic and adrenergic, rather than opioidergic systems. 
These studies, taken together with evidence from imaging studies that 
demonstrate the involvement of supraspinal regions in the analgesic effects of 
MIPM, provide clear evidence that central pain mechanisms are potentially 
the most plausible explanation for MIPM analgesia.      
2.6.4.  Psychological factors influencing MIPM analgesia 
While psychological factors (e.g. placebo) are inadequately investigated in 
manual therapy, it appears that placebo is influential in conventional or 
alternative therapies dealing with musculoskeletal pain, such as massage and 
acupuncture. Kalauokalani et al. (2001) randomly allocated 135 CLBP 
participants into 2 groups receiving acupuncture or massage treatments for 10 
weeks. Prior to randomization, participants were asked to rate their 
expectations for the usefulness of each interventions on a scale of 0 to 10. The 
modified Roland Disability scale was the main functional outcome measure 
used at 10 weeks. They found that participants with higher expectation for 
massage and having massage had significantly better outcomes than those 
participants with higher expectations for acupuncture and having massage, 
and vice versa. This study suggested that expectation for helpfulness of a 
treatment was significantly associated with better clinical outcomes. 
Therefore, in a similar way, placebo may exert its analgesic effects in manual 
therapy, via supraspinal analgesic mechanisms. 
A patient’s expectations about manual therapy effectiveness was shown to be 
influential in determining the extent of their response to the treatment. Bishop 
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et al. (2013) in their secondary analysis of a clinical trial using thrust 
manipulation and exercise to treat neck pain found that expectations of 
patients for the effectiveness of physiotherapy treatments have a considerable 
effect on outcomes. Out of 140 patients, in excess of 80% expected moderate 
symptom relief, prevention of disability, increased activity levels and getting 
better sleep. Of manual therapy modalities, both manipulation and massage 
had the maximum percentage of patients expecting these treatments to 
considerably relieve their cervical pain. At 1 month, lower likelihood of 
reporting a successful effect was demonstrated by patients who were 
uncertain of achieving full pain relief as compared to those who predicted full 
relief. The likelihood of success was decreased by believing that manipulation 
would help and not receiving manipulation in comparison with believing 
manipulation would help and receiving manipulative. The study concludes 
that expectation of help among patients with neck pain strongly affects clinical 
outcomes. 
Bialosky et al. (2008) studied the impact of expectation of pain reduction on 
the analgesic effect of lumbar spine manipulation on painful heat stimulation 
among three groups of asymptomatic volunteers. The positive expectation 
group was instructed that the spinal manipulation, ‘is a very effective form of 
manipulation used to treat LBP and we expect it to reduce your perception of 
heat pain’. The negative group was given the opposite instruction involving 
expectation of increased heat pain. The neutral expectation group was advised 
that the manipulation treatment has, ‘an unknown effect’ on their heat pain 
perception. The negative expectation group showed a substantial increase in 
pain response to thermal sensitivity testing, while no effect was observed in 
pain perception in the other groups.  
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 Therapeutic interaction 
The therapeutic relationship between a patient and therapist, or the so called 
patient-therapist interaction, can be generally expressed as a sense of 
partnership, warmth, and support between therapist and patient in the clinical 
setting (Ackerman & Hilsenroth 2003). Effective patient-therapist interaction 
may involve a positive connection (or rapport) between the patient and 
therapist developed through respect, empathy, trust, and verbal and non-
verbal communications (Pinto, Ferreira & Oliveira 2012).  
Evidence from a growing body of research indicates that the patient-therapist 
interaction is associated with positive treatment outcomes such as lower pain 
levels, decreased disability, and greater clinical satisfaction (McGilton et al. 
2009). Hall et al. (2010) conducted a systematic review of quantitative studies 
to investigate the effect of the patient-therapist interaction on several clinical 
outcomes (including pain, disability, quality of life, depression, adherence, 
and satisfaction with treatment) in physical rehabilitation. In their analysis, 
they included thirteen studies from different fields of rehabilitation (including 
brain, musculoskeletal, and cardiac). The authors found a positive association 
between patient-therapist interaction (alliance) and the clinical outcomes in 
rehabilitation. A more recent systematic review by Lakke and Meerman (2016) 
examined the influence of the therapeutic alliance (i.e. patient-therapist 
interaction) on pain and physical functioning in patients with musculoskeletal 
pain. The authors included five studies (one randomised controlled trial (RCT) 
and four cohort studies) involving 1,041 patients with chronic musculoskeletal 
pain. In this review, positive therapeutic interaction was a significant predictor 
of reduced pain and enhanced physical functioning in chronic musculoskeletal 
pain. 
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Research also suggests that patient-therapist interaction can be manipulated 
to modify clinical pain. A recent study by Fuentes, Armijo-Olivo and 
Funabashi (2014) manipulated the therapist-patient interaction (enhanced or 
limited) to investigate the pain relieving effect of a single session of 
interferential current (IFC) (sham or active) on CLBP. Compared to the other 
groups, the group that received active IFC with enhanced interaction 
experienced the most significant pain relief on the numerical pain scale. There 
was also a significant increase in PPT for both the active and sham IFC groups 
combined with enhanced interaction. The authors concluded that an enhanced 
interaction positively influences clinical outcomes when combined with active 
IFC in the treatment of CLBP. 
The effect of experimental manipulation of the patient-therapist interaction is 
not clear. Mistiaen et al. (2016) performed a comprehensive systematic review 
of randomised and quasi-randomised controlled trials to assess the effects of 
different types of experimentally manipulated patient-practitioner interaction 
on pain. 51 studies with a total of 5079 patients were included in their analysis. 
Three types of therapeutic interaction intervention were identified: cognitive 
care, empathetic (emotional) care and procedural preparation. Overall, there 
was a significant, but small, effect of therapeutic interaction on pain. Positive 
suggestion and informational preparation seemed to reduce pain while 
negative suggestion appeared to increase pain. In relation to empathetic care, 
the authors reported that the included studies were of poor quality, in which 
various types of interactions were combined and as a result the selective effect 
of empathetic interaction could not be completely isolated. Therefore, the 
empathetic interaction had a weak and indirect effect on reducing pain 
although the level of evidence was very low. In the light of the reviewed 
research studies, the effective elements of the therapeutic interaction could not 
be clearly identified.    
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 Summary  
Clinical research has demonstrated that individuals with dysfunctional EA 
system, manifested as less efficient CPM, are more likely to experience chronic 
pain. Accordingly, understanding the role of descending modulatory 
pathways in chronic musculoskeletal pain may lead to finding new therapies.  
Recent research evidence also suggests that both CPM and MIPM represent an 
adequate stimulus for activating descending pain inhibitory pathways. 
Literature also suggests the initial pain relieving effect of CPM and MIPM may 
be mediated by common neurophysiological mechanisms in the EA systems 
in which serotonergic and adrenergic systems have an important function. 
This apparent neuro-physiological link between CPM and MIPM is reinforced 
by the fact that their analgesic responses can be affected by psychological and 
pharmacological interventions that exert an influence on EA. This raises the 
possibility that individuals who demonstrate a functional response to CPM 
could also consistently show a good response to MIPM. Therefore, clinicians 
can potentially utilise CPM test to identify MIPM responders and MIPM non-
responders and, thus, customise treatment plan for each individual patient. 
Evidence also provides an excellent base from which to investigate the 
possibility of enhancing either CPM and/or MIPM analgesic effects by 
combining them with other treatment modalities (i.e. empathetic interaction 
and aerobic exercise) to potentiate management of musculoskeletal pain.  
The overall objective of this thesis was to investigate whether CPM and MIPM 
could exhibit similar patterns of analgesic responses through a series of 
experimental paradigms targeted to facilitate the function of the endogenous 
descending pain inhibitory (modulation) systems. These experimental 
paradigms looked at the association between CPM and MIPM analgesic 
response and then manipulated their analgesic effects using psychological and 
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physical interventions, through enhanced empathetic interaction and aerobic 
exercise, respectively.  Each of these experimental paradigms are considered 
separately in the following chapters.  
In this investigation, LE has been used as a clinical model for testing as the 
analgesic effect of MIPM in LE is firmly confirmed (de Camargo et al. 2011; 
Fernandez-Carnero, Fernandez-de-las-Penas & Cleland 2008; Vicenzino et al. 
1998a; Vicenzino et al. 1998b; Vicenzino, Collins & Wright 1996). This has 
rendered the comparison with CPM reasonable, where its efficiency in LE is 
yet to be demonstrated. Additionally, compared to other chronic 
musculoskeletal pain conditions, LE can be seen as a ‘clean’ musculoskeletal 
condition where pain experience is less likely to be confounded by other 
variables of chronic pain (e.g. chronic pain medications).   
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 Study One 
The Reliability of pressure pain threshold and duration of 
conditioned pain modulation after-effect  
 Introduction  
In a series of preliminary studies, conditioned pain modulation (CPM) and 
manipulation therapy induced pain modulation (MIPM) analgesic responses 
will be assessed using established CPM (Locke et al. 2014) and MIPM 
(Vicenzino, Collins & Wright 1996) assessment protocols, respectively. Both 
protocols will use as the main outcome pressure pain threshold (PPT) 
measured by a handheld digital algometer. Previous investigations have 
shown a relatively high reliability for PPT (Balaguier, Madeleine & Vuillerme 
2016; Paungmali et al. 2012; Smidt et al. 2002) in assessment of pressure 
hyperalgesia (Wright, Thurnwald & Smith 1992). Waller et al. (2015) reported 
excellent inter-rater and intra-rater intra-class correlation coefficients (ICCs) of 
PPT, ranging from 0.92-0.95 and 0.80-0.99 respectively, when tested over 4 
different body sites. However, this level of reliability is dependent upon tester 
skills. Therefore, the was a need for the specific investigator in this thesis to 
evaluate his own test-retest reliability 
A CPM protocol using the cold pressor test (CPT) and PPT, as the conditioning 
and testing stimuli respectively, has been demonstrated to be the most 
effective method to induce an efficient CPM effect (Oono et al. 2011). CPM 
analgesic effect is exhibited by the degree of PPT elevation in response to the 
CPT. This protocol requires repeated PPT measures (at baseline, at 1 minute, 
at 3 minutes and at 5 minutes) and so it is important to demonstrate the 
reliability of repeated PPT measurements within the timeframe of the testing 
protocol.  
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Previous research has reported different durations for the length of time that 
the CPM effect lasts. Willer, De Broucker and Le Bars (1989) found that the 
elevated PPT from the conditioning stimulus took between 6-9 minutes to 
return to baseline levels. However, Tuveson, Leffler and Hansson (2006) 
reported that CPM lasted 30 minutes after conditioning stimulus removal 
whilst Graven-Nielsen et al. (1998) reported a one hour latency. Therefore, 
there is uncertainty around the duration of CPM after-effect that warrants 
further investigation and therefore it was important to specifically assess the 
duration of CPM response using the methodology supplied in other studies in 
this thesis.  
The initial aim of this study was to therefore to determine the reliability of 
repeated PPT measurements. The second aim of the study was to determine 
the duration of a measurable (meaningful) CPM effect to assist in determining 
a suitable rest period before any assessment of MIPM effect would occur in 
future studies. The final aim was to provide data to facilitate the calculation of 
the sample size required for the design of the subsequent studies reported in 
this thesis.   
 Methods  
3.2.1. Participants  
In this study two separate groups of pain-free participants (N = 11 and N = 10) 
were recruited through advertisements on noticeboards in the Bentley area, 
Perth, Western Australia. To ensure that only pain-free subjects were included, 
all participants were asked to fill out a screening questionnaire prior to 
commencing the study. Potential participants were required to be between 18-
70 years of age. Participants were excluded if they presented with:  
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 History of chronic pain conditions (e.g. fibromyalgia, irritable bowel 
syndrome, temporomandibular dysfunction, migraines) 
 Neurological or sensory dysfunction (especially in the upper limbs) 
 History of chronic musculoskeletal pain (e.g. arthritis, chronic low back 
pain) 
 Contraindications to cold application (i.e. Reynaud’s disease, diabetes) 
 Current or long-term use of pain medication or anti-depressants 
 Inability to communicate in English  
All testing was carried out at the Physiotherapy Clinic (Building 404), School 
of Physiotherapy and Exercise Science, Curtin University. The study was 
approved by Curtin University Human Research Ethics Committee (HREC)    
(HRE2016-0181-01). All participants gave written informed consent before 
commencing testing.  
3.2.2. Procedure  
A single group pretest/posttest design was used in this two-part study. Eleven 
healthy participants attended a single test session where they underwent a 
PPT test-retest protocol for the wrist site (Phase 1) followed by a CPM testing 
protocol (Phase 2), with a rest period of 10 minutes in between. On a separate 
session, 10 healthy participants completed the Phase 1 test-retest protocol for 
the elbow site. The experimental protocols were performed by the same 
investigator. All instructions were standardized (Figure 3.1).  
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3.2.3. Outcome measures 
 Pressure pain threshold (PPT) 
For both the first (wrist test-retest and CPM duration) and second (elbow test-
retest only) sub-studies, PPT was assessed using a hand-held digital pressure 
algometer (Somedic, Sweden), modified with a footswitch rather than the 
standard hand switch control (Locke et al. 2014). A 1 cm² algometer tip was 
applied perpendicularly over the marked site by the assessor and the pressure 
stimulus was applied at a standard rate of 40 kPa/s. The digital algometer used 
had an on-screen dial to facilitate standardizing the rate of application. 
Participants were instructed to press the footswitch at the moment they 
perceived the pressure began to have become painful.  The standardised wrist 
test site was identified and marked at the mid-point on the posterior aspect of 
the right wrist 2 cm proximal to the wrist crease (Locke et al. 2014). The 
standardized elbow site was identified and marked at a point on the lateral 
aspect of the right elbow, 2 cm distal to the lateral epicondyle. For all testing, 
participants sat on a chair of adjustable height so the right forearm was 
comfortably positioned in pronation on a table. The test procedure was first 
conducted at the left forearm for familiarization. For each test site, three PPT 
measurements were then taken on the right forearm with 15-20 seconds 
intervals between each. PPT measures were the pressure values (kPa) recorded 
from the algometer.  
3.2.4. Testing protocols  
For the first sub-study PPT test-retest protocol at the wrist was followed by 
CPM protocol, with a 10 minute rest period in between.  For the second sub-
study, only PPT test-retest at the elbow was carried out (Figure 3.1). 
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 PPT test-retest protocol  
The assessor measured PPT using an electronic digital algometer (Somedic AB, 
Sweden) as described above. Measurements were taken at the test site (wrist 
for sub-study 1 and elbow for sub-study 2) at baseline, at 1 minute, at 3 
minutes and at 5 minutes. Three PPT measurements were taken at each time 
point with a 15-20 seconds interval between each. Mean values were then used 
in analysis. (Figure 3.1 a) 
 Conditioned pain modulation (CPM) testing protocol   
PPT was used as the test stimulus and measurements were carried out in the 
manner described above.  
The cold pressor test (CPT) was used as the conditioning stimulus to elicit the 
CPM response. The left (non PPT-tested) hand was submerged to 10 cm above 
the wrist crease in a cold water bath with temperature maintained at 7°C, for 
a period of 2 minutes (Locke et al. 2014). The water bath contained a mix of 
water and ice and a circulating pump ensured uniformity of water 
temperature at the skin. A thermometer was used to monitor water 
temperature throughout the testing. PPT at the right wrist site was tested at 
baseline prior to CPT, after 1 minute during immersion (CPT) to calculate CPM 
response, and then at various time points post immersion (1 minute, 5 minutes, 
15 minutes, 30 minutes, 45 minutes, and 60 minutes) to determine the time 
point at which PPT returned to the baseline value. At each time point, PPT was 
measured three times with 15-20 second rest intervals in between. The mean 
value of the three measurements at each time point was used for statistical 
analysis (Figure 3.1 b).  
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Figure 3.1  Preliminary study with testing protocols: PPT test-retest (a) and CPM 
testing protocols (b).  
 
3.2.5. Data analysis  
For all analyses, P<0.05 was considered statistically significant. Statistical 
analyses were performed using SPSS Statistics Version 24.0 (IBM Corp., 
Amonk, NY, USA) and Stata/IC (version 15.0: StataCorp LLC, TX).  
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 Reliability testing  
For PPT reliability, the intra-class correlation coefficient (ICC) of the mean 
value for each time point in the PPT test-retest protocol (baseline, at 1 minute, 
at 2 minutes and at 5 minutes) was calculated at the wrist (for sub-study 1) and 
at the elbow for sub-study 2. The intra-rater reliability for each site was 
calculated using an ICC for consistency under a two way-mixed effects model, 
using the average of the 4 measures obtain by the single rater: ICC (3,4).  
 Assessment of duration of CPM after-effect  
To determine at which time-point the CPM response returned to baseline, 
mean PPT values obtained at each time point post CPT at the right wrist site 
were evaluated using a linear mixed regression model with random 
participant effects. The mean PPT percentage increase from baseline at each 
time point was also compared to the percentage increase determined for 
meaningful CPM effect as determined by Locke et al. (2014). In Locke et al. 
(2014) study, CPM effect was considered meaningful if the percentage increase 
in wrist PPT from baseline was greater than the standard error of 
measurement (SEM) for repeated PPT measures. The authors computed the 
SEM for each time point using the formula SD x √(1-ICC), where ICC 
represented the intra-class correlation coefficient of the mean value for each 
time point.  They then added the SEM to the PPT mean value for each time 
point to indicate the maximum upper value of normal variation in repeated 
PPT measures. They then transformed each value to a percentage change value 
by dividing it by the PPT mean value. The mean of these percentage change 
values represented the meaningful CPM effect (105.28%). The time point at 
which there was no significant difference between mean PPT values and 
baseline mean PPT values and where the mean percentage increase in PPT was 
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less than the meaningful CPM effect (5.29%) was designated as the limit of any 
analgesic response.  
 Sample size calculations  
Sample size calculations were conducted using Stata/IC (version 15.0: 
StataCorp LLC, TX). Calculations of the required sample size were based on 
means and standard deviations of PPT measured at the elbow site for a power 
of 0.80 with a p value of 0.05. Descriptive statistics of the mean and standard 
deviation for each time point in the PPT test-retest protocol using the elbow 
site (baseline, at 1 minute, at 2 minutes and at 5 minutes) were calculated and 
then pooled. The minimal clinical important difference (MCID) in PPT at the 
elbow was based on data from a major clinical trial comparing corticosteroid 
injections and physiotherapy management of tennis elbow (Coombes et al. 
2013). The MCID was considered to be 88 kPa (Coombes & Vicenzino 2017; 
personal communication). In determining our sample size, we used a 
difference value of 50 kPa with the pooled standard deviation calculated. 
 Results  
3.3.1. Reliability analysis for PPT at the wrist site 
In the first test cohort for the wrist site study, two females and 9 males 
participated. All participants were able to complete the wrist PPT test-retest 
protocol measurements, except for one male whose PPT measurements at 
minute 5 was not taken accidentally. Therefore, data for 10 participants (age 
range: 20-40 years, mean: 31.2, SD: 6.2) were included in the wrist site 
reliability analysis.  
ICC analysis using PPT mean value at the wrist site at each time point showed 
excellent intra-rater reliability: ICC (3,4) = 0.991 (Table 3.1). 
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3.3.2. Reliability analysis for PPT at elbow site 
In the second cohort, two females and 8 males participated. All participants 
were able to complete the elbow PPT test-retest protocol measurements. 
Therefore, data for 10 participants (age range: 21-43 years, mean: 31.5, SD: 6.8) 
were included in the reliability analysis.  
ICC analysis using PPT mean value at the elbow site at each time point also 
showed excellent intra-rater reliability: ICC (3,4) = 0.986 (Table 3.2).  
 
 
 
 
 
 
Table 3.1  Intra-class Correlation Coefficients at the wrist test site 
          95% CI F Test with True Value 0 
       ICC 
Lower 
Bound 
Upper 
Bound Value 
         
df1 
      
df2 P 
Single Measures 
0.963 0.907 0.990 105.535 9 27 <0.001 
Average 
Measures 0.991 0.975 0.997 105.535 9 27 <0.001 
ICC: Intra-class Correlation Coefficient, CI: confidence interval, df: degree of    
freedom. Level of significance, <0.05 
 
Table 3.2  Intra-class Correlation Coefficients at the elbow test site 
         95% CI F Test with True Value 0 
       ICC 
Lower 
Bound 
Upper 
Bound Value 
         
df1 
      
df2 P 
Single Measures 
0.946 0.869 0.985 71.701 9 27 <0.001 
Average 
Measures 0.986 0.963 0.996 71.701 9 27 <0.001 
ICC: Intra-class Correlation Coefficient, CI: confidence interval, df: degree of    
freedom. Level of significance, <0.05 
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3.3.3. Assessment of duration of CPM after-effect 
All participants from the first sub-study (2 females and 9 males) were able to 
complete phase 2 of the study and therefore 11 data sets were included in the 
analysis. The differences in PPT across time points from baseline are presented 
in Table 3.3. A linear mixed model showed that mean PPT measured at 1 
minute during immersion and 1 minute post immersion increased 
significantly relative to baseline (P values: <0.001 and 0.002, respectively). This 
indicates a significant CPM effect above the meaningful CPM cut-off value of 
5.29% (Locke et al. 2014) at these time points. There was however no significant 
difference in PPT measures taken at 5 minutes (P=0.103), 15 minutes (P=0.258), 
30 minutes (P=0.198), 45 minutes (P=0.715) and 60 minutes (P=0.252) post 
immersion when compared to baseline measure. The pattern of PPT values 
(Figure 3.2) therefore demonstrated that the values returned to baseline levels 
below 5.29% from 5 minutes post immersion. 
 
 
 
 
 
 
 
 
 
Table 3.3  Mixed regression models for PPT values across 7 time points: 
predicted marginal means: differences between time points relative to 
baseline.  
Time point Mean 95% CI (mean) p 
Baseline (Pre) 219.27 180.41 – 258.14 - 
1 minute During 369.39 330.53 - 408.26 < 0.001 
1 minute Post 260.97 222.10 - 299.84 0.002 
5 minutes Post 241.33 202.47 - 280.20 0.103 
15 minutes Post 234.57 195.71 - 273.44 0.258 
30 minutes Post 236.67 197.80 - 275.53 0.198 
45 minutes Post 224.21 185.35 - 263.08 0.715 
60 minutes Post 234.78 195.89 - 273.62 0.252 
PPT: pressure pain threshold, CI: confidence interval.  
Level of significance, <0.05 
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3.3.4. Sample size calculations 
PPT data at the elbow site for 10 participants (2 females and 8 males) were 
used in the analysis (Table 3.4). The pooled mean of 307.21 kPa and the pooled 
standard deviation of 73.22 kPa were calculated. In determining our sample 
size we used a difference value of 50 kPa (Coombes & Vicenzino 2017; personal 
communication) with the pooled standard deviation of 73.22 kPa resulting in 
an effect size difference of 0.68. An a priori power analysis (alpha = 0.05, beta 
= 0.80) indicated a required sample size of 68 (34 per group). 
 
 
 
 
 
Table 3.4  Descriptive statistics for PPT measured at the elbow test site  
 Minimum Maximum Mean SD 
Baseline PPT 235.67 468.00 307.07 66.90 
1 minute 233.33 495.67 307.90 77.17 
3 minutes 244.00 480.33 310.03 71.23 
5 minutes 222.33 490.00 303.83 77.56 
 PPT: pressure pain threshold, SD: standard deviation 
 
Figure 3.2  CPM pattern of analgesic responses (PPT) at different time points 
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 Discussion  
The results of the PPT test-retest protocol demonstrated high intra-rater 
reliability when measuring PPT at 4 time points.  Locke et al. (2014) in their 10 
subject pilot study demonstrated high intra-rater reliability (ICC=0.949). A 
study with a larger sample of healthy volunteers by Waller et al. (2015) also 
showed that intra-rater ICCs ranged from 0.81 to 0.97 at the wrist site. 
Vicenzino et al. (2001) also reported an excellent level of reliability (ICC=0.95) 
at the elbow site. The ICC results of these studies are comparable to the ICC 
results of 0.991 and 0.986 at the wrist and elbow sites, respectively, in this 
reliability study. Despite this comparability of ICC values, our study 
demonstrated higher ICC values denoting higher degree of consistency in PPT 
measurements. 
This study also assessed the pattern of CPM analgesic response as measured 
by PPT over a one-hour time period in a group of healthy pain-free 
individuals.  During CPT, all participants exhibited a CPM effect as 
determined by the meaningful CPM cut-off value of 5.29% calculated by Locke 
et al. (2014).  PPT measurements returned to baseline levels and below the 
5.29% value by 5 minutes post immersion. This is in accordance with Fujii, 
Motohashi and Umino (2006) study that showed that the CPM effect lasted 5 
minutes after removing the conditioning stimulus. In contrast to these 
findings, other studies have demonstrated a more prolonged CPM after-effect 
lasting for 30 minutes (Tuveson, Leffler & Hansson 2006) and up to 60 minutes 
(Graven-Nielsen et al. 1998). However, these studies used very different 
conditioning stimuli to induce CPM over longer periods of time than the 
current study, which involved a 2-minute CPT conditioning stimulus. To 
inhibit pressure pain, Tuveson, Leffler and Hansson (2006) used an ischemic 
pain model with pressure cuff inflation applied for about 10 minutes while 
Graven-Nielsen et al. (1998) administered hypertonic saline for 15 minutes. 
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These variations in the conditioning stimulus and time-frame used to induce 
endogenous analgesia could be the reason for these differences in the CPM 
durations. Further, the Locke et al. (2014) study showed that some participants 
still demonstrated a CPM effect at 5 minutes but did not investigate the pattern 
of CPM effect beyond 5 minutes post CPT. Therefore, this study further 
explored the duration of analgesic effect following CPM testing (using PPT as 
a testing stimulus and CPT as a conditioning stimulus) that has not been 
explicitly investigated in previous research. 
Finally, the sample size calculated (N=68) that will be used in the subsequent 
studies (i.e. Studies 3 and 4) is higher than any sample size used in previous 
studies looking at the effect of manual therapy on musculoskeletal 
dysfunction. The elbow site was chosen for sample size calculation since PPT 
will be used as the main outcome measure to quantify the manual therapy 
effect in lateral epicondylalgia (LE), which will be used as a model for 
musculoskeletal pain in the subsequent studies.  
 Conclusion  
This study established a high level of intra-rater reliability for PPT measured 
at both the wrist and elbow sites using a digital handheld algometer. It also 
found that a CPM analgesic response is induced during and 1-minute post a 
CPT conditioning stimulus but that this response returned to baseline levels 
by 5 minutes post stimulus completion.  The findings of this study will be used 
to determine the duration of the rest period between CPM and MIPM 
assessment protocols, and the required minimum sample size that will be used 
in the subsequent studies described in this thesis.  
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 Study Two 
Association between the analgesic effects of CPM and MIPM 
 Introduction 
Perception of noxious stimuli is modulated by pain inhibitory and facilitatory 
mechanisms in the central nervous system. Endogenous analgesia (EA) 
generally involves multiple central circuits that modulate pain inhibition. 
Diffuse noxious inhibitory controls (DNIC) is one of the most extensively 
studied forms of EA and it involves the phenomenon of pain inhibiting pain 
(Lebars, Dickenson & Besson 1979; Reinert, Treede & Bromm 2000). DNIC 
involves a cortically mediated spinal-bulbo-spinal inhibitory pathway acting 
through inhibition of wide dynamic range (WDR) neurons in the dorsal horn 
of the spinal cord (Lebars, Dickenson & Besson 1979). There is also compelling 
evidence that the descending inhibitory component of the DNIC pathway is 
mediated via neural networks located in the rostral brainstem, involving 
serotoninergic and noradrenergic descending neurons (Bannister et al. 2017). 
It is recommended to use the term Conditioned Pain Modulation (CPM) to 
specifically define the DNIC phenomenon in humans (Yarnitsky et al. 2010). 
Data from early research suggested that DNIC analgesia involves an opioid 
mediated mechanism (Bouhassira, Villanueva & Le Bars 1992; Le Bars, Willer 
& De Broucker 1992; Willer, Le Bars & De Broucker 1990). However, more 
recent research has demonstrated that the CPM response in humans is 
partially reversed (Sprenger, Bingel & Buchel 2011) or not affected (Hermans 
et al. 2018) by naloxone, suggesting that there may be a limited role for opioid 
neurotransmitters in CPM.  
CPM has been used as a reliable measure for EA efficiency (Kennedy et al. 
2016). A less efficient CPM effect is associated with chronic pain states, 
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implying dysfunctional pain modulatory mechanisms (Yarnitsky 2015). 
However, the absence of CPM response has also been observed in some 
healthy individuals (Locke et al. 2014).  
Another form of EA is Manipulation Induced Pain Modulation (MIPM). 
Wright (1995) has suggested that MIPM is a multifaceted phenomenon 
exerting its analgesic effects through activation of several mechanisms. It is 
proposed that in the clinical setting it is the interaction between these systems 
that produces the MIPM effect, rather than a particular system in isolation 
(Bialosky et al. 2009; Wright 1995). 
Several studies have shown a close association between MIPM following 
cervical joint mobilisation and centrally-mediated sympatho-excitation in 
patients with chronic lateral epicondylalgia (LE) (Chiu & Wright 1996; 
Sterling, Jull & Wright 2001; Vicenzino et al. 1998b; Vicenzino, Collins & 
Wright 1996; Vicenzino et al. 1995). In the same way, changes in sympathetic 
nervous system function (e.g. increased heart rate, increased blood pressure) 
were significantly positively associated with CPM response in pain-free 
healthy individuals (Chalaye et al. 2013) and in a patient population with 
fibromyalgia (Chalaye et al. 2014). This concurrent association of sympathetic 
responses with MIPM and CPM suggests a role for central pain modulatory 
mechanisms in producing the analgesia associated with MIPM and CPM 
(Vicenzino et al. 1998b).  
Data from pharmacological studies has also shown that CPM and MIPM share 
similar neurophysiological mechanisms. Systemic or local administration of 
an α1-adrenoceptor agonist (Makino et al. 2010), systemic administration of a 
selective α2-adrenergic receptors (α2-AR) agonist (Sanada et al. 2009) or 5-HT7 
(5-hydroxytryptamine 7) receptor antagonist SB269970 (Bannister et al. 2017) 
inhibited DNIC/CPM responses. Likewise, MIPM analgesia was partially 
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blocked by intrathecal injection of an α2-AR antagonist while a 5-HT 
(serotonin) receptor antagonist completely blocked the analgesic effect of 
MIPM (Skyba et al. 2003). Spinal blockade of γ-aminobutyric acid (GABA) or 
opioid receptors however did not affect MIPM analgesia (Skyba et al. 2003). 
These data suggest that CPM and MIPM analgesia is potentially mediated by 
descending serotonergic and noradrenergic mechanisms. 
Reports on the association between different naturally induced forms of 
analgesia are limited. The current available evidence shows that CPM is 
positively associated with exercise induced analgesia (EIA) (Lemley, Hunter 
& Bement 2015; Vaegter et al. 2015). To date there has been no study assessing 
the association between CPM and MIPM analgesia.  
The initial aim of this study was to assess the association between the analgesic 
effects of CPM and MIPM in patients with LE. The second aim was to 
investigate whether there was a difference in MIMP effect between those who 
demonstrated and who did not demonstrate a clear CPM effect. LE was used 
as a clinical model as the effect of MIPM in LE (Vicenzino et al. 1998b) has been 
previously established. 
 Methods  
4.2.1. Null hypotheses  
1. There will be no difference between time points in the level of CPM and 
MIPM analgesia detected by measures of PPT at the wrist and elbow.  
2. There will be no difference between the level of CPM and MIPM 
analgesia overtime (CPM vs MIPM measures). 
3. There will be no correlation between the level of MIPM and CPM 
analgesia as detected by measures of PPT at the wrist and elbow. 
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4. There will be no difference in the level of MIPM analgesia overtime 
between those participants who do and those who do not exhibit a CPM 
response (CPM responders vs non-responders). 
4.2.2. Study design  
This was a quasi-experimental single-group, pretest-posttest study design 
conducted in one testing session. Curtin University Human Research Ethics 
Committee approved the study (HREC project approval number: HRE2017-
0198-02). The study was also registered with the Australia New Zealand 
Clinical Trials Registry (ANCTR) (ID number ACTRN12617000218392). On the 
study testing day, all participants were given a more detailed description of 
the study in the form of a Participant Information Sheet. Written informed 
consent was obtained from all participants prior to commencing testing.   
4.2.3. Participants  
A convenience sample of 70 volunteers with LE was recruited through Curtin 
Radio advertisements, a specialised clinical trials recruitment agency, adverts 
on social media and in sports clubs and a range of musculoskeletal and sports 
physiotherapy clinics in Perth. Inclusion criteria (Haker & Lundeberg 1990) 
and exclusion criteria were as follows: 
 Inclusion criteria   
 Aged 18 years or older 
 Unilateral elbow pain > 6 weeks duration reproduced on at least two of 
the following tests: 
 Palpation of the lateral epicondyle 
 Isometric testing of the wrist extensors 
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 Middle finger extension test 
 Passive stretch of wrist extensors 
 Resisted hand gripping using a dynamometer 
 Upper limb neurodynamic test-radial nerve bias (ULNDT-RN) 
 Exclusion criteria 
 Neurological and radicular dysfunctions  
 History of fracture/surgery in the forequarter (past 2 years) 
 History of generalized arthritis 
 Steroid injection into the elbow (preceding 6 weeks)  
  Contraindications to cold application 
 Inability to communicate in English  
 Current use of antidepressants for > 12 weeks 
Potential participants were initially contacted via phone. They were 
questioned about LE diagnosis, age, history of pain, and the exclusion criteria 
(see above) to ensure that they had LE. To further confirm that the eligibility 
criteria were met, a thorough clinical examination, including the diagnostic 
tests outlined in the inclusion criteria, of all participants was carried out by a 
single assessor prior to commencing the study. All testing was carried out at 
the Physiotherapy Clinic, Curtin University. Participants were asked to avoid 
taking pain medications 24 hours prior to testing and to avoid any additional 
physiotherapy treatment and other physical treatments (e.g. chiropractic or 
acupuncture) on the testing day. A $20 voucher was given to each participant 
to help pay for travel or parking. 
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4.2.4. Pain-related outcome measures  
 Pressure pain threshold (PPT) 
PPT was measured using an electronic digital algometer (Somedic AB, 
Sweden) with slightly modified methodology (Coombes, Bisset & Vicenzino 
2015; Locke et al. 2014). PPT has been shown to have a high intra-rater 
reliability with excellent intra-class correlation coefficient (ICCs: 0.81-0.99) 
when measured at 4 different body sites (Waller et al. 2015) and more 
particularly when used for assessment of pain in LE (ICC > 0.86) (Fernandez-
Carnero et al. 2009). ICCs of 0.991 and 0.986 were demonstrated at the wrist 
and elbow sites, respectively, by the current researcher (i.e. the same single 
assessor) during preliminary reliability testing (Chapter 3). The assessor 
identified the most tender point at the lateral aspect of the affected elbow by 
palpation. The assessor also identified a mid-point on the posterior aspect of 
the wrist, 2 cm proximal to the wrist crease. These measurement sites were 
then marked. For the CPM assessment protocol, a modified pressure 
algometer with a footswitch control was used to assess PPT (Locke et al. 2014). 
The participant was sitting on a chair of adjustable height so the forearm was 
comfortably positioned in pronation on a table. A 1 cm² algometer tip was 
applied perpendicularly over each marked site by the assessor and the 
pressure stimulus was applied at a standard rate of 40 kPa/s. The participant 
was instructed to press the footswitch control at the moment they perceived 
the pressure becoming painful. Using a footswitch enabled participants to 
place one hand in the cold water and still respond to the pressure stimulus. 
For the MIPM assessment protocol the participant was comfortably lying 
supine on a plinth and a pressure algometer with the same handswitch control 
was used for testing. PPT measures were the pressure value (kPa) recorded 
from the algometer. The test procedure was first conducted at the unaffected 
forearm for familiarization. Three PPT measurements were taken at each site 
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on the symptomatic side with 10-15 seconds intervals between each. Mean 
values were used in analysis. 
 Pain free grip (PFG) 
Pain on gripping is a clinical sign of LE (Vicenzino et al. 1998b). Pain free grip 
(PFG) refers to the amount of grip force that can be applied prior to the onset 
of pain (Paungmali et al. 2003). PFG was measured with an electronic digital 
dynamometer (MIE, Medical Research Ltd.) using standard methodology 
(Coombes, Bisset & Vicenzino 2015). It has been demonstrated to be both a 
reliable (ICC > 0.97) (Smidt et al. 2002) and valid (Paungmali et al. 2003) 
measure used in patients with LE. The participant was lying supine with the 
affected arm by their side, positioned in elbow extension and forearm 
pronation. The participant was then requested to squeeze the dynamometer 
handles until they first felt their lateral elbow pain, and then to stop the 
squeezing action. The PFG force value was then recorded from the digital 
display. The PFG test was performed three times with 10-20 seconds rest 
intervals in between. The average value was used for analysis.   
 Upper limb neurodynamic test with radial nerve bias (ULNDT-RN) 
The upper limb neurodynamic test with radial nerve bias (ULNDT-RN) has 
been used to assess primarily neural mobility of the forequarter (Butler 2000). 
Pain free range of motion in the test is restricted in patients with LE (Yaxley & 
Jull 1993). The participant’s symptomatic arm was progressively positioned in 
scapular depression and protraction, elbow extension, internal rotation, 
forearm pronation, wrist and finger flexion. Scapular depression was 
sustained while performing the test. The arm was slowly taken into shoulder 
abduction. The participant was instructed to say ‘now’ to indicate the onset of 
pain with this movement and the arm was returned to the start position. The 
shoulder abduction range at the onset of pain was measured using an M180 
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twin axis electrogoniometer (Penny & Giles, United Kingdom) positioned over 
the anterior shoulder (Vicenzino, Collins & Wright 1996). Three readings were 
taken with 20-30 seconds intervals in between. The average of these readings 
was used for analysis.   
4.2.5. Assessment protocols    
 Conditioned pain modulation (CPM) assessment protocol  
Test stimulus: PPT was used as the test stimulus, using an electronic digital 
algometer (Somedic AB, Sweden) as outlined above. Participants were seated 
on a chair of adjustable height so the affected forearm was comfortably 
positioned in pronation on a table. PPT was then tested as outlined above on 
the two marked locations of the affected arm at baseline prior to cold water 
immersion, after 1 minute during immersion, and 1 minute post immersion. 
At each time point, PPT was measured three times with 10-15 seconds rest 
intervals in between. The mean value of the three measurements at each time 
point was used for analysis.   
Conditioning stimulus: The Cold Pressor Test (CPT) was used as a 
conditioning stimulus to elicit the CPM response. The unaffected hand was 
submerged 10 cm above the wrist crease in a cold water bath, with 
temperature maintained at 10°C for a period of 2 minutes (Hoffken et al. 2017). 
The water bath contained a mix of water and ice and it was supplied with a 
circulating pump to ensure uniformity of water temperature at the skin. 
Separate PPT measures were obtained for the wrist and elbow sites. 
 Manipulation induced pain modulation (MIPM) assessment 
protocol  
The existence of a MIPM effect was assessed using a very similar protocol to 
CPM testing. 
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Test stimulus: PPT was the test stimulus. The measures of PPT at both test 
sites were carried out at baseline, during (i.e.at the start of the third minute of 
treatment) and immediately after the conditioning stimulus (C5/6 cervical 
lateral glide). Testing was performed with the participants lying supine on a 
plinth. The PFG test and ULNDT-RN bias test were performed pre and post 
MIPM to provide additional measures of the MIPM effect. 
Mobilisation stimulus: a grade III passive oscillatory, contralateral lateral 
glide (CLG) mobilisation of the C5/6 motion segment of the cervical spine was 
used to induce MIPM (Vicenzino, Collins & Wright 1996). The participant was 
comfortably lying supine with arms by their side and instructed to report if 
they felt any discomfort or pain during execution of the mobilisation. In 
contrast to CPM this conditioning stimulus should be painless (Vicenzino et 
al. 1999). The therapist (experienced in manual therpy) cradled the occiput and 
neck above the C5/6 segment and applied a grade III passive oscillatory CLG 
directed towards the unaffected upper limb at an appropriate rate that would 
be generally used in a normative clinical practice.  The CLG stimulus was 
performed for 60 seconds, and was repeated three times, with 60 seconds rest 
periods in between (5 minutes total) (Vicenzino, Collins & Wright 1996). 
Separate PPT measures were obtained for the wrist and elbow sites and the 
PFG and ULNDT measures were completed pre and post mobilisation. 
4.2.6. Tennis elbow specific assessment instrument (PRTEE) 
The Patient Rated Tennis Elbow Evaluation (PRTEE), a condition-specific 
assessment instrument, was used to measure both pain (5 items) and 
functional disability levels (10 items) on a scale of 0-10 experienced during 
daily activities, work, and sports over the preceding week (Macdermid 2005). 
Responses were aggregated to give one overall score of 0 (no pain or disability) 
to 100 (worst possible pain and disability). Participants completed the PRTEE 
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in a paper and pencil format. PRTEE is a reliable (Overend et al. 1999; Rompe, 
Overend & MacDermid 2007) and valid (Vincent et al. 2013) measure for 
evaluation of pain and function in tennis elbow (or LE) pathology. 
4.2.7. Procedure  
After clinical examination and eligibility criteria were confirmed, each 
participant was asked to attend for CPM and MIPM assessment protocols in a 
single session. The CPM assessment protocol was initially conducted followed 
by the MIPM assessment protocol with a rest period of 15 minutes in between 
to control for any carryover effect. This time interval was determined based 
on findings from our preliminary Study (Chapter 3: approval number: 
HRE2016-0181). The cold pressor test was administered as described above. 
The CLG was delivered by one of three experienced musculoskeletal 
physiotherapists who received adequate training prior to the initial testing to 
ensure consistent administration of the technique. All instructions were 
standardized. (See Figure 4.1). 
4.2.8. Sample size calculation  
Sample size calculations were generated using Stata/IC (version 15.0: 
StataCorp LLC, TX). The aim of the study was to determine the correlation 
between cross sectional PPT measures obtained for MIMP (PPTMIPM) and CPM 
(PPTCPM) assessment protocols. As there is no current literature that quantifies 
the correlation between PPTMIPM and PPTCPM, we estimated that the 
correlation coefficient between these variables would be 0.35, just above the 
minimum effect size required to detect a sizeable correlation (Cohen 1992). In 
determining our sample size, we set alpha at 0.05 and power at 80% to detect 
at least a correlation coefficient of 0.35. Therefore, the minimum required 
sample size for a one-sample correlation test was 62, based on a two-tailed test.  
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4.2.9. Statistical analysis  
For all analyses, P<0.05 was considered statistically significant. Data were 
analysed using Stata/IC (version 15.0: StataCorp LLC, TX). Demographic data 
were analysed using descriptive statistics. Frequency distributions and 
percentages were obtained for categorical variables (i.e. gender and elbow 
tested). Depending on normality, means and standard deviations (SD) or 
medians and interquartile ranges (IQR) were calculated for continuous 
variables (i.e. age, duration and PRTEE score). Univariate group comparisons 
between CPM groups (responders vs non-responders) included χ2 and Fisher 
exact tests for categorical comparisons, and independent t-tests or Mann-
Whitney U tests for continuous variables, as appropriate.   
All outcome data were evaluated for normality using Shapiro-Wilk tests and 
graphical review.  Non-normally distributed data were transformed using 
natural logarithms (PPT) or square roots (PFG and ULNDT-RN).   
To test null hypotheses 1 (i.e. there will be no difference between time points 
in the level of CPM and MIPM analgesia detected by measures of PPT at the 
wrist and elbow) and 2 (i.e. there will be no difference between the level of 
CPM and MIPM analgesia overtime (CPM vs MIPM measures)), measures of 
CPM and MIPM responses were first obtained for the wrist and elbow sites. 
Separate linear mixed models with random participant effects were then used 
to test these hypotheses.  
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Figure 4.1   Testing session. PPT: pressure pain threshold, CPM: conditioned pain modulation, CPT: cold pressor test, 
PRTEE: patient rated tennis elbow evaluation, PFG: pain free grip, ULNDT-RN: upper limb neurodynamic test- radial nerve, 
CLG: cervical lateral glide. 
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To test null hypothesis 3 (i.e. there will be no correlation between MIPM and 
CPM analgesic effects), the Pearson partial correlation coefficient (r) was used 
to measure the strength and direction of the linear relation between CPM 
(explanatory variable) and MIPM PPT measures (dependent variable) whilst 
controlling for baseline CPM and MIPM PPT measures. The strength of the 
partial correlations were interpreted according to the guidelines defined by 
Cohen (1988): (small: 0.10 ≤ r ≤ 0.29; medium: 0.30 ≤ r ≤0.49; large: 0.50≤ r ≤1.0).  
Univariate linear regression models were then used to calculate regression 
coefficients (B), and their 95% confidence intervals (CI) and p-values, and 
adjusted coefficients of determination (adj. R2) to evaluate the association 
between CPM (explanatory variable) and MIPM (dependent variable) across 
different time points. The baseline CPM and MIPM PPT measures were 
identified as potential confounders and therefore these were controlled for in 
the regression analyses.  
To test null hypothesis 4 (i.e. there will be no difference in the level of MIPM 
analgesia overtime between those participants who do and those who do not 
exhibit a CPM response (CPM responders vs non-responders), participants 
were initially assigned post hoc into two groups, based on whether or not they 
demonstrated a meaningful CPM effect at the wrist test site. Locke at al. (2014) 
considered CPM effect clinically meaningful if the percentage increase in PPT 
was greater than the inherent measurement error. The meaningful CPM cut-
off value of 5.3%, previously calculated by Locke et al. (2014) in pain free 
healthy individuals, was used to classify participants into two groups: CPM 
responders and CPM non-responders. Therefore, participants with a CPM 
effect above 5.29% were classified as CPM responders and those with a CPM 
effect below this percentage were classified as CPM non-responders since their 
response did not exceed the inherent measurement variability. Linear mixed 
models with random participant effects were used to explore between-group 
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overtime differences in MIPM analgesia by computing the interaction between 
group and time, whilst adjusting for PRTEE and gender in the analyses.  
 Results  
A total of 70 participants met the eligibility criteria and participated in the 
study.  All volunteers received both CPM and MIPM assessment protocols and 
were analysed with regards to all outcome measures. Based on the meaningful 
CPM cut-off value (Locke et al. 2014), out of the 70 participants, 62 participants 
were considered as CPM responders while 8 participants (11%) were 
categorized as CPM non-responders. Characteristics of the participants and 
the CPM groups are summarised in Table 4.1. (See also Figure 4.2: Consort 
Diagram). 
 
 
 
 
 
 
 
 
 
 
 
Table 4.1 Descriptive summaries for the research sample and by CPM 
groups 
 Data summarised as Mean (SD) unless otherwise specified* 
Demographic Sample  
(N=70) 
 
Responders 
(n=62) 
Non-
responders  
(n=8) 
p 
Gender n (%)* F 24 (34.3) 20 (32.3) 4 (50.0) 0.269 
 M 46 (65.7) 42 (67.7) 4 (50.0)  
Elbow affected/tested 
n (%)* 
L 33 (47.1) 30 (48.4) 3 (37.5) 0.422 
 R 37 (52.9) 32 (51.6) 5 (62.5)  
Age (years)  46.20 (10.6) 46.9 (10.0) 41.1 (14.0) 0.150 
Duration (years) med IQR*  0.67 (0.42, 1.5) 0.67 (0.4, 1.5) 1.3 (0.8, 2.3) 0.152 
PRTEE  38.73 (16.4) 39.08 (17.1) 36 (9.6) 0.458 
F: female, M: male, L: left, R: right, PRTEE: patient rated tennis elbow evaluation 
questionnaire, med: median, IQR: interquartile range. Level of significance, 
p<0.05 
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Figure 4.2   Consort Diagram. Flow of participants during the recruitment 
process 
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4.3.1. Demographics 
The demographic characteristics of the whole research sample are shown in 
Table 4.1. There were no significant differences (P>0.05) in the demographic 
characteristics of participants in each of the CPM responder and non-
responder groups (11% of the sample) (i.e. gender (P=0.269), affected elbow 
tested (P=0.422), age (P=0.150), duration of tennis elbow condition (P=0.152)). 
4.3.2. PRTEE 
Both CPM groups showed no statistical difference in the PRTEE score 
(P=0.458, >0.05). The PRTEE score was 39.08 points (SD=17.1) reported for the 
CPM responders group and 36.0 points (SD=9.6) for the CPM non-responders 
group. 
4.3.3. Analgesic effect of CPM and MIPM 
PPT was used as the main objective outcome measure to quantify the analgesic 
responses produced by CPM and MIPM. The overall differences in CPM and 
MIPM analgesia between time points are presented in Table 4.2. Participants 
demonstrated a significant increase in PPT measured at wrist and elbow sites 
during and immediately post CPM and MIPM (p<0.001). There was also a 
significant increase (p<0.001) in MIPM secondary outcome measures (PFG and 
ULNDT-RN) immediately post the CLG. 
4.3.4. Comparison of CPM and MIPM analgesia  
There were significant differences between CPM and MIPM analgesia 
measured at the wrist (p<0.001) and elbow (p<0.001) during the CPM and 
MIPM interventions, with higher levels of analgesia measured during CPM. 
The mean increase in analgesic levels (PPT) during CPM and MIPM was 198.85 
kPa and 124.50 kPa, respectively. However, no differences were detected at 
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both testing sites post CPM (mean 120.15 kPa) and MIPM (mean 122.83 kPa) 
(Wrist: p=0.569, elbow: p=0.839). (See Figure 4.3).  
4.3.5. The correlation between MIPM and CPM analgesic 
effects 
Changes in PPT measures induced by both MIPM and CPM assessment 
protocols were used to quantify the analgesic effects. The partial correlation 
values for the association between PPT measures for MIPM and CPM at each 
assessment time point are presented in Table 4.3. The partial Pearson 
correlation coefficient (r) values show statistically significant, moderate and 
positive linear relationships between CPM PPT and MIPM PPT measures at 
different time points (r: 0.40 – 0.54, p<0.001). This implies that higher levels of 
CPM PPT analgesia are associated with higher levels of MIPM PPT. The 
regression analysis shows that CPM PPT is a significant predictor of MIPM 
PPT (p<0.001) measured at both sites over different time points. The adjusted 
coefficient of determination (adj. R2) values range between 0.73 and 0.85. This 
indicates that, based on this research sample, between 73% and 85% of the 
variability in MIPM PPT is explained by CPM PPT values obtained at 
particular time points. 
4.3.6. Comparison between CPM responders and CPM non-
responders levels of MIPM analgesia  
There were significant differences in MIPM analgesia between both CPM 
groups overtime, with significantly higher levels of MIPM analgesia observed 
for the CPM responders group measured at the wrist (during: p=0.033, post: 
p=0.017) and elbow (during: p=0.021, post: 0.014). No between-CPM group 
differences were observed for the PFG (p=0.083) and ULND-RN measures 
(p=0.653). (Table 4.4. See also Figure 4.4). 
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Table 4.2  Mixed regression models for CPM and MIPM responses (predicted marginal means): overall 
differences between time points.  
Test/ 
measurement  
 
 pre CPM/MIMP 
 
During 
CPM/MIPM 
 
Post 
CPM/MIPM 
Pre to 
During 
CPM/MIPM 
Pre to  
Post CPM/ 
MIPM 
 Mean 95%CI Mean     95%CI Mean    95%CI p p 
CPM Wrist PPT  540.60 494.18 - 587.02 742.47 696.05 - 788.88 654.84 608.42 - 701.25 <0.001 <0.001 
 
CPM Elbow PPT  275.82 256.85 - 296.19 465.95 433.91 - 500.36 396.71 369.42 - 426.00 <0.001 <0.001 
 
MIPM Wrist PPT   534.48   491.02 - 577.94 664.13 620.67 - 707.59 657.60 614.14 - 701.06 <0.001 <0.001 
 
MIPM Elbow PPT  310.54 283.60 - 337.48 433.55 406.61 -  460.49 434.04 407.10 - 460.98 <0.001 <0.001 
PFG  198.24 174.65 - 221.82 - - 245.80 222.21 - 269.38 - <0.001 
 
ULNDT- RN  13.35 11.87 - 14.84 - - 20.76 19.28 -    22.25 -   <0.001 
 
CPM: conditioned pain modulation, MIPM: manipulation induced pain modulation, CI: confidence interval, PPT: 
pressure pain threshold, PFG: pain free grip, ULNDT-RN: upper limb neurodynamic test-radial nerve bias. Level of 
significance, p<0.05 
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Table 4.3  Correlations and regression models for CPM and MIPM analgesia within different time points adjusted 
for baseline PPT 
CPM PPT  
      vs. 
MIPM PPT  
Partial  
correlation 
coefficient  
(r) 
Regression 
coefficient 
(B) 
Standard 
Error  
(B) 
95%CI  
(B) 
Adjusted 
R-
squared  
(R2) 
       p 
(r) 
p 
(B) 
p 
(F-test) 
 
CPM PPT Wrist During  
              vs.  
MIPM PPT Wrist During 
 
0.44 
 
0.55 
 
0.14 
 
0.28 - 0.82 
 
0.82 
 
<0.001 
 
<0.001 
 
<0.001 
CPM PPT Elbow During 
              vs.  
MIPM PPT Elbow During 
 
0.45 
 
0.47 
 
0.11 
 
0.24 - 0.70 
 
0.73 
 
<0.001 
 
<0.001 
 
<0.001 
CPM PPT Wrist Post  
              vs.  
MIPM PPT Wrist Post 
 
0.40 
 
0.43 
 
0.12 
 
0.19 - 0.68 
 
0.85 
 
<0.001 
   
0.001 
 
<0.001 
CPM PPT Elbow Post 
              vs.  
MIPM PPT Elbow Post 
 
0.54 
 
0.47 
 
0.09 
 
0.29 - 0.65 
 
0.82 
 
<0.001 
 
<0.001 
 
<0.001 
CPM: conditioned pain modulation, MIPM: manipulation induced pain modulation, PPT: pressure pain threshold, 95%CI: 95% 
confidence interval. Level of significance, p<0.05 
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Table 4.4  Mixed regression models for MIPM predicted marginal means, adjusted for PRTEE and gender: Differences in MIPM 
responses between (CPM responder and CPM non-responder) groups overtime. 
Test/ 
measurement  
 
CPM 
group  
 
 pre MIPM 
 
During 
MIPM 
 
Post 
MIPM 
Pre to 
During 
MIPM 
Pre to  
Post  
MIPM 
  Mean 95%CI Mean     95%CI Mean    95%CI p p 
 
MIPM Wrist PPT 
Non-responders  555.67 439.99 - 671.36 635.63 519.95 - 751.32 623.26 507.57 -  738.94 0.033 
 
0.017 
 Responders  531.75 490.53 - 572.96 667.81 626.59 - 709.02 662.03 620.82 -  703.25 
 
MIPM Elbow PPT
Non-responders  318.10 244.29 - 391.91 394.85 321.04 - 468.66 392.27 318.45 -  466.08 
0.021 
 
0.014 
 
Responders  309.56 283.25 - 335.87 438.54 412.23 - 464.85 439.43 413.12 -  465.73 
 
PFG  
 
Non-responders  225.37 164.89 - 285.86 - - 246.75 186.26 -  307.24 
- 
 
0.083 
 
Responders  194.74 173.18 - 216.29 - - 245.67 224.12 -  267.22 
 
ULNDT-RN             
Non-responders  11.54 7.23 - 15.85 - - 18.46 14.15 - 22.76 
- 0.653 Responders  13.59 12.05 - 15.12  -  - 21.06 19.52 - 22.59 
CPM: conditioned pain modulation, MIPM: manipulation induced pain modulation, 95%CI: 95% confidence interval, PPT: pressure pain 
threshold, PFG: pain free grip, ULNDT-RN: upper limb neurodynamic test-radial nerve bias. Level of significance, p<0.05 
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Figure 4.3  CPM and MIPM predicted marginal means: Differences in PPT 
between CPM and MIPM over time. *Level of significance p<0.05 
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Figure 4.4  MIPM predicted marginal means, adjusted for PRTEE and 
gender: Differences in MIPM PPT (analgesia) between CPM groups 
(responders and non-responders) over time. *Level of significance <0.05 
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 Discussion 
This is the first study to investigate the association between CPM and MIPM 
analgesia. The group demonstrated a significant increase in PPT during and 
post CPM and MIPM indicating an analgesic response to both stimuli 
measured at different time points over two testing sites. The results showed 
significant differences between the levels of CPM and MIPM analgesia 
measured at the wrist and elbow during, but not post, CPM and MIPM. There 
was also a significant association between the CPM and MIPM analgesia in a 
sample population with LE. Lastly, the results showed a significant difference 
in the levels of MIPM analgesia (PPT) between CPM responders and CPM 
non-responders. This has allowed for a valid comparison with CPM, where its 
effect needs to be investigated.  
In this study LE was chosen as a clinical model based on a number of 
considerations. Several studies have previously demonstrated the analgesic 
effect of MIPM (i.e. CLG) in LE (de Camargo et al. 2011; Fernandez-Carnero, 
Fernandez-de-las-Penas & Cleland 2008; Vicenzino et al. 1998a; Vicenzino et 
al. 1998b; Vicenzino, Collins & Wright 1996). This has allowed for a valid 
comparison with CPM, where its effect needs to be investigated. 
This study showed for the first time an intact CPM response in people with 
LE, represented by a significant increase in PPT measures during and post the 
cold pressor test (CPT). This is in accordance with recent research findings of 
preserved CPM response reported for other chronic musculoskeletal 
conditions such as chronic local back pain (Gerhardt et al. 2017), patello-
femoral pain (Rathleff et al. 2017), long term trapezius myalgia (Leffler, 
Hansson & Kosek 2002). The functional CPM response found in this LE sample 
is also similar to the positive CPM response observed in pain-free healthy 
populations (Locke et al. 2014; Pud, Sprecher & Yarnitsky 2005), suggesting 
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unaltered endogenous inhibitory mechanisms in LE. However, a recent CPM 
study by Lim, Sterling and Vicenzino (2017) reported an impaired CPM effect 
in patients with LE when compared to healthy controls. The difference in the 
CPM responses reported in both studies may be explained by variations in the 
testing parameters used. The Lim, Sterling and Vicenzino (2017) study used 
contact thermal heat as the conditioning stimulus to stimulate CPM responses. 
Our CPM protocol however used CPT as a conditioning stimulus and that has 
been found to induce the most pronounced analgesic effect when used with 
PPT as a testing stimulus (Oono et al. 2011). In pain free healthy controls, Lim, 
Sterling and Vicenzino (2017) reported a 19.02 (SD=27.49) % to 24.75 
(SD=26.21) % change in PPT, for the dominant and non-dominant arm 
respectively, during thermal pain compared to a 35.80 (SD=26.26)%  change 
reported  by Locke et al. (2014) during CPT. Our LE study sample 
demonstrated a percentage change in PPT of 40 (SD=19.91)% and 71 
(SD=33.79)% at the wrist and elbow sites, respectively, during CPT. This 
suggests there may be a weaker CPM effect in response to contact thermal heat 
relative to CPT and this may provide a reason for the less efficient CPM in the 
LE group in the Lim, Sterling and Vicenzino study. Further, almost 11% of LE 
patients in our study sample were classified as CPM non-responders, which is 
comparable to 10% reported by Locke et al. (2014). Altogether, these data are 
highly indicative of efficient CPM in LE found in our study. Although Lewis, 
Rice and McNair (2012) have suggested that these methodological differences 
do not have a significant impact on CPM activation in many chronic pain 
states, their influence on the CPM effect in LE is not fully established and 
accordingly it requires further investigation.  
Consistent with earlier studies evaluating the analgesic effects of cervical 
manual therapy in LE (de Camargo et al. 2011; Fernandez-Carnero, 
Fernandez-de-las-Penas & Cleland 2008; Vicenzino et al. 1998b; Vicenzino, 
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Collins & Wright 1996), this study showed a significant immediate increase in 
PPT at the elbow and improvements in PFG and ULNDT-RN after CLG. This 
study is also the first to report a positive increase in PPT values over the 
ipsilateral wrist in LE indicating a widespread effect of MIPM (i.e. CLG). A 
similar pattern of MIPM responses was reported by Moss, Sluka and Wright 
(2007) locally at the knee and remotely at the ipsilateral heel after knee 
mobilisation.  This suggests that central inhibitory mechanisms may be 
involved in MIPM analgesia (Vicenzino et al. 1998b).  
There is a lack of research studies investigating the association between 
different forms of EA. In this respect, research has been limited to investigating 
the association between CPM and exercise induced analgesia (EIA) in a pain-
free healthy population (Lemley, Hunter & Bement 2015; Vaegter et al. 2015). 
Courtney et al. (2016) enhanced the CPM response via the addition of MIPM 
in patients with knee osteoarthritis (OA) but these authors did not examine 
the association between CPM and MIPM. Therefore, to the best of our 
knowledge, this is the first study to investigate the association between CPM 
and MIPM in people with musculoskeletal pain.   
The study demonstrated a significant association between PPT measures over 
the wrist and elbow during and post CPM and MIPM. While PPT significantly 
increased during and post CPM and MIPM, the levels of CPM analgesia 
during CPT were significantly higher than the levels of MIPM analgesia 
during CLG suggesting stronger analgesic responses associated with the cold 
conditioning stimulus (CPT), which is painful, compared to the non-painful 
CLG. These results indicate that both CPM and MIPM may share similar 
neurophysiological mechanisms, but with a clear distinction in the exact 
mechanism identified for each paradigm, that requires further research to 
elucidate.  
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The study results showed that there were between-group differences in MIPM 
analgesia between CPM responders and CPM non-responders. This means 
that participants with a clear CPM response showed a stronger response to 
MIPM than those who exhibited a limited CPM effect. This supports the theory 
that both CPM and MIMP analgesia are mediated by similar endogenous 
systems. Despite the small number of CPM non-responders (n=8) found in this 
cohort compared to CPM responders (n=62), the demographic characteristics 
and PRTEE scores of both CPM groups were equivalent. There were no 
significant between-group differences in PFG and ULNDT-RN responses 
although the PFG measure approached significance. Although not significant, 
the PFG between-group-difference approached significance (p=0.083) that 
could be attributed to type II error due to small sample size of the non-
responder group. Therefore, we anticipate that differences in these measures 
might become significant with a larger sample of CPM non-responders.   
Recent imaging studies in humans provided an opportunity to visualize 
cortical activity accompanying CPM and MIPM analgesia. (La Cesa et al. 2014) 
reported that activity in several cortical structures was revealed by functional 
magnetic resonance imaging (fMRI) in response to cold water hand immersion 
in healthy participants, including: medial parts of the postcentral gyrus (S1) 
bilaterally, the secondary somatosensory cortex (S2), posterior parts of the 
insular cortex, different parts of the cingulate cortex, and the cerebellum. 
Cortical activity was also shown in other areas during CPM such as: thalamus, 
medulla, the amygdala (Sprenger, Bingel & Buchel 2011), supplementary 
motor area and prefrontal cortex (Piche, Arsenault & Rainville 2009). In the 
same way, Gay et al. (2014) found that MIPM analgesia was associated with 
immediate changes in functional cortical connectivity of S1, posterior insular 
cortex, posterior cingulate cortex, and the periaqueductal grey region in 
experimentally induced low back pain. Other brain areas such as S2, premotor 
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and supplementary areas, the amygdala, insula, anterior cingulate cortex 
(ACC), thalamus (Sparks et al. 2013), anterior cerebellum, and middle frontal 
cortex (Boendermaker et al. 2014) are also active during manual therapy. These 
data suggest that both CPM and MIPM analgesia are mediated by similar 
cortical structures, which supports the hypothesis of potentially shared supra-
spinal mechanisms responsible for both forms of analgesia.  
There is also pharmacological evidence suggesting that CPM and MIPM 
induced analgesia is mediated by serotonergic and noradrenergic endogenous 
analgesic mechanisms. In a diabetic neuropathy model of pain, CPM effect 
was reinstated in patients with less efficient CPM by the selective serotonin (5-
HT) and noradrenaline (NA) reuptake inhibitor, duloxetine (Yarnitsky et al. 
2012), and in another study by a combined µ-opioid receptor (MOR) agonist 
and noradrenaline reuptake inhibitor (NRI), Tapentadol (Niesters et al. 2014). 
In an animal neuropathic pain model, blockade of α2-adrenergic 
receptors (AR) in intact animals through α2-AR antagonists, spinal 
atipamezole or subcutaneous yohimbine, abolished the DNIC/CPM effect, but 
it was augmented in spinally injured animals after intrathecal administration 
of a norepinephrine reuptake inhibitor (NRI), reboxetine, or systemic injection 
of an NRI and a -opioid receptor (MOR) agonist, tapentadol (Bannister et al. 
2015). Some studies have shown that CPM-induced analgesia was not affected 
by naloxone (an opioid antagonist) administration in humans (Edwards, Ness 
& Fillingim 2004; Hermans et al. 2018; Peters et al. 1992) suggesting a non-
opioid form of analgesia. Other human studies have however demonstrated 
that naloxone partially (Sprenger, Bingel & Buchel 2011) or completely 
reversed CPM analgesia (Pertovaara et al. 1982; Willer, Le Bars & De Broucker 
1990). Therefore, the current evidence on the involvement of opioid pathways 
in CPM analgesia is inconclusive. In human MIPM models, administration of 
naloxone (an opioid antagonist) did not block spinal (Vicenzino et al. 2000; 
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Zusman, Edwards & Donaghy 1989) or peripheral (Paungmali et al. 2004) 
MIPM analgesia. This suggests that non-opioid mechanisms are likely to be 
involved in MIPM analgesia. In an animal study, Sluka and Wright (2001) 
showed that knee joint mobilisation decreased ankle hyperalgesia induced by 
joint inflammation in an animal model of articular pain. Skyba et al. (2003) 
used the same pain model and reported that intrathecal administration of the 
α2-AR antagonist, yohimbine partially blocked and the 5-HT receptor 
antagonists, methysergide and NAN-190 completely blocked the analgesic 
effect of joint mobilisation. They also showed that intrathecal administration 
of naloxone did not block the MIPM response. They concluded that spinal 
serotonergic and noradrenergic receptors linked to descending serotonergic 
and noradrenergic neurons play a key role in mediating MIPM. These data 
suggest CPM/DNIC and MIPM analgesia activates endogenous pain 
mechanisms involving serotonergic and noradrenergic pathways in the 
central nervous system. There appears to be some variation between the two 
forms of EA in terms of the degree to which the analgesic effect is blocked or 
reversed by naloxone.  
Data from human and animal research suggest that both the cold pressor test 
(CPT) and the cervical lateral glide (CLG) mobilisation activate central 
mechanisms, to mediate their analgesic effects. The research evidence also 
suggests that MIPM and CPM analgesia are widespread effects, as indicated 
by changes in PPT detected at a remote body sites. In addition, both forms of 
analgesia are influenced by pharmacological agents that can abolish or 
enhance CPM or MIPM analgesia through their effect on serotonergic and 
adrenergic, systems. These data, when taken together with the evidence from 
imaging trials on the involvement of supra-spinal centers in the analgesic 
effects of CPM and MIPM, provide evidence that central pain modulation 
mechanisms are potentially involved in CPM and MIPM. Some variation in 
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the specific mechanism of modulation may exist, as suggested by the 
differences in response to naloxone administration and the potential 
differentiation of the two phenomena as opioid and non-opioid forms of 
analgesia.  
 Clinical implications 
The association between both forms of analgesia was evaluated to improve 
our understanding of EA analgesia. The study provides strong evidence of the 
analgesic effects of MIPM in immediately reducing pain in LE. This research 
has also improved our knowledge of the mechanism of action of MIPM. This 
study will therefore lay the foundation for future clinical trials that will 
investigate/compare the impact of different treatment interventions on CPM 
and MIPM responses. Additionally, there is a prospect of using CPM as a 
prognostic test to potentially identify individuals who do or do not respond to 
MIPM interventions. This would help clinicians to individualise their patients’ 
management plans accordingly.   
 Limitations 
First, this study was designed to assess the correlation between CPM and 
MIPM only. Therefore, it did not allow for manipulation of CPM and MIPM 
analgesia. As a result, neither the assessor nor the participants were blinded. 
In addition, we could not make a conclusion on casual inference as to which 
form of analgesia (i.e. CPM, MIPM) would be influenced by the other. Second, 
this study included only participants with tennis elbow. Thus, the external 
validity of the findings may not be applied to other chronic musculoskeletal 
conditions. Future research would need to investigate whether there are 
similar patterns of CPM and MIPM analgesia found in other clinical 
conditions. Third, there was a chance that the CPM and MIPM responses were 
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affected by the assessor interaction during testing. However, all instructions 
were standardised and communications with the participants were kept to the 
minimum. Fourth, the study assessed short term changes in CPM and MIPM 
analgesic responses. It would therefore be worthwhile to examine these 
changes over a longer follow-up period.  
 Conclusion  
The present study showed that CPM and MIPM analgesic responses were 
significantly correlated in a sample population with LE. The study also 
demonstrated that there were between-group over time differences in the level 
of MIPM analgesia between CPM responders and CPM non-responders. This 
suggests that both forms of EA share similar neuro-physiological mechanisms, 
potentially involving descending serotonergic and noradrenergic systems.   
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 Study Three  
Influence of empathetic interaction on CPM and MIPM 
analgesia  
 Introduction  
A positive therapeutic interaction is essential for the delivery of clinical care 
(Hassan, McCabe & Priebe 2007). Therapeutic interaction involves an 
emotional bond and joint agreement between therapists and their patients in 
relation to treatment goals and interventions (Bordin 1979). This requires the 
therapist to positively connect with patients (Adnoy Eriksen et al. 2014), 
through development of rapport (Crowden 2013), respect (Egan 2014), 
empathy and trust (Crowden 2013), and collaboration (Morley & Cashell 
2017). A positive therapeutic interaction has been shown to improve patient 
engagement in therapy, patient satisfaction and treatment effectiveness 
(Fuertes et al. 2007; Fuertes et al. 2017). In order to optimise outcomes it is 
therefore vital to foster a patient-centered interaction (Broady 2014; 
Hebblethwaite 2013) which explicitly focuses on features such as empathy, 
trust, respect and collaboration.  
Previous research has identified various aspects of an enhanced therapeutic 
interaction (Di Blasi et al. 2001). In their review, Mistiaen et al. (2016) classified 
patient-therapist interaction into three main components: cognitive care, 
emotional care and procedural preparation. Cognitive care involves 
manipulating patient’s expectations to produce a positive, neutral or negative 
therapeutic outcome. Emotional care includes interventions intended to 
improve the perceived empathy of the clinician and so put patients at ease. 
This can encompass strategies such as continuous verbal support and 
reassurance (Faymonville et al. 1997), active listening (Fuentes et al. 2014), 
showing friendliness and warmth (White et al. 2012), encouraging a sense of 
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control (Lang et al. 2000), using non-verbal strategies (eye contact, head 
nodding, smiling) (Vangronsveld & Linton 2012), and explaining questions 
clearly (White et al. 2012). Procedural preparation deals with arrangements 
made to facilitate therapeutic interventions, such as information giving, 
procedural instructions, and relaxation (Mistiaen et al. 2016). Mistiaen et al. 
(2016) reported that manipulating these components in experimental settings 
can influence patients’ perception of their pain. They have concluded however 
that more research is necessary to distinguish the most influential 
components.    
Recent research has shown that manipulating cognitive factors such as 
expectation can alter pain perception in experimental settings, either 
positively or negatively. Wang et al. (2008) reported a significant increase in 
postoperative pain (i.e. nocebo) after abdominal hysterectomy in patients who 
received negative suggestions about patient-controlled analgesia. Nir et al. 
(2012) investigated the effect on conditioned pain modulation (CPM) of 
placebo (positive) and nocebo (negative) suggestions about the effects of 
anaesthetic cream in healthy participants. The placebo group showed a 
reduction in the conditioning stimulus pain, and therefore a CPM effect. In 
contrast the nocebo group demonstrated an increase in the conditioning 
stimulus pain so no CPM effect and a hyperalgesic response. In another study, 
Cormier, Piche and Rainville (2013) investigated the impact of verbally 
initiated positive or negative expectations on CPM analgesia.  Compared to 
the control group that received simple instructions, the nocebo group 
demonstrated an increase in pain in response to the suggestion that cold 
application would be painful, while the placebo group showed a reduction in 
the test stimulus pain as a result of suggestion of decreased pain. This 
highlights the importance of cognitive influences on a CPM response. 
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The influence of cognitive factors on manual therapy analgesia has not been 
widely investigated. With respect to spinal manipulation, Bialosky et al. (2008) 
studied the impact of expectation (positive, negative, neutral) of analgesia on 
the analgesic effect of lumbar spine manipulation, evaluated using a painful 
heat stimulus in asymptomatic volunteers. The positive expectation group 
was informed that lumbar manipulation ‘is a very effective form of 
manipulation used to treat low back pain (LBP) and we expect it to reduce 
your perception of heat pain’. The negative expectation group was given the 
opposite instruction, that manipulation would increase their perception of 
heat pain, while the neutral group was informed that manipulation had ‘an 
unknown effect’ on heat pain perception.  The negative expectation group 
showed a substantial increase in pain response during thermal sensitivity 
testing (i.e. a nocebo response), while no effect was observed on pain 
perception in the positive or neutral expectation groups. Expectation may 
have an influence on manipulation induced pain modulation (MIPM), 
however, that effect does not appear to be as consistent as it is for CPM.  
The current evidence indicates that a good therapeutic interaction may have a 
positive effect on pain and disability levels (Lakke et al. 2009) and satisfaction 
(Hall et al. 2010). Fuentes et al. (2014) recently investigated the effect of patient-
therapist interaction on pain responses in patients with chronic low back pain 
(CLBP) after a single session that involved either sham or active interferential 
current (IFC)).  The authors found a significant improvement in pressure pain 
threshold (PPT) in both active and sham groups that received an enhanced 
interaction. The active group also reported improved analgesia (measured on 
a numerical pain scale) following IFC. However, other existing evidence of the 
impact of empathetic interaction on clinical pain is inconsistent and weak 
(Mistiaen et al. 2016). To date, there have been no studies investigating the 
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influence of an enhanced, empathetic interaction on pain in musculoskeletal 
physiotherapy in general, and on CPM and MIPM analgesia in particular.  
This study aimed to evaluate, in individuals with tennis elbow, the effect of a 
positive, supportive empathetic interaction, compared to a neutral interaction, 
on a person’s hypoalgesic response as measured by CPM and MIPM analgesia. 
Where an effect was observed the study evaluated whether the effect was 
similar for CPM and MIPM analgesia. Tennis elbow was used as the clinical 
model since evidence for the analgesic effect of cervical manual therapy in 
lateral epicondylalgia (LE) is well established (Vicenzino et al. 1998a; 
Vicenzino et al. 1998b; Vicenzino, Collins & Wright 1996) and there has been 
some published data evaluating CPM analgesia in this clinical group (Lim, 
Sterling & Vicenzino 2017). 
 Methods 
5.2.1. Null Hypotheses  
1. There will be no difference between time points (i.e. during CPM, and 
post CPM and MIPM) relative to baseline in the level of CPM and 
MIPM analgesia detected by measures of PPT at the wrist and elbow.  
2. There will be no difference in the level of CPM and MIPM analgesia 
overtime between those participants who receive an enhanced 
empathetic interaction and those who receive a neutral interaction  
5.2.2. Study design  
A randomised, controlled between-group experimental design was used. 
Eligible participants were randomised to receive either an enhanced 
empathetic interaction (active) condition or a neutral interaction (control) 
condition in one single session (see experimental conditions).  
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5.2.3. Randomisation 
A randomisation sequence was computer-generated and held by a researcher 
who was not otherwise involved in the study. Prior to commencing the testing 
session, the research assistant (RA) actor contacted the holder of the allocation 
schedule to ascertain the group allocation for each participant.  
5.2.4. Participants  
In this study, a sample of 68 volunteer participants with LE, (aged between 18 
and 60 years) were recruited from Perth, Western Australia between March 
2017 and April 2018 through Curtin Radio advertisements, adverts on social 
media and sports clubs, via a range of musculoskeletal and sports 
physiotherapy clinics and through a specialised clinical trials recruitment 
agency. Inclusion criteria (Haker & Lundeberg 1990) and exclusion criteria 
were as follows: 
 Inclusion and exclusion criteria   
Inclusion and exclusion criteria were as indicated in Chapter 4, Section 4.2.3. 
Participants were initially contacted via phone to screen for eligibility and to 
provide a brief explanation regarding the study protocols and requirements. 
Additional information about the study was provided via email.  To confirm 
the eligibility criteria were met, a thorough clinical examination of all 
participants was carried out by the primary investigator prior to commencing 
the study. All testing was carried out at the Physiotherapy Clinic, School of 
Physiotherapy and Exercise Science, Curtin University. Participants were 
asked to abstain from taking pain medications 24 hours prior to initial testing 
and to avoid any additional physiotherapy treatment and other physical 
treatments (e.g. chiropractic or acupuncture) on the testing day.  
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Curtin University Human Research Ethics Committee approved the study 
(HREC approval number: HRE2016-0175). On the testing day, all participants 
were given a more detailed description of the study in the form of a Participant 
Information Sheet. Written informed consent was obtained from all 
participants prior to commencing testing. Each participant was provided with 
a $20 voucher to help pay for travel or parking. 
5.2.5. Pain related measures 
Pressure pain threshold (PPT), pain free grip (PFG) and the upper limb 
neurodynamic test with radial nerve bias (ULNDT_RN) measures were 
obtained using the same methodology described in Chapter 4, Section 4.2.4. 
All measures were obtained in triplicate. PPT measures were obtained at the 
wrist and elbow test sites. 
All participants were also required to complete the Patient Rated Tennis 
Elbow Evaluation (PRTEE) as described in Chapter 4, Section 4.2.6. 
5.2.6. Procedure 
All participants attended a single test session where they underwent a CPM 
protocol and a MIPM protocol, with either enhanced or neutral interactions as 
described below. A rest period of 15 minutes was provided between protocols 
(Figure 5.1). This rest period was based on findings from the initial Study, 
(approval number: HRE2016-0181, Chapter 3) to control for any carry-over 
effect of CPM on MIPM. Both CPM and MIPM testing protocols were 
performed by the same investigator, who was blinded to the experimental 
group of each participant. The interaction between the assessor and all 
participants was standardised. The enhanced/neutral interactions were all 
provided by a professional role play actor, playing the part of an additional 
research assistant (RA).  
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Figure 5.1  Testing session. PPT: pressure pain threshold, CPM: conditioned pain modulation, CPT: cold pressor test, PRTEE: 
patient rated tennis elbow evaluation, PFG: pain free grip, ULNDT-RN: upper limb neurodynamic test- radial nerve, CLG: 
cervical lateral glide. 
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At the start of the test session, the participant was greeted by the RA actor. The 
participants gave written informed consent in the presence of the RA actor. 
The main investigator then entered the room to confirm the LE diagnosis, and 
then left.  The RA actor initially spent 15 minutes of either enhanced or neutral 
interaction with the participant, as described below. After 15 minutes of 
enhanced/neutral interaction, the main investigator entered the room to 
conduct the CPM protocol, and then left. The participant was then given a 15 
minute rest period, during which the RA actor resumed the enhanced/neutral 
interaction with the participant. After the rest period, the investigator returned 
to the room to conduct the MIPM assessment protocol. Following completion 
of the experiment, all participants were thanked for participation and received 
a debriefing session by the main investigator, in the presence of the RA actor, 
to explain to them the purpose of the study and the role of the RA actor in both 
experimental conditions. Any questions were also answered.  
5.2.7. Assessment protocols    
 Conditioned pain modulation (CPM) protocol  
Test stimulus: PPT was used as the test stimulus, using an electronic digital 
algometer (Somedic AB, Sweden) as outlined below. Participants were seated 
on a chair of adjustable height so the affected forearm was comfortably 
positioned in pronation on a table. PPT was then tested on three occasions on 
the wrist and elbow sites of the affected arm described below: at baseline prior 
to cold water immersion; at 1 minute during immersion; and at 1 minute post 
immersion. At each time point, PPT was measured three times at each site with 
10-15 second rest in-between. The mean value of the three measurements at 
each site was used for analysis.   
Conditioning stimulus: The Cold Pressor Test (CPT) was used as a 
conditioning stimulus to elicit a CPM response. The unaffected hand was 
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submerged to 10 cm above the wrist crease in a cold water bath, (maintained 
at 10°C) for a period of 2 minute (Hoffken et al. 2017). The water bath 
contained a mix of water and ice and had a circulating pump to ensure 
uniformity of water temperature at the skin.  
 Manipulation induced pain modulation (MIPM) protocol  
The presence of a MIPM effect was assessed using a very similar protocol to 
CPM. 
Test stimulus: PPT at both the wrist and elbow test sites was used as the test 
stimulus. Baseline PPT was assessed at both test sites and immediately after 
the manual therapy stimulus (C5/6 cervical lateral glide (CLG)). Testing was 
performed with the participants lying supine on a plinth. The pain-free grip 
(PFG) and Upper Limb neurodynamic-radial nerve (ULND-RN) bias tests 
were also performed pre and post MIPM to provide additional measures of 
the MIPM effect (described below). 
Mobilisation stimulus: a grade III passive oscillatory, contralateral lateral 
glide (CLG) mobilisation of the C5/6 motion segment of the cervical spine was 
used to induce MIPM (Vicenzino, Collins & Wright 1996). The participant was 
comfortably lying supine with arms by their side and instructed to report if 
they felt any discomfort or pain during execution of the mobilisation. In 
contrast to CPM, this mobilisation stimulus was intended to be painless 
(Vicenzino et al. 1999). The therapist cradled the occiput and neck above the 
C5/6 segment and applied a grade III passive oscillatory CLG directed towards 
the unaffected upper limb.  The CLG stimulus was performed for 60 seconds, 
and was repeated three times, with 60-second rest periods in between (5 
minutes total) (Vicenzino, Collins & Wright 1996).  
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5.2.8. Experimental conditions: enhanced and neutral 
interactions 
Both enhanced and neutral interaction conditions were provided by the RA 
actor at two time-points during the test session: 15 minutes at the start of the 
session before the CPM assessment protocol and 15 minutes during the rest-
period between CPM/MIPM protocols (Figure 5.2). The RA actor remained in 
the room during the period that the main investigator spent conducting the 
assessment protocols but undertook some administrative activities and did 
not directly interact with the participant. 
 Enhanced empathetic interaction condition 
The RA actor engaged in a very positive, supportive and empathic interaction 
with the participant. The actor’s interaction was carefully controlled to include 
features that were likely to enhance empathy. The RA actor was very positive 
and enthusiastic about their assistance with the project and supportive about 
the participants’ LE condition. They established good rapport with the 
participant through use of positive communication strategies and body 
language such as: assuming open posture, maintaining appropriate eye 
contact, head nodding, being friendly and warm, using the person’s name, 
listening to them without interruption, showing an interest in their life and 
interests, asking about the impact of LE on them, and they used appropriate 
disengagement to smoothly transition the discussion from one topic to another 
or to initiate procedural activities as required.  
 Neutral interaction condition 
In the 15 minutes before the CPM protocol, the RA actor spent 5 minutes on 
normal, business-like interactions with the participant. The actor greeted and 
briefly advised the participant about the study without being particularly 
positive, supportive, or enthusiastic in relation to the study. The actor’s 
92 
 
interaction was carefully controlled so as not to include features that were 
likely to enhance empathy (i.e. none of the above). There was then a 10 minute 
interval during which the participant was asked to rest and the RA actor 
completed some administrative tasks and minimized interaction with the 
participant. The RA actor did not initiate conversation but politely and 
concisely answered questions when asked. They made minimal eye-contact, 
showed more interest in their laptop or phone and concerned themselves with 
their own issues. In the rest period, 15 minutes before the MIPM protocol 
conducted, there was only a short discussion and only minimal interaction 
with the RA actor as before.  
5.2.9. Intervention integrity  
The actor was given a detailed script explaining the key attitudes that should 
be portrayed during each period of time on each testing day. The professional 
role play actor underwent a comprehensive coaching session prior to the start 
of the experiment, in which they were trained to perform the enhanced 
empathetic and neutral interactions by the research team, including a 
simulation expert.  
5.2.10. Audit of actor interactions 
The actor’s adherence to experimental procedures was audited by a member 
of the research team during randomly selected testing sessions, to ensure 
intervention fidelity. Actor interactions with participants from both groups 
were observed and recorded on several occasions during testing. During 
neutral interactions it was observed that the actor engaged with the participant 
only minimally. If initiated by the actor, interactions were almost entirely 
instructional. For example, requesting that the participant complete a 
questionnaire, informing the participant that the investigator would return in 
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a certain amount of time. If conversation was initiated by the participant, the 
actor replied politely but briefly and used closed body language to 
demonstrate that they did not wish to engage further. In contrast, during the 
enhanced interactions, the actor used open body language to demonstrate 
interest in the participant. The actor also actively engaged the participant in 
conversation throughout the time periods when the investigator was not in the 
room. This conversation focused on the individual participant, for example, 
chatting about their interests or work. Although not all participants in the 
enhanced group were easy to engage, it was observed that there was a clear 
difference in actor interactions between the enhanced and neutral groups. 
5.2.11. Empathetic interaction outcome measure 
At the end of the testing session, and in the absence of the RA actor, all 
participants were asked by the main investigator to complete the Consultation 
and Relational Empathy (CARE) Measure (Mercer et al. 2004) to rate the 
overall interaction they experienced with the Research Assistant (RA). It 
included 10 items rated on a 5 point scale (poor=1, excellent=5) that were 
summed to give a total score out of 50. A maximum of 2 ‘does not apply’ 
responses were permitted and these were substituted by the mean average 
score of other responses (Mercer et al. 2004). The CARE Measure has been 
validated for assessment of empathetic interaction in primary (Mercer et al. 
2008) and secondary (Mercer & Murphy 2008) care, and in rehabilitation 
settings (Kersten, White & Tennant 2012). It has been shown to have a high 
reliability (Cronbach’s α=0.92) and an excellent validity (mean r=0.85) 
compared to other measures of empathy (Mercer et al. 2004). 
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5.2.12. Actor Evaluation 
The RA actor was also required to rate how well they were able to deliver an 
enhanced or neutral interaction session with the participants using a quality 
of session scale: (1-10; unsatisfactory to excellent).  
5.2.13. Sample Size calculation  
Sample size calculations were conducted using Stata/IC (version 15.0: 
StataCorp LLC, TX). Based on data from a large clinical trial comparing 
corticosteroid injections and physiotherapy management of tennis elbow 
(Coombes et al. 2013) the minimal clinically important difference (MCID) in 
pressure pain threshold at the elbow was considered to be 88 kPa (Coombes & 
Vicenzino 2017; personal communication). In determining our sample size we 
used a difference value of 50 kPa (just above half of the MCID), with a pooled 
standard deviation of 73.22 kPa (based on our Pilot Study data, Chapter 3) 
resulting in an effect size difference of 0.68. An a priori power analysis (alpha 
= 0.05, beta = 0.80) indicated a required sample size of 68 (34 per group).  
5.2.14. Statistical analysis  
Data were analysed using Stata/IC (version 15.0: StataCorp LLC, TX). For all 
analyses, P<0.05 was considered statistically significant. Descriptive statistics 
were based on frequency distributions for categorical data (i.e. gender and 
elbow tested) and means and standard deviations (SD) or medians and 
interquartile ranges (IQR) for continuous data (age, duration CARE, RA rating 
and PRTEE), depending on normality. Univariate group comparisons between 
intervention groups included χ2 and Fisher exact tests for categorical 
comparisons, and independent t-tests or Mann-Whitney U tests for continuous 
outcomes.   
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All outcome data were evaluated for normality using Shapiro-Wilk tests and 
graphical review.  Non-normally distributed data were transformed using 
natural logarithms (PPT: CPM and MIPM Wrist) or square roots (MIPM Elbow 
PPT, PFG and ULNDT-RN).   
Linear mixed models with random subject effects were used to calculate the 
overall differences (relative to baseline) between time points (all participants) 
and between groups overtime for CPM and MIPM outcomes (i.e. PPT, PFG 
and ULNDT-RN). The respective marginal means, 95% confidence intervals 
(CI), and p-values of these differences were calculated. The analysis was 
adjusted for CARE, RA rating and sex.  
Number needed to treat (NNT) analysis was also performed for each 
interaction group to compare CPM and MIPM effect using an online NNT 
calculator (Herbert 2013). We defined a difference of 50 kPa (the value used in 
our sample size calculations) between the pre and post PPT measures obtained 
for CPM and MIPM protocols as a clinically positive outcome.   
 Results  
A total of 68 participants met the eligibility criteria and participated in the 
study.  There were no drop-outs. All participants received the intended 
interaction intervention for their group (n=34 per group), and all data were 
analysed. Characteristics of the participants are summarised by group in Table 
5.1. 
5.3.1. Demographics  
There were no significant differences (p>0.05) in the characteristics of 
participants in each of the experimental groups (i.e. affected elbow tested 
(p=0.097), age (p=0.950) and duration of tennis elbow condition (p=0.738). 
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Although there was a greater number of females in the enhanced interaction 
group, the gender difference did not reach significance (p=0.112).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2  Consort Diagram. Flow of participants during the recruitment 
process. 
97 
 
5.3.2. Self-reported measures 
 Patient Reported Tennis Elbow Evaluation (PRTEE) 
There was no statistically significant difference between groups in the PRTEE 
scores (p=0.203, >0.05). The mean PRTEE score was 37.1 points (SD=17.7) for 
the neutral interaction group and 42.5 points (SD=17.1) for the enhanced 
interaction group.  
 
 
 
 
 
 
 
 
 
 
 
 Empathetic interaction outcome measures 
At the end of the interaction there was a significant statistical difference in the 
CARE Measure score (p<0.001) between groups, with the enhanced group 
reporting higher empathy: neutral (27.5, SD=12.6), enhanced (43.8, SD=7.2). 
Table 5.1 Descriptive summaries for the research sample by 
intervention groups. 
Data are presented as mean and standard deviation (SD) unless otherwise specified* 
  Neutral 
n=34 
Mean (SD) 
Enhanced 
n=34 
Mean (SD) 
 
p 
Gender n (%)* F 15 (44.1) 21 (61.8) 0.112 
 M 19 (55.9) 13 (38.2)  
Elbow tested n (%)* L 8 (23.5) 14 (41.2) 
     0.097 
 R 26 (76.5) 20 (58.8) 
Age (years)  50.8 (11.2) 50.6 (9.6) 0.950 
Duration (years) median, (IQR)*  0.6 (0.3, 2.1) 0.5 (0.3, 2.0) 0.738 
PRTEE   37.1 (17.7) 42.5 (17.1) 0.203 
CARE Measure  27.5 (12.6) 43.8 (7.2)    <0.001 
RA rating of rapport (1-10 scale)  8.0 (1.7) 8.8 (1.5) 0.052 
F: female, M: male, L: left, R: right. IQR: interquartile range, PRTEE: patient 
rated tennis elbow evaluation, CARE: consultation and relational empathy 
measure, RA: research assistant. Level of significance, p<0.05 
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The RA rating of the delivery of sessions was close to significant (p=0.052) 
suggesting more effective delivery of the enhanced interaction sessions 
although the scores for both groups were high (8.8/10, SD 1.5 compared with 
8.0/10, SD 1.7) suggesting that the professional actor believed that sessions 
were delivered appropriately.  
5.3.3. Between-time points (all participants) 
 PPT 
CPM and MIPM protocols used change in PPT as the main objective outcome 
measure to compare participants’ analgesic response to neutral or enhanced 
interactions. The overall differences between time-points for all participants 
are presented in Table 5.2. Both interaction groups (all participants) 
demonstrated a significant analgesic effect (increase in PPT), at both wrist and 
elbow sites for CPM (baseline to during (wrist: 88.31; elbow: 87.57, p<0.001) 
and baseline to immediately post CPM (wrist: 41.56; Elbow: 37.59, p<0.001), 
and for MIPM (baseline to post MIPM (wrist: 56.41; elbow: 67.07, p<0.001).  
 PFG and ULNDT-RN 
PFG and ULNDT-RN were used as a secondary outcome measures of 
analgesic effect of MIPM (Table 5.2). All participants exhibited a significant 
increase in PFG (p<0.001) and ULNDT-RN (p<0.001) following CLG in MIPM.   
5.3.4. Time x group interaction effects  
 PPT 
Table 5.3 shows that there were significant group x time interaction effects for 
PPT change at both test sites during CPM (wrist: p<0.001; elbow: p<0.001), post 
CPM (wrist: p<0.001; elbow: p=0.002) and post MIPM (wrist: p=0.004; elbow: 
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p<0.001). In each case, higher levels of analgesia were observed for the 
enhanced interaction group (during CPM mean 113.80 kPa, post CPM mean 
54.80 kPa, post MIPM mean 78.29 kPa) compared to the neural group (during 
CPM mean 62.08 kPa, post CPM mean 24.35 kPa, post MIPM mean 45.20 kPa). 
(Figure 5.3) 
 PFG and ULNDT-RN   
There were no significant group x time interaction effects for change in PFG 
(p=0.398) or ULNDT-RN (p=0.668). (Table 5.3) 
5.3.5. Number needed to treat  
The number need to treat (NNT) values for CPM (baseline to post) and MIPM 
(baseline to post) analgesic effect outcomes were also calculated, with a change 
in PPT of 50kPa or more considered a positive outcome.  Table 5.4 shows that 
there were a greater number of positive outcomes for the enhanced interaction 
group than for the neutral interaction group. NNT values were lower for the 
elbow site for both protocols. The lowest NNT was for MIPM effect at the 
elbow (2.13) indicating a greater influence of the enhanced interaction for this 
measure. 
 Discussion 
The results showed that both groups demonstrated a significant analgesic 
response measured at both the local elbow and more distant wrist sites. There 
was also a significant difference in PPT between both groups over time with 
the enhanced empathetic interaction group demonstrating higher levels of 
analgesia compared to the neutral interaction group. Participants’ evaluation 
of the session also clearly distinguished the enhanced and neutral interaction 
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conditions. In addition, there was a higher number of positive outcomes for 
the enhanced empathetic interaction group. 
This is the second study in this thesis to demonstrate a positive CPM effect in 
a patient population with LE. The finding of efficient CPM in LE is consistent 
with other research in patients with pain states such as: chronic local back pain 
(Gerhardt et al. 2017) and long term trapezius myalgia (Leffler, Hansson & 
Kosek 2002). An efficient CPM response has also been reported in pain-free 
healthy samples (Locke et al. 2014; Pud, Sprecher & Yarnitsky 2005), which 
supports the finding that the endogenous inhibitory system is functional in 
LE. This differs from findings of Lim, Sterling and Vicenzino (2017) as 
discussed in Chapter 4. 
Similar to the previous study (Chapter 4) and other published research (as 
discussed in Chapter 4, Section 4.4), participants in this study showed an 
immediate analgesic effect in response to MIPM and CPM at both test sites. 
There was also a significant overall increase in MIPM secondary outcome 
measures of PFG and ULNDT-NR. This is in agreement with previous research 
in the same clinical group (Vicenzino et al. 1998a; Vicenzino et al. 1998b; 
Vicenzino, Collins & Wright 1996). However, there were no significant 
difference in PFG and ULNDT-RN between both interaction groups. The 
study was powered to detect the difference in PPT (the primary outcome) 
which could explain the lack of statistical difference between the interaction 
groups in these secondary outcome measures. However, further studies are 
required to particularly investigate the effect of empathetic interaction on 
these secondary outcome measures of MIPM analgesia.   
The results indicated that the enhanced interaction group scored higher on the 
CARE Measure as compared to the neutral interaction group. This higher 
score is an indication that the positive and empathetic interactions of the RA 
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actor when dealing with the participants in the enhanced interaction group 
were effective. This between-group difference in the CARE Measure scores 
confirms the RA actor interaction with the enhanced group was clearly distinct 
from the neutral group from the participants’ perspective. The RA rating of 
the effective delivery of the interaction sessions approached significance 
(p=0.052) with a rating for the enhanced interaction group of 8.8/10 indicating 
that the actor found it somewhat easier to deliver the enhanced interaction 
than it was to deliver the more limited, neutral interaction (8/10). The relatively 
high score for both measures however suggests that overall the two different 
types of interaction were appropriately and adequately delivered. 
The current study found that an empathetic interaction improved analgesia 
produced by both CPM and MIPM in an experimental setting. However, this 
finding is not consistent with a recent systematic review of randomised and 
quasi-randomised controlled trials conducted by Mistiaen et al. (2016). The 
authors analysed 14 studies to measure the effect of empathetic manipulation 
on clinical pain. The authors reported that these studies were poor quality, and 
various types of interactions were combined. The majority of these studies 
showed no evidence of the direct influence of empathy on pain, while 4 studies 
demonstrated a weak effect on pain. The authors concluded that the effect of 
empathetic interaction on pain was not strong and the level of evidence was 
very low. Thus, to our knowledge, this is the first well-designed randomised 
controlled study that focuses on the positive effect of empathetic interaction 
on pain relief in musculoskeletal physiotherapy.   
A number of recent studies have highlighted the importance of psychological 
influences on CPM responses. Gougeon et al. (2016) studied the role of 
empathy in influencing CPM during three experimental conditions: pain 
condition, self-observation condition, and spouse-observation condition.    
Both the self-observation and spouse-observation conditions showed 
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Table 5.2  Mixed regression models for CPM and MIPM responses: predicted marginal means adjusted for the CARE 
Measure, RA rating and sex: overall differences between time points (all participants). 
  Pre CPM/MIMP During CPM 
Post 
CPM/MIPM 
Pre to 
During 
CPM 
Pre to post 
CPM/MIPM 
 Mean 95%CI      Mean 95%CI Mean 95%CI       p      p 
CPM Wrist PPT 358.58 
 
332.74 - 386.43 444.81 412.75 - 479.35 399.26     370.49 - 430.26 <0.001 <0.001 
CPM Elbow PPT 238.06 222.01 - 255.27 
 
324.79 302.89 - 348.27 276.21     257.59 - 296.19 <0.001 <0.001 
MIPM Wrist PPT 369.53 340.69 - 400.82 
 
- - 425.39    392.18 - 461.41 - <0.001 
MIPM Elbow PPT 268.13 
 
248.53 - 288.48 
 
- - 335.13 
 
   313.17 - 357.83 
 
- <0.001 
PFG  
 
165.13 149.29 - 181.76 - - 197.61    180.25 - 215.77 - <0.001 
ULNDT-RN             12.63 11.26 - 14.08 - - 17.94     16.30 - 19.66 - <0.001 
CPM: conditioned pain modulation, MIPM: manipulation induced pain modulation, 95% CI: 95% confidence interval, PPT: 
pressure pain threshold, PFG: pain free grip, ULNDT-RN: upper limb neurodynamic test-radial nerve bias. Level of significance, 
p<0.05 
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Figure 5.3   CPM and MIPM PPT predicted marginal means, adjusted for CARE, RA rating and sex: overtime differences 
between enhanced and neutral interaction groups. There were significant differences in CPM (a and b) and MIPM (c and d) 
analgesia, with higher levels of analgesia observed for the enhanced empathetic interaction group at both test sites. Levels  of 
significance <0.05*. 
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Table 5.3  Mixed regression models for CPM and MIPM responses: predicted marginal means adjusted for CARE, RA 
rating and sex: differences between enhanced and neutral interaction groups over time. 
 
CPM: conditioned pain modulation, MIPM: manipulation induced pain modulation, PPT: pressure pain threshold, PFG: pain free 
grip, ULNDT: upper limb neurodynamic test- radial nerve bias 95%CI: 95% confidence interval. Level of significance, P<0.05 
 
Test/ 
measurement  
 
Interaction 
group  
 
 pre CPM/MIMP 
 
During 
CPM 
 
Post 
CPM/MIPM 
Pre to 
During 
CPM 
Pre to  
Post CPM/ 
MIPM 
  Mean 95%CI Mean     95%CI Mean    95%CI p p 
 
CPM Wrist PPT 
Enhanced  
 
341.81 302.31 - 386.47 452.09 399.85 - 511.15 395.46 349.77 - 447.12 
       <0.001        0.002 
Neutral  376.17 332.71 - 425.32 437.65 387.08 - 494.82 403.09 356.51 - 455.75 
 
CPM Elbow PPT 
Enhanced  
 
226.06 201.72 - 253.34 335.54 299.40 - 376.03 276.38 246.62 - 309.74  
    <0.001      0.002 
Neutral  250.70 223.70 - 280.95 314.38 280.53 - 352.32 276.05 246.32 - 309.36 
 
MIPM Wrist 
PPT 
Enhanced  
 
349.86 306.09 - 399.88 _ _ 417.83 365.56 - 477.57 
_     0.004 
Neutral  390.32 341.49 - 446.12 _ _ 433.09 378.91 - 495.01 
 
MIPM Elbow PPT
Enhanced  
 
252.81 222.02 - 285.59 _ _ 337.62 301.89 - 375.35 
_    <0.001 
Neutral  283.91 251.23 - 318.59 _ _ 332.64 297.18 - 370.10 
 
PFG  
 
Enhanced  
 
144.47 120.61 - 170.48 _ _ 172.41 146.24 - 200.73  
    0.398 
Neutral   187.17 159.86 - 216.63 _ _ 224.52 194.51 - 256.69 
 
ULNDT-RN             
Enhanced  
 
12.09 9.94 - 14.46 _ _ 17.13 14.54 - 19.93  
  0.668 
Neutral  13.18 10.93 -15.65 _ _ 18.77 16.06 - 21.70 
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significant CPM effects, even in the absence of a painful conditioning stimulus. 
The authors in their study investigated the impact of participants’ empathy on 
CPM in response to emotional triggers.  Our study however examined the 
effect of empathetic interaction on CPM responses and this has not been 
previously investigated. The current study therefore provides new data in 
relation to the effect of manipulating the empathetic component of the 
patient/therapist interaction on CPM response.  
Evidence from previous research also suggested that enhanced therapeutic 
interactions with patients is significantly associated with better clinical 
outcomes (Hall et al. 2010; O'Keeffe et al. 2016). A recent study by Fuentes et 
al. (2014) manipulated the therapist-patient interaction (enhanced, limited) to 
investigate the pain relieving effect of a single session of interferential current 
(IFC) (sham, active) on chronic low back pain (CLBP). Compared to other 
groups, the group that received active IFC with an enhanced interaction 
experienced the most significant pain relief on a numerical pain scale. There 
was also a significant increase in PPT for both groups (sham, active) when 
combined with an enhanced interaction. The authors concluded that enhanced 
Table 5.4 Number need to treat analysis (NNT) 
Measurement 
of analgesia   
(PPT) 
 
Empathetic interaction 
(no. of positive 
outcomes*) 
Neutral interaction 
(no. of positive 
outcomes) 
NNT  
CPM Wrist 14 8 5.67 
CPM Elbow  16 9 4.86 
MIPM Wrist  21 13 4.25 
MIPM Elbow  28 12 2.13 
PPT: pressure pain threshold, CPM: conditioned pain modulation, MIPM: 
manipulation induced pain modulation. *An outcome was considered positive 
if there was a change in PPT of 50kPa or more.  
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interactions positively influenced clinical outcomes when combined with 
active IFC in the treatment of CLBP. This is in agreement with the findings 
from our study that the enhanced empathetic interaction significantly 
improved the elbow pain in LE. Although Fuentes et al. manipulated the 
enhanced interaction through verbal and nonverbal behaviours and empathy, 
they measured expectancy, but not the empathetic, component of therapeutic 
interactions. Our study however specifically manipulated the empathetic 
interactions and appropriately assessed the interaction using the CARE 
Measure.  
We used the number needed to treat (NNT) analysis to compare the influence 
of the interactions on CPM and MIPM effects. An NNT value of 2.13 for PPT 
change at the elbow following MIPM is a strong indication of the added value 
of empathetic interaction to potentially reduce pain in musculoskeletal 
practice. However, the extent of achieving these potential benefits in different 
musculoskeletal models is unpredictable and as a result it warrants additional 
study.        
 Clinical implications 
The result of this study suggest that patient’s perception of a clinician’s 
empathy is associated with improvement in objective analgesic response. 
Clinicians are often encouraged to be more empathetic as part of a client 
centered approach to achieve better patient outcomes. This notion is based on 
evidence from the business sphere, where clients will be more satisfied with 
the service they receive if they have an enhanced interaction with the service 
provider (Fuertes et al. 2007; Fuertes et al. 2017). Our study findings therefore 
provide objective evidence to support the use of enhanced interaction with 
patients to reduce their pain in any clinical encounter.  
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 Limitations  
There are several potentially limiting factors in this study that need to be taken 
into consideration. First, there was a difference in the gender balance between 
the groups, with the enhanced interaction group having more females (63.6%) 
than the neutral interaction group (45.5%). This might explain the lower 
baseline PPT threshold values recorded for this group, as females tend to have 
lower PPT values than males (Fillingim et al. 2009; Racine et al. 2012; Skovbjerg 
et al. 2017). However, statistically the group gender difference was not 
significant (p=0.112). Having said that, gender was also controlled for in the 
analysis.  
Although interacting for 15 minutes prior to CPM and MIPM protocols was 
sufficient to induce significant analgesic responses in the enhanced interaction 
group in people with LE, it remains unclear whether higher levels of analgesia 
or a positive effect on PFG and ULNDT would have been achieved with a 
longer enhanced interaction. Equally, only the immediate analgesic responses 
of CPM and MIPM were measured. Although, in this study we tried to 
investigate the degree of CPM and MIMP analgesia induced by a short term 
interaction, it would be useful to gather more information on the pattern of 
CPM and MIPM analgesic responses gathered over longer follow-up periods.  
It must be noted that participants underwent diagnostic screening with the 
same assessor who conducted the CPM and MIPM protocols. While it is 
acknowledged that this additional interaction might affected treatment 
responses, it was highly standardised, as neutral as possible and kept to a 
minimum.  
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 Conclusion 
The current study showed that a single session of enhanced empathetic 
interaction positively influenced CPM and MIPM analgesic responses in 
people with LE. Results, however, showed that both interaction groups 
demonstrated high levels of natural analgesia following CPM and MIPM 
protocols. Although this increase in CPM and MIPM responses is not 
necessarily linked to improvement in clinical pain outcomes, CPM and MIPM 
may share similar neurophysiological mechanisms when activating 
endogenous descending pain inhibitory systems.  Further research is 
recommended into the effect of a longer period of enhanced empathetic 
intervention on CPM and MIPM analgesia and into the exact mechanisms 
through which CPM and MIPM exert their effects.     
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 Study Four  
The influence of aerobic exercise on CPM and MIPM analgesia  
 Introduction  
Exercise is a key physiotherapeutic modality that has been shown to improve 
physical (Kaleth et al. 2013), cognitive and psychosocial function (Kennedy et 
al. 2016), and life expectancy (Wen et al. 2011). In people with chronic pain, 
exercise has been shown to improve depression and mood alterations (Hauser 
et al. 2010) and to reduce fatigue and sleep disturbance (Langhorst et al. 2013). 
Further, exercise has been shown to be effective in the management of pain 
associated with chronic musculoskeletal conditions (Ambrose & Golightly 
2015). For example, exercise has been shown to prevent the development 
(Landmark et al. 2013) and subsequent recurrence of chronic low back pain 
(Choi et al. 2010).  
Exercise has also been widely shown to reduce pain sensitivity, a phenomenon 
termed ‘exercise induced analgesia’ (EIA) (Koltyn 2000, 2002). EIA has been 
reported following aerobic (Vaegter, Handberg & Graven-Nielsen 2014), 
isometric (Hoeger Bement et al. 2008), and resistance exercise (Focht & Koltyn 
2009), using a range of pain related modalities (e.g. pressure, thermal or 
electrical stimuli) (Vaegter et al. 2018). In the case of aerobic exercise, EIA is 
induced when performed at moderate to high intensity (Vaegter, Handberg & 
Graven-Nielsen 2014). Naugle, Fillingim and Riley (2012) compared the 
immediate effect of high (75% VO2max) and moderate (50%% VO2max) 
intensity aerobic exercise, elicited by stationary cycling, on the magnitude of 
EIA in healthy participants. The results showed that high intensity exercise 
induced greater levels of EIA than moderate intensity exercise, suggesting a 
dose-response relationship. In contrast, several other studies have reported a 
significant EIA response after high intensity aerobic exercise only (Hoffman et 
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al. 2004; Vaegter, Handberg & Graven-Nielsen 2014).  Thus, the optimal 
intensity for eliciting a significant EIA response needs further investigations.  
While EIA has been clearly demonstrated in healthy individuals (Koltyn 2000; 
Naugle, Fillingim & Riley 2012), the evidence for EIA induction in chronic pain 
conditions is ambiguous. In their review, Cunha et al. (2016) concluded that 
EIA is functional in some chronic musculoskeletal pain states (e.g. 
osteoarthritis (OA), rheumatoid arthritis (RA)) but is impaired in others (e.g. 
fibromyalgia (FM), chronic whiplash disorders). This discrepancy in EIA 
responses between chronic pain conditions could be attributed to a preserved 
endogenous analgesia (EA) system across the chronic pain groups with 
functional EIA. Equally it may be that subgroups within the same pain 
condition exhibit differing levels of EIA (i.e. low pain sensitivity vs. high pain 
sensitivity subgroups), data that is not captured if only group means are 
reported (Vaegter, Handberg & Graven-Nielsen 2016). Consequently, further 
studies are required to clarify the effect of aerobic exercise on EIA in chronic 
pain conditions.  
There is some evidence to suggest that aerobic exercise activates endogenous 
analgesic mechanisms similar to those implicated in conditioned pain 
modulation (CPM) and manipulation induced pain modulation (MIPM) 
analgesia. Cardiovascular and blood pressure changes (i.e. a rise in pulse rate 
and blood pressure) were shown to concurrently occur with EIA (Koltyn & 
Umeda 2006), CPM (Chalaye et al. 2013; Chalaye et al. 2014), and MIPM (Chiu 
& Wright 1996; Sterling, Jull & Wright 2001; Vicenzino et al. 1998b; Vicenzino, 
Collins & Wright 1996; Vicenzino et al. 1995). Similarly, serotonergic 
mechanisms have been reported as being important for EIA (Soares, Naffah-
Mazzacoratti & Cavalheiro 1994; Steinberg et al. 1998), CPM (Yarnitsky 2015), 
and MIPM (Skyba et al. 2003). Naloxone (an opioid antagonist) did not reverse 
MIPM analgesia (Paungmali et al. 2004; Vicenzino et al. 2000; Zusman, 
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Edwards & Donaghy 1989), suggesting a non-opioid mechanism.  However, 
the effect of naloxone on CPM and EIA is inconclusive: some studies show that 
naloxone reversed EIA (Haier, Quaid & Mills 1981) and CPM analgesia (King 
et al. 2013; Pertovaara et al. 1982; Willer, Le Bars & De Broucker 1990); while 
other studies report no reversal (EIA: (Droste et al. 1991); CPM: (Edwards, 
Ness & Fillingim 2004; Hermans et al. 2018; Peters et al. 1992)). Consequently, 
there is some ambiguity regarding the involvement of the opioid system in 
EIA and CPM. Further research to elucidate the exact mechanisms involved in 
each form of EA is needed.   
Functional EIA has been shown to be associated with efficient CPM analgesia 
(Lemley, Hunter & Bement 2015; Vaegter, Handberg & Graven-Nielsen 2014; 
Vaegter et al. 2015). Fingleton, Smart and Doody (2017) compared EIA 
responses in patients with knee OA between those with efficient and 
inefficient CPM. EIA was induced by 5 minutes of isometric knee extension 
followed by 4-10 minutes of aerobic cycling (cycling exercise was terminated 
if the knee pain exceeded 3/10 irrespective of reduced workload). The efficient 
CPM group showed a functional EIA response, while the inefficient CPM 
group showed a dysfunctional EIA response, both during and post aerobic 
and isometric knee exercises. Further, in a comparison between groups of 
inactive and active healthy volunteers, Vaegter et al. (2018) compared between 
the EIA induced after 15 minutes of high intensity aerobic cycling (75% 
VO2max) and CPM analgesia. Higher levels of EIA and stronger CPM effect 
were demonstrated by the active group, although EIA and CPM analgesia 
were positively associated in both groups.  
Based on these findings, it may be hypothesized that a similar association may 
exist between EIA and MIPM analgesia. It may also be that there is potential 
for MIPM analgesia to be potentiated by a preliminary period of aerobic 
exercise. Exercise and manual therapy are often combined within a 
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multimodal program to reduce pain in conditions such as chronic low back 
pain (Chan, Mok & Yeung 2011; Childs et al. 2004; Cleland et al. 2009; 
Hallegraeff et al. 2009). However, these studies have not specifically examined 
the immediate combined effect of aerobic exercise and manual therapy on 
chronic pain.    
The first aim of this randomized, controlled study was to compare the 
immediate effect of a single session of moderate or high intensity aerobic 
exercise using a cycle ergometer on pain in a patient population with lateral 
epicondylalgia (LE). The second aim was to determine whether aerobic 
exercise potentiates CPM and MIPM analgesia, and whether it affects both 
CPM and MIPM responses to a similar degree. The third aim was to assess the 
association between EIA and CPM and MIPM analgesia.  
 Methods  
6.2.1. Null hypotheses 
1. There will be no difference in the magnitude of exercise induced 
analgesia (EIA) between those participants who receive moderate 
intensity aerobic exercise and those who receive high intensity aerobic 
exercise.  
2. There will no difference between time points (i.e. during and post CPM 
and MIPM) in the level of CPM and MIPM analgesia, relative to 
baseline, detected by measures of PPT at the wrist and elbow (all 
participants).  
3. There will be no difference in the magnitude of CPM and MIPM 
analgesia between those participants who receive moderate intensity 
aerobic exercise and those who receive high intensity aerobic exercise.  
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4. There will be no correlation between magnitudes of EIA and MIPM and 
CPM analgesia as detected by measures of PPT at the wrist and elbow. 
6.2.2. Study design  
A randomised, controlled between-group experimental design was used in 
this study. Eligible participants were randomised to receive either moderate 
intensity aerobic exercise (control condition) or high intensity aerobic exercise 
(active condition) during two separate test sessions. (See protocol description)  
6.2.3. Randomisation 
A randomisation sequence was computer-generated and held by the 
Physiotherapy Clinic supervisor at Curtin University, who was not involved 
in delivery of care or assessment of outcomes for the study. Randomisation 
was stratified for males and females. Prior to commencing each testing session, 
a research assistant contacted the holder of the allocation schedule to ascertain 
group allocation for each participant. This research assistant conducted the 
aerobic exercise sessions. The primary investigator (AM) who undertook all 
outcomes testing remained blind to group allocation throughout the study. 
6.2.4. Participants  
A gender stratified convenience sample was used to recruit 68 participants 
with LE, aged between 18 and 60 years, from Perth, Western Australia. 
Recruitment took place from October 2017 until June 2018 through Curtin 
Radio advertisements, adverts in sports clubs, via a range of musculoskeletal 
and sports physiotherapy clinics and through a specialised social media 
clinical trials recruitment agency.  
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6.2.5. Eligibility criteria  
Inclusion (Haker & Lundeberg 1990) and exclusion criteria were as outlined in 
Chapter 4, Section 4.2.3. Participants were excluded if they were found 
ineligible for aerobic exercise intervention.  
Participants were initially contacted via phone to screen for eligibility and to 
provide a brief explanation of the study protocol. Additional information 
about the study was provided via email. Prior to commencing the study, each 
participant underwent a thorough clinical examination, carried out by the 
primary investigator to confirm eligibility. Participants were also required to 
complete the Adult Pre-exercise Screening System (APSS) tool, a tool 
developed by Exercise and Sport Science Australia (ESSA), Fitness Australia 
(FA), and Sports Medicine Australia (SMA) to assess participants’ eligibility 
and safety for aerobic exercise testing (Norton 2012). All testing was carried 
out at the Physiotherapy Clinic, School of Physiotherapy and Exercise Science, 
Curtin University. Participants were asked to abstain from taking pain 
medications 24 hours prior to initial testing and to avoid any additional 
physiotherapy treatment or other physical treatments (e.g. physical exercise, 
aerobic exercise, chiropractic or acupuncture) 3 days before and on the testing 
day.  
Curtin University Human Research Ethics Committee approved the study 
(HREC project approval number: HRE2017-0198-02). The study was also 
prospectively registered with the Australia New Zealand Clinical Trials 
Registry (ANCTR) (ID number ACTRN12617000219381). Written informed 
consent was obtained from all participants before the start of testing.   
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6.2.6. Procedure  
After confirming eligibility, the primary investigator tested all participants for 
pressure pain threshold (PPT) at both elbow and wrist test sites, as described 
below, and then left the room. These PPT values were used as the baseline 
value for EIA calculations (Baseline 1). Following baseline PPT measurement, 
the aerobic exercise session was then conducted under the supervision of a 
research assistant who had received training in the exercise protocol. 
Participants were allocated to receive either moderate (50% HRmax) or high 
intensity (75% HRmax) aerobic exercise based on the randomisation schedule. 
Each participant completed two sessions, both at the same exercise intensity, 
separated by three days. Following the completion of the cycling exercise, the 
primary investigator re-entered the room and conducted either a CPM or a 
MIPM assessment protocol, in a random order. In both cases, a second set of 
PPT measures (Baseline 2) were taken before the CPM or MIPM stimulus was 
applied. These measures provided an indication of the EIA effect and 
constituted a baseline measure to assess the CPM or MIPM response. 
Additional sets of PPT measures were then taken during and post CPM and 
MIPM stimuli respectively, as described below. All PPT assessments was 
performed by the primary assessor, who remained blind to the experimental 
group of each participant. (Figure 6.1) 
6.2.7. Pain-related outcome measures  
Pain-related measures of pressure pain threshold (PPT), pain free grip (PFG) 
and the upper limb neurodynamic test with radial nerve bias (ULNDT_RN) 
measures were measured using the same methodology outlined in Chapter 4, 
Section 4.2.4. All measures were obtained in triplicate. PPT measures were 
assessed at the wrist and elbow test sites. 
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6.2.8. Assessment protocols 
Conditioned pain modulation (CPM) and manipulation-induced pain 
modulation (MIPM) assessment protocols were performed using the same 
methodology described in Chapter 4, Section 4.2.5.  The mobilisation stimulus 
was carried out by an experienced practitioner who was different from the 
main investigator. The change in PPT at each test site from Baseline 1 (pre-
exercise task) to during and post conditioning and mobilisation stimuli was 
considered as the CPM and MIPM analgesic effects, respectively.   
6.2.9. Exercise-induced analgesia (EIA) 
EIA was calculated as the change in PPT at each test site from pre-exercise 
(Baseline 1) to pre-conditioning stimulus (CPM) or mobilisation stimulus 
(MIPM), depending on test day (Baseline 2). 
 
Figure 6.1  Testing session with inhibitory assessment protocols. PPT: pressure 
pain threshold, CPM: conditioned pain modulation, MIPM: manipulation induced 
pain modulation  
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6.2.10. Tennis Elbow specific assessment instrument 
At test session one, before physical testing, all participants were asked to 
complete the Patient Rated Tennis Elbow Evaluation (PRTEE) as described in 
Chapter 4, Section 4.2.6.  
6.2.11. Physical activity assessment  
Participants were also asked to complete at baseline the Global Physical 
Activity Questionnaire (GPAQ) (World Health Organization 2005) to evaluate 
their physical activity levels. This is a 16-question self-report questionnaire 
measuring the typical weekly time spent on three main domains of physical 
activities (work, transport and recreation) and sedentary behaviour. The total 
GPAQ score was calculated using the GPAQ guidelines (World Health 
Organization 2005) to analyse the data. The total amount of physical activity 
expressed as Metabolic Equivalents (MET)-minute/week was used for 
analysis. The GPAQ was shown to be a reliable measure (moderate to 
substantial strength, Kappa: 0.67-0.73) of physical activity, with a moderate to 
strong concurrent validity (0.45 to 0.65) compared to the International Physical 
Activity Questionnaire (IPAQ) and a poor to fair criterion validity (0.06 to 0.35) 
(Bull, Maslin & Armstrong 2009).  
6.2.12. Experimental conditions 
The method described here is based on a study by Naugle et al. (2014). 
Participants completed two separate stationary cycling sessions, both at either 
high or moderate intensity (randomly allocated) and for 15 minutes duration. 
The primary investigator was not present in the room at any time during the 
exercise sessions. Before starting the first session, a target heart rate (THR) was 
calculated for each participant by the study research assistant, based on age-
predicted maximal heart rate (HRmax), where maximal HR = 220-age (Fox & 
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Naughton 1972). THR for those in the high intensity group was determined 
using the formula maximal HR × 75%. THR for those in the moderate intensity 
group was calculated as maximal HR × 50%.  
All participants completed their exercises sessions using a cycle ergometer 
(828E Ergometer, Monark, Vansbro, Sweden). The cycle seat post was 
individually adjusted so that the participant’s knee remained at approximately 
5˚ flexion when the pedal was at the bottom of a revolution, with the ankle 
held in neutral. Heart rate was monitored during exercise using a chest heart 
rate monitor (Monark Heart Rate Monitor, Monark Exercise AB), which was 
fitted at the start of the session. The targeted exercise intensity level was 
achieved through adjusting the speed and the resistance of the cycle 
ergometer. Participants started the exercise session by warming up for 5 
minutes. For the first two minutes, participants cycled at low intensity (HR = 
40%-45% maximal HR) to familiarise themselves with the cadence. The 
resistance was then gradually increased over the next three minutes to reach 
the desired THR by the end of the first 5 minutes. Participants then continued 
cycling for the following 10 minutes while maintaining the exercise intensity 
at THR. Heart rate was continuously monitored to stay within a range of 10% 
above and 5% below the THR. Every five minutes during the cycling session 
participants were instructed to rate their perceived exertion (RPE) using the 
Borg-Scale (6-20) (Borg 1998). Heart rate (beats/minute) and workload (in 
watts) were recorded every minute during the first five minutes and every 30 
seconds and one minute, respectively, during the main exercise session. Mean 
RPE, HR and workload data collected during the 10 minutes of the high 
aerobic intensity was used for the analysis.  
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6.2.13. Sample Size calculation  
Sample size was calculated using the same methodology described in Chapter 
5, Section 5.1.2.13. A priori power analysis (alpha = 0.05, beta = 0.80) indicated 
a required sample size of 68 (34 per group).  
6.2.14. Statistical analysis 
Data were analysed using Stata/IC (version 15.0: StataCorp LLC, TX). For all 
analyses, p<0.05 was considered statistically significant. Descriptive statistics 
were based on frequency distributions for categorical data (gender and elbow 
tested) and means and standard deviations (SD) (age, PRTEE and RPE) or 
medians and interquartile ranges (IQR) for continuous data (duration of LE, 
GPAQ, HR, workload). Univariate group comparisons between intervention 
groups at baseline and during exercise sessions included χ2 and Fisher exact 
tests for categorical comparisons, and independent t-tests or Mann-Whitney U 
tests for continuous outcomes, as suitable.   
All outcome data were evaluated for normality using Shapiro-Wilk tests and 
graphical review.  Non-normally distributed data (PPT, PFG, ULNDT-RN) 
were transformed using natural logarithms.  
For hypotheses 1, 2 and 3, linear mixed models with random subject effects 
were used to calculate the overall differences (relative to baseline PPT 
measures) between time points (all participants) and between exercise groups 
over time for EIA, CPM and MIPM outcome variables (i.e. PPT, PFG and 
ULNDT-RN). The respective marginal means, 95% confidence intervals (CI), 
and p-values of these differences were calculated. The analysis was controlled 
for PRTEE, GPAQ and sex.  
For hypothesis 4, partial correlations and univariate regression models were 
run to determine the relationships between EIA (i.e. independent variable) 
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and CPM and MIPM analgesia (i.e. dependent variables), measured both 
during and post cold water immersion / mobilisation stimuli at both test sites. 
The strength of the correlations were interpreted according to the guidelines 
defined by Cohen (1988): (small: 0.10 ≤ r ≤ 0.29; medium: 0.30 ≤ r ≤0.49; large: 
0.50≤ r ≤1.0). Univariate regression models were used to calculate regression 
coefficients (B), and their 95% confidence intervals (CI) and p-values. The 
adjusted coefficients of determination (adj. R2) were also calculated in order to 
determine the proportion of variability in CPM /MIPM PPT (dependent 
variable) that is explained by post cycling PPT (EIA, explanatory variable). 
Due to the anticipated between-individual variability in PPT, baseline PPT 
(Baseline 1) was identified as a potential confounder for the association and 
therefore it was adjusted for in the partial correlations and regression analyses.  
 Results  
A total of 68 participants met the eligibility criteria and participated in the 
study.  All volunteers were randomly allocated into each group (n=34), 
received the intended aerobic exercise interventions, completed both CPM and 
MIPM assessment sessions, and were analysed with regards to outcomes 
(Figure 6.2). Characteristics of all participants are summarised by group in 
Table 6.1.  
6.3.1. Demographics  
There were no significant differences between exercise groups (p>0.05) in 
demographic characteristics of participants: gender (p=1.00), affected elbow 
tested (p=1.00), age (p=0.571) and duration of tennis elbow condition (p=0.551). 
There were equal numbers of females 12 and males 22 in each aerobic exercise 
group.  
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6.3.2. Self-reported measures at baseline 
 PRTEE 
There was no statistical difference in the PRTEE scores between exercise 
groups (p=0.960, >0.05): mean PRTEE scores 37.59 (SD=14.44) for the moderate 
intensity aerobic group; 37.78 (16.79) points for the high intensity group.  
 GPAQ 
The GPAQ scores were also not significantly different between groups 
(p=0.883): moderate intensity group 3090 MET-minute/week, (IQR=1660-5760; 
high intensity group 2960 MET-minute/week, (IQR=1440-5720).  
6.3.3. Exercise intensity measurements during cycling tasks  
There were statistically significant differences between the exercise groups 
during their two cycling sessions in exercise intensity measurements (Table 
6.2).  As anticipated, the high intensity group maintained significantly higher 
HR (beats/minute, p<0.001) and workload (Watts, p<0.001) and reported 
significantly higher perceived exertion (Borg, p<0.001). 
6.3.4. Between time points differences (all participants)  
 PPT 
Both aerobic exercise groups (all participants) exhibited a significant increase 
in all PPT measures for both CPM and MIPM protocols) at the wrist and elbow 
sites from Baseline 1 (pre cycling) to: Baseline 2 (immediately post cycling - 
EIA effect) p<0.001 for both sites; during CPM p<0.001 both sites, and during 
MIPM p<0.001 both sites; and immediately post both CPM and MIPM, p<0.001 
both protocols and both sites). (Table 6.3) 
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Figure 6.2  Consort diagram illustrating overall experimental procedure    
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 Table 6.1  Descriptive summaries for the research sample by intervention groups. 
Data are presented as mean and standard deviation (SD) unless otherwise specified* 
 
 
 Sample 
(N=68) 
Moderate intensity 
(n=34) 
High intensity  
(n=34) 
p 
Gender n (%)* F 24 (35.29) 12 (35.29) 12 (35.29) 1.000 
 M 44 (64.71) 22 (64.71) 22 (64.71)  
Elbow tested n (%)* L 29 (42.65) 15 (44.12) 14 (41.18) 1.000 
 R 39 (57.35) 19 (55.88) 20 (58.82)  
Age (year)  46.47 (9.62) 45.80 (9.57) 47.14 (9.77) 0.571 
Duration Median (IQR)(year)*  0.67 (0.42, 1.5) 0.58 (0.38, 2) 0.67 (0.50, 1.50) 0.551 
PRTEE   37.68 (15.54) 37.59 (14.44) 37.78 (16.79) 0.960 
GPAQ Median (IQR)* 
(MET-min/week)  
 3090 (1650, 5740) 3090 (1660, 5760) 2960 (1440, 5720) 0.883 
F: female, M: male, L: left, R: right, PRTEE: patients rated tennis elbow evaluation, GPAQ: general 
physical activity questionnaire, MET: metabolic equivalent. IQR: interquartile range, SD: standard deviation. 
Level of significance, p<0.05. 
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 PFG and ULNDT-RN (MIPM protocol only) 
PFG and ULNDT-RN were used as secondary measures of the analgesic effect of 
MIPM. Both aerobic exercise groups exhibited a significant increase in PFG (p<0.001) 
and ULNDT-RN (p<0.001) from pre to post MIPM (Table 6.3). 
 
 
 
 
 
 
 
 
 
6.3.5. Between-group differences over time (group x time 
interaction effect)  
 PPT 
There were significant group x time interaction effects for PPT both at the elbow and 
the wrist test sites at Baseline 2 (immediately post cycling) (p <0.001), during CPM (p 
<0.001), during MIPM (p <0.001), post CPM (p <0.001) and post MIPM (p <0.001). 
Significantly higher levels of PPT (analgesia) were measured for the high intensity 
exercise group at both sites across all time-points (Table 6.4 and Figure 6.3). The 
percentage change in PPT (kPa) from Baseline 1 (pre cycling) to each time-point at 
Table 6.2  Exercise intensity measurements for each exercise group 
during CPM and MIPM assessment session  
Data summarised as median (IQR) (except RPE data summarised as mean (SD))  
Exercise descriptor  
  
Moderate intensity 
 (n=34) 
High intensity     
    (n=34) 
p 
 
CPM cycling     
   HR  89.65 (85.9, 95.3) 134.75 (126, 144.2) <0.001 
   Workload 31.6 (21, 55.8) 112.6 (83.8, 158.7) <0.001 
   RPE (6-20) 9.68 (2.15) 13.29 (1.79) <0.001 
MIPM cycling     
   HR 89.95 (84.8, 97.4) 134.65 (126.9, 140.9) <0.001 
   Workload 39.55 (59.2, 23.6) 104.45 (73.8, 154.7) <0.001 
   RPE (6-20) 10.26 (1.82) 13.34 (1.81) <0.001 
HR: heart rate (beats/minute), workload (watt), RPE: rating of perceived 
exertion (Borg), IQR: interquartile range, SD: standard deviation. Level of 
significance p<0.05  
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both test sites for each exercise group is shown in Figure 6.4. There was an increase in 
PPT (decreased sensitivity) for both exercise groups, for all inhibitory protocols (EIA, 
CPM and MIPM), but this analgesic effect was considerably greater in the high 
intensity exercise group. This analgesic effect was consistently greater at the affected 
elbow rather than the wrist site, for all protocols. Further, there was a clear additive 
analgesic effect for both CPM and MIPM after exercise (on EIA). For example, for the 
high intensity group, the percentage increase in PPT at the elbow improved from 
72.70% immediately following exercise to 125.50% during CPT, and to 119.60% during 
mobilisation. Data additionally show that whereas the CPM effect started to reduce 
immediately post CPT completion, it continued to increase immediately following 
mobilisation. 
 PFG and ULNDT-RN   
There was a significant group x time interaction effect for change in ULNDT-RN 
(p<0.001) but this did not quite reach significance for PFG (p=0.052) (Table 6.4).  
6.3.6. Between-group differences over time (group x time 
interaction effect) whilst controlling for Baseline 2  
The same analysis performed above was conducted without including Baseline 1 data 
and controlling for differences in Baseline 2 data (See Table 6.5). There were significant 
group x time interaction effects for PPT both at the wrist test sites during (p <0.001) 
and post (p <0.001) CPM and MIPM. While the over time differences between both 
groups for PPT at the elbow region were significant post CPM (p=0.016), during MIPM 
(p=0.037) and post MIPM (p=0.010), the difference was not significant during CPM 
(p=0.335). The high intensity group demonstrated significantly higher levels of CPM 
and MIPM analgesia (PPT) at both test sites across all times points, except for the PPT 
measured during CPM at the elbow region. When controlling for Baseline 2 in this 
analysis, the analgesic responses become more variable at the elbow compared to 
those at the wrist that have been consistent across all time points in the both analyses.    
126 
 
6.3.7. The correlation between EIA and CPM analgesia  
There were significant positive and large partial correlations between PPT values 
measured post aerobic exercise (EIA) and PPT values during (p<0.001) and post 
(p<0.001) cold water immersion (CPM), with Pearson correlation coefficients (r) 
ranging between 0.90 and 0.93. The subsequent regression analyses showed that EIA 
is a significant predictor of CPM PPT measured at both test sites during (p <0.001) and 
post cold water immersion (p <0.001). The adjusted coefficient of determination (adj. 
R2) values range between 0.92 and 0.95. This indicates that, based on this research 
sample, between 92% and 95% of the variability in CPM PPT measures is explained 
by the EIA response. The correlation and regression analyses of the association 
between EIA and CPM analgesia, adjusting for baseline PPT values, are presented in 
Table 6.6. 
6.3.8. The correlation between EIA and MIPM  
The partial correlation and regression analyses for the association between PPT values 
measured post aerobic exercise (EIA) and PPT measured during and post the 
mobilisation stimulus (MIPM) are presented in Table 6.7. Significant positive, large 
partial correlations were seen between EIA and MIPM analgesia measured during 
(p<0.001) and post (p<0.001) the mobilisation stimulus (r values range between 0.68 
and 0.86). The regression analyses, adjusting for baseline PPT, show that EIA is a 
significant predictor of MIPM PPT measured at both sites during (p <0.001) and post 
mobilisation (p<0.001). The adj. R2 values range between 0.73 and 0.93. This indicates 
that based on this cohort between 73% and 93% of the variability in MIPM PPT 
measures is explained by the EIA response. 
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 Table 6.3  Mixed regression models for CPM and MIPM responses: predicted marginal means adjusted for PRTEE, GPAQ and 
sex: overall differences between time points (all participants). 
 
 
 
 Baseline 1 (pre-cycling) 
Baseline 2 
(pre CPM/MIMP) 
During 
CPM/MIPM 
Post 
CPM/MIPM 
Baseline 1 
to Baseline 
2 (EIA 
effect) 
Baseline 1  
to During 
CPM/ 
MIPM 
Baseline 1 to 
Post CPM/ 
MIPM 
*pre-post 
MIPM 
 Mean 95%CI Mean 95%CI Mean 95%CI Mean 95%CI      p       p      p 
CPM Wrist PPT 494.48 
 
463.60 - 527.42 
 
609.44 
 
571.38 - 650.04 
 
731.70 
 
    686.00 - 780.44 
 
671.62 
 
     629.68 - 716.36 
 
<0.001 <0.001 <0.001 
CPM Elbow PPT 274.91 
 
255.48 - 295.83 
 
390.16 
 
362.58 - 419.83 
 
502.50 
 
   466.98 - 540.73 
 
446.02 
 
     414.49 - 479.95 
 
<0.001 <0.001 <0.001 
MIPM Wrist PPT 490.32 
 
458.38 - 524.48 
 
590.88 
 
552.39 - 632.05 
 
665.31 
 
621.97 - 711.66 
 
682.20 
 
 637.76 - 729.73 
 
<0.001 <0.001 <0.001 
MIPM Elbow PPT 270.36 
 
248.64 - 293.97 
 
382.17 
 
351.47 - 415.54 
 
469.71 
 
431.99 - 510.74 
 
479.45 
 
 440.94 - 521.32 
 
<0.001 <0.001 <0.001 
PFG  
 
  216.72 
 
201.52 - 233.08 
 
  255.71 
 
  237.77 - 275.00 
 
  <0.001* 
ULNDT-RN                13.27 12.08 - 14.58   20.16  18.36 - 22.15 
 
        <0.001* 
CPM: conditioned pain modulation, MIPM: manipulation induced pain modulation, PPT: pressure pain threshold, PFG: pain free grip, ULNDT: upper limb neurodynamic 
test-radial nerve bias, 95%CI: 95% confidence interval. Level of significance, p<0.05 
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Table 6.4  Mixed regression models for CPM and MIPM predicted marginal means, adjusted for PRTEE, GPAQ and sex: 
differences between moderate and high intensity aerobic groups over time. 
 
CPM: conditioned pain modulation, MIPM: manipulation induced pain modulation, PPT: pressure pain threshold, PFG: pain free grip,    
ULNDT: upper limb neurodynamic test- radial nerve bias, 95%CI: 95% confidence interval. *pre-post MIPM. Level of significance, p<0.05 
 
 
Measurement  
 
Exercise 
group 
 
Baseline 1 
(pre-cycling) 
 
Baseline 2 
(pre CPM/MIMP) 
 
During 
CPM/MIPM 
 
Post 
CPM/MIPM 
Baseline 1 
to Baseline 
2 (EIA 
effect) 
Baseline 1 
to During 
CPM/ 
MIPM 
Baseline 1 to 
Post CPM/ 
MIPM 
*pre-post 
MIPM 
  Mean 95%CI Mean 95%CI Mean 95%CI Mean 95%CI p p p 
 
CPM Wrist PPT 
Moderate 
 
508.02 
 
  468.15 - 551.28 
 
544.29 
 
   501.58 - 590.65 
 
629.67 
 
580.25 - 683.29 
 
579.15 
 
  533.70 - 628.47  
<0.001 
(EIA) 
<0.001  <0.001 High  
 
481.31 
 
  443.54 - 522.30 
 
682.39 
 
   628.83 - 740.50 
 
850.27 
 
783.55 - 922.69 
 
778.86 
 
  717.74 - 845.19 
 
CPM Elbow PPT 
Moderate  
 
286.16    260.51 - 314.34 340.80 310.25 - 374.37 
 
433.97 395.06 - 476.70 
 
378.63     344.69 - 415.92 
  <0.001 
    (EIA) 
<0.001 <0.001 High 
 
264.11 240.43 - 290.12 446.66 406.61 - 490.64 
 
581.86 529.70 - 639.16 
 
525.40   478.30 - 577.14 
 
 
MIPM Wrist PPT 
Moderate  
 
498.29 
 
  457.13 - 543.15 
 
541.02 
 
496.34 - 589.73 
 
571.79 
 
524.57 - 623.27 
 
578.57 
 
530.78 - 630.66 
  <0.001 
     (EIA) 
<0.001 <0.001 High  
 
482.48 
 
  442.63 - 525.92 
 
645.33 
 
592.03 - 703.43 
 
774.11 
 
710.18 - 843.81 
 
804.38 
 
737.95 - 876.80 
 
 
MIPM Elbow PPT 
Moderate  
 
271.23 244.06 - 301.43 325.75 293.11 - 362.02 
 
387.81 348.96 - 430.99 392.90   353.54 - 436.65  
<0.001 
    (EIA) 
<0.001 <0.001 High  
 
269.48 242.49 - 299.49 448.36 403.44 - 498.28 
 
568.91 511.91 - 632.25 
 
585.07   526.45 - 650.21 
 
PFG  
 
Moderate  
 
  212.30 191.71 - 235.11   243.09   219.51 - 269.21   
0.052* High  
 
  221.24    199.77 - 245.00   268.99   242.90 - 297.89   
 
ULNDT-RN              
Moderate  
 
   12.05 
 
  10.67 - 13.63 
 
  16.70 
 
14.77 - 18.88 
 
  
<0.001* High  
 
  14.62 12.93 - 16.52   24.35   21.54 - 27.53   
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Figure 6.3  Significant group x time interaction effects for PPT both at the wrist (a and c) and the elbow (b and d) test 
sites, with higher PPT values measured for the high intensity aerobic exercise group at baseline 2 (post cycling), 
during CPM/MIPM, post CPM/MIPM. Level of significance, p<0.05* 
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Table 6.5  Mixed regression models for CPM and MIPM predicted marginal means, adjusted for Baseline 2 (dropping Baseline 1), 
PRTEE, GPAQ and sex: differences between moderate and high intensity aerobic groups over time. 
 
CPM: conditioned pain modulation, MIPM: manipulation induced pain modulation, PPT: pressure pain threshold, PFG: pain free grip,    
ULNDT: upper limb neurodynamic test- radial  nerve bias, 95%CI: 95% confidence interval. *pre-post MIPM. Level of significance, p<0.05 
 
 
 
 
Exercise 
intensity 
group 
 
Baseline 2 
(pre CPM/MIMP) 
 
During 
CPM/MIPM 
 
Post 
CPM/MIPM 
Baseline 
2 to 
During 
CPM/ 
MIPM 
Baseline 2 to  
Post CPM/ 
MIPM 
*pre-post 
MIPM 
  Mean 95%CI Mean     95%CI Mean    95%CI p p 
 
CPM Wrist PPT 
Moderate 
 
544.30 502.32 - 589.79 629.67 581.10 - 682.29 
 
 579.15 534.48 - 627.55 
 <0.001  <0.001 High  
 
682.38 629.75 - 739.41 850.27 784.69 - 921.33 778.86 718.79 - 843.95 
 
CPM Elbow PPT 
Moderate  
 
340.83 
 
310.58 - 374.02 
 
434.00 395.49 - 476.26 378.66 345.06 - 415.54 
  0.335   0.016 High 
 
446.62 406.99 - 490.11 581.82 530.19 - 638.48 525.36 478.74 - 576.52 
 
MIPM Wrist PPT 
Moderate  
 
541.02 497.58 - 588.25 571.79 525.88 - 621.71 578.57 532.11 - 629.07 
 <0.001  <0.001 High  
 
645.33 593.52 - 701.67 774.11 711.97 - 841.70 804.34 739.80 - 874.61 
 
 
MIPM Elbow PPT 
Moderate  
 
325.76 294.68 - 360.13 387.83 350.81 - 428.75 392.92 355.42 - 434.37 
 0.037      0.010 High  
 
448.34 405.55 - 495.65 568.89 514.60 - 628.92 585.05 529.21 - 646.78 
 
PFG  
 
Moderate  
 
212.30 191.71 - 235.11 - - 243.09 219.51 - 269.21 
 
 
    0.052 High  
 
221.23 199.77 - 245.00 - - 269.00 242.90 - 297.89 - 
 
ULNDT-RN             
Moderate  
 
12.05 10.66 - 13.63   16.70 14.77 - 18.88  
   <0.001 High  
 
14.62  12.93 - 16.52   24.35 21.54 – 27.53  
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Table 6.6  Regression models for EIA and CPM analgesia within different time points adjusted for baseline PPT 
EIA PPT (time point) 
vs. 
CPM PPT (time point) 
Partial 
correlation 
coefficient (r) 
Regression 
coefficient 
B 
Standard 
error 
(B) 
95%CI 
(B) 
Adjusted 
R2 
p 
(r) 
p 
(B) 
p 
(F-test) 
 
EIA PPT Wrist 
vs. 
CPMPPT Wrist During 
0.90 0.70 0.04 0.62 - 0.79 0.94 <0.001 <0.001 <0.001 
EIA PPT Elbow 
vs. 
CPMPPT Elbow During 
0.92 0.88 0.05 0.79 - 0.98 0.92 <0.001 <0.001 <0.001 
EIA PPT Wrist 
vs. 
CPM PPT Wrist Post 
0.90 0.72 0.04 0.63 - 0.80 0.95 <0.001 <0.001 <0.001 
EIA PPT Elbow 
vs. 
CPM PPT Elbow Post 
0.93 0.86 0.04 0.77 - 0.94 0.93 <0.001 <0.001 <0.001 
CPM: conditioned pain modulation, MIPM: manipulation induced pain modulation, PPT: pressure pain threshold, 
95%CI: 95% confidence interval. Level of significance, P<0.05 
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Table 6.7  Regression models for EIA and MIPM analgesia within different time points adjusted for baseline PPT 
EIA  PPT (time point) 
vs. 
MIPM PPT (time point) 
Partial 
correlation 
coefficient 
(r) 
Regression 
coefficient      
B 
Standard 
error 
(B) 
95%CI 
(B) 
Adjusted 
R2 
 
p 
(r) 
p 
(B) 
 
p 
(F-test) 
EIA PPT Wrist 
vs. 
MIPM PPT Wrist During 
0.86 0.60 0.05 0.51 - 0.69 0.93 <0.001 <0.001 <0.001 
EIA PPT Elbow 
vs. 
MIPM PPT Elbow During 
0.68 0.58 0.08 0.42 - 0.73 0.73 <0.001 <0.001 <0.001 
EIA PPT Wrist 
vs. 
MIPM PPT Wrist Post 
0.86 0.59 0.04 0.51 - 0.68 0.93 <0.001 <0.001 <0.001 
EIA PPT Elbow 
vs. 
MIPM PPT Elbow Post 
0.86 0.75 0.05 0.64 - 0.85 0.89 <0.001 <0.001 <0.001 
CPM: conditioned pain modulation, MIPM: manipulation induced pain modulation, PPT: pressure pain threshold, CI: 
confidence interval. Level of significance, p<0.05 
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 Discussion  
This study showed that participants with lateral epicondylalgia (LE) 
demonstrated a significant increase in PPT (analgesic response) at both a local 
(elbow) and more distant test site immediately post aerobic exercise indicating 
an exercise induced analgesia (EIA) response, regardless of exercise intensity. 
Participants also showed a significant CPM and MIPM response immediately 
following both moderate and high intensity aerobic exercise. Significantly 
higher levels of analgesia as indicated by higher PPT measures were however 
seen for the high intensity aerobic exercise group at each time-point post 
exercise and during CPM and MIPM testing. The study further showed that 
the EIA response was significantly correlated with the analgesic response 
induced by both CPM and MIPM. 
To our knowledge, this is first study to investigate the effect of aerobic exercise 
on pain sensitivity in LE. The results showed a significant increase in PPT at 
 
 
Figure 6.4  Percentage change in PPT at the wrist and elbow from Baseline 1 (pre-
cycling) to each time-point: post cycling (EIA effect), during CPM/MIPM, post 
CPM/MIPM. 
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the wrist and elbow and therefore a significant generalised hypoalgesic effect 
of exercise-induced analgesia (EIA). This supports other studies reporting a 
significant EIA response following aerobic exercise in healthy participants 
(Kodesh & Weissman-Fogel 2014; Koltyn 2000; Naugle, Fillingim & Riley 2012) 
and in chronic pain conditions such as rheumatoid arthritis (Meeus et al. 2015), 
and chronic low back pain (Hoffman et al. 2004; Meeus et al. 2010). In further 
agreement with previous studies, our study showed significant EIA responses 
at remote non-exercising locations (i.e. wrist and elbow) (Koltyn et al. 1996; 
Naugle et al. 2014). This appears to indicate a generalised pain inhibitory effect 
(Vaegter et al. 2015). However, it must be noted that other research has 
reported a dysfunctional EIA response after aerobic exercise (i.e. increase 
rather than decrease in pain sensitivity) in chronic fatigue syndrome (Meeus 
et al. 2010) and other chronic pain conditions such fibromyalgia (Meeus et al. 
2015) and chronic whiplash associated disorder (Van Oosterwijck et al. 2012). 
It may therefore be that the effect of aerobic exercise on pain sensitivity, and 
thus the functionality of endogenous analgesia varies between chronic pain 
conditions (Vaegter, Handberg & Graven-Nielsen 2016) and possibly even 
between individuals with the same condition (Fingleton, Smart & Doody 
2017). This requires further investigation.  
This study was similar to the previous studies (Chapters 4 and 5) and other 
published research (as discussed in Chapter 4, Section 4.4), that demonstrated 
an efficient CPM effect in a patient population with LE. This however 
contradicts findings from a study by Lim, Sterling and Vicenzino (2017) as 
previously discussed in the same section.  
Further, all participants in this study showed an immediate and efficient 
MIPM effect following cervical lateral glide (CLG) that is in agreement with 
previous studies (Chapter 4 and 5) and other research reports outlined in 
Chapter 4, Section 4.4. This reduction in pain sensitivity away from the site of 
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intervention suggest that central mechanisms are implicated in MIPM 
analgesia (Vicenzino et al. 1998a). 
In this study CPM analgesia was also demonstrated at distant (and contra-
lateral) wrist and elbow regions. The parallel temporal (i.e. pre and post 
CPT/CLG) and spatial (i.e. at the wrist and elbow) patterns observed for both 
CPM and MIPM analgesia (and EIA) may indicate that they are potentially 
mediated by similar neurophysiological mechanisms. However, further 
clarification is needed across a range of healthy and clinical populations. 
The findings of this study indicated reduced pressure pain sensitivity (EIA) 
after both moderate (50% HRmax) and high intensity (75% HRmax) aerobic 
cycling, although with a greater hypoalgesic effect induced after high intensity 
exercise. This is consistent with Naugle et al. (2014) who showed a similar 
increase in PPT after similar exercise protocols in healthy, pain free individuals 
and it has also been reported in chronic pain states such as fibromyalgia 
(Newcomb et al. 2011). However, other studies have reported a significant 
increase in PPT only after high intensity aerobic exercise (Hoffman et al. 2004; 
Vaegter, Handberg & Graven-Nielsen 2014). Possible reasons for this 
discrepancy could be related to methodological differences such as lack of 
controls and unmasking of assessors in these earlier studies. Our study 
specifically addressed these issues by including a control comparison and 
maintaining strict assessor blinding.  
The finding from our study of a strong significant correlation between MIPM 
and EIA, to the best of our knowledge has not be previously reported. 
However, the correlation between CPM and EIA in participants with LE 
shown in our study is in agreement with other recent findings in pain-free 
individuals (Lemley, Hunter & Bement 2015; Vaegter et al. 2015), although the 
correlations in our study were stronger. Again there were methodological 
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differences between studies in the CPM protocol used. In Lemley, Hunter and 
Bement (2015), CPM effect was assessed using pressure pain threshold at the 
finger as the test stimulus and cold water immersion of the foot as the 
conditioning stimulus.  Vaegter et al. (2015) applied a similar CPM protocol to 
ours but used different PPT test sites, measuring at exercising and non-
exercising muscles (biceps and quadriceps) whereas our study measured PPT 
at remote, non-exercising, sites (wrist and lateral epicondyle). Although CPM 
analgesia has previously been found to predict EIA (Ellingson et al. 2014; 
Lemley, Hunter & Bement 2015; Stolzman & Bement 2016), our study appears 
to be the first to show that an aerobic EIA model predicts both CPM and MIPM 
analgesia.  This implies that participants who exhibited higher levels of EIA 
demonstrated greater analgesia during and post CPM and MIPM. This also 
suggests the possibility that MIPM analgesia may be enhanced by a 
preliminary bout of aerobic exercise.  
CPM as a mechanism was previously proposed to mediate EIA by Ellingson 
et al. (2014). The authors compared the responses to pain sensitivity following 
three exercise sessions: painful, non-painful and quiet rest. In the painful 
exercise session, the authors used pressure cuffs to induce quadriceps muscle 
pain (as a conditioning stimulus) to inhibit heat pain sensitivity (test stimulus). 
A significant EIA (reduced pain sensitivity to heat) was induced during both 
painful and non-painful aerobic exercise sessions, with higher levels of EIA 
observed after the painful aerobic exercise. As EIA was induced after non-
painful exercise, the authors suggested that CPM could partially contribute to 
EIA. Our exercise protocol only assessed perceived exertion rather than pain 
during the aerobic exercise and therefore we do not have sufficient data to 
assess whether any of the exercise was painful, although none of the 
participants spontaneously reported exercise related pain (some did report 
pain related to sitting on the saddle and holding the bike handle bars). None 
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the less, significantly stronger CPM analgesia was induced in the current 
study after high intensity exercise compared with moderate intensity, exercise 
suggesting a greater additive effect of CPM and MIPM on EIA when the 
exercise is more strenuous.  Future studies could be directed towards further 
evaluating the potential for additive or synergistic analgesic effects when 
combining exercise with CPM or MIPM. 
The comparable multi-segmental effects of EIA, CPM and MIPM suggest a 
potential overlap in the neurophysiological mechanisms. Evidence from 
several studies suggest that EIA is mediated by a non-opioid mechanism. In 
human studies, aerobic exercise has been shown to activate both sympathetic 
responses (i.e. increased HR and blood pressure) and analgesia (Koltyn & 
Umeda 2006), as has CPM (Chalaye et al. 2013; Chalaye et al. 2014), and MIPM 
(Chiu & Wright 1996; Sterling, Jull & Wright 2001; Vicenzino et al. 1998a; 
Vicenzino et al. 1998b; Vicenzino, Collins & Wright 1996; Vicenzino et al. 1995). 
Further, an elevation in levels of serotonin after aerobic exercise has been 
reported (Soares, Naffah-Mazzacoratti & Cavalheiro 1994; Steinberg et al. 
1998). Serotonin has similarly been found to be involved in both CPM 
(Yarnitsky 2015), and MIPM (Skyba et al. 2003) analgesia. In support of this, 
administration of naloxone (an opioid antagonist) has been shown not to 
reverse the analgesia induced by aerobic exercise (Droste et al. 1991), CPM 
(Edwards, Ness & Fillingim 2004; Hermans et al. 2018; Peters et al. 1992), or 
MIPM (Paungmali et al. 2004; Vicenzino et al. 2000; Zusman, Edwards & 
Donaghy 1989), suggesting a non-opioid mechanism. However, other studies 
have reported that naloxone did reverse the analgesia induced after aerobic 
exercise (Haier, Quaid & Mills 1981; Janal et al. 1984; Olausson et al. 1986), or 
CPM (King et al. 2013; Pertovaara et al. 1982; Willer, Le Bars & De Broucker 
1990) suggesting an involvement of the endogenous opioid system. The extent 
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to which opioidergic mechanisms are involved in EIA, CPM or MIPM-induced 
analgesia is therefore still unclear and warrants further investigation.  
 Clinical implications 
Clinicians should consider assessment of EIA in chronic pain populations 
when utilising manual therapy or aerobic exercise as a treatment option to 
enhance descending analgesia. A simple aerobic exercise task (even at 
moderate intensity only) could be applied to calculate EIA and so predict the 
extent to which a manual therapy intervention may reduce pain in an 
individual with chronic pain. Equally, aerobic exercise could be used to 
potentiate MIPM analgesia. This would be clinically valuable for those 
clinicians who often combine different treatment modalities to manage 
musculoskeletal pain.  
 Limitations  
There are some limitations for this study that must be acknowledged. First, 
this study did not include a non-exercising control group, although a previous 
study by our research group (reported in Chapter 4) has shown a strong CPM 
and MIPM response in people with LE without any intervention. Second, the 
true intensity of aerobic cycling sessions was not objectively measured using 
an exhaustive laboratory fitness test (such as VO2max) but it was estimated 
using a vicarious age-predicted HRmax calculation. Perceived and objective 
exercise intensity was closely monitored during the exercise session using the 
Borg RPE and HR. This allowed for adequate differentiation between the 
moderate and high intensity levels of exercise, as shown by the differences in 
values between groups. Third, the study did not assess the impact of 
psychological factors on EIA (e.g. expectation of the effect of exercise, pain 
catastrophizing) that needs to be considered in the interpretation of the results. 
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It must be acknowledged that the findings of this study cannot be generalised 
to other chronic musculoskeletal pain populations other than LE. Finally, the 
study only measured the immediate effects of a single session of aerobic 
exercise on CPM and MIPM analgesia. Therefore, there is uncertainty about 
whether similar results would be demonstrated over longer follow-ups, 
following single or multiple aerobic exercise sessions. It is recommended to 
address these issues in future research.  
 Conclusion  
The present study demonstrated that a single session of aerobic cycling 
exercise reduced pressure pain sensitivity in people with LE. It also showed 
that high intensity aerobic exercise enhanced CPM and MIPM analgesic 
responses. Further, EIA responses were significantly correlated with CPM and 
MIPM responses in this group with LE, and the level of EIA response was 
predictive of the level of CPM and MIPM response. This suggests that there 
may be an overlap in the neurophysiological mechanisms mediating EIA, 
CPM and MIPM. 
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 Discussion  
The primary objective of this thesis was to improve our knowledge and 
understanding of the relationship between CPM and MIPM analgesia through 
a series of experimental studies aiming to explore and highlight similarities 
and differences in the patterns of the analgesic responses to CPM and MIPM. 
This thesis has presented a series of four studies. The first study (Chapter 3) 
established the reliability of PPT (the main outcome measure) measurements 
over the assessment timeframe for the subsequent studies, the duration of 
CPM after-effect to determine the rest period between CPM and MIPM 
protocols, and the minimal sample size necessary for the subsequent studies. 
This was followed by a quasi-experimental one-group, repeated measures 
study (Study 2, Chapter 4) investigating the extent of CPM and MIPM 
analgesic effect in a sample of participants with LE and the association 
between the two phenomena. This study also investigated whether there was 
a difference in MIPM analgesia between CPM responders and non-
responders. Study 3 (Chapter 5) was a randomised controlled trial (RCT) 
comparing the effect of an enhanced empathetic interaction to that of a neutral 
(business-like) interaction on CPM and MIPM analgesia in participants with 
LE. The final study (RCT) compared the EIA effect of moderate and high 
intensity aerobic cycling in people with LE and examined its potential additive 
analgesic effect on CPM and MIPM analgesia. The study also assessed 
associations between levels of analgesia induced by aerobic exercise, CPM and 
MIPM.  
 The analgesic effect of CPM and MIPM 
The studies presented in Chapters 4, 5 and 6 of this thesis are the first studies 
to consistently show an increase in homotopic (ipsilateral) PPT at the elbow 
and wrist, denoting a functioning CPM effect and MIPM effect, and indicating 
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that pain inhibitory systems function effectively in people with LE. One recent 
study (Lim, Sterling & Vicenzino 2017) conflicts with these findings in 
reporting that a CPM response was impaired in the same clinical group. The 
difference between these findings may be attributed to methodological 
differences in the CPM protocol used. This was discussed in detail in Chapter 
4 (Section 4.4). As far as MIPM effect is concerned, the current work has also 
confirmed findings from previous literature regarding the effectiveness of the 
CLG mobilisation technique in reducing elbow pain in LE. In addition the 
studies have provided a new finding that CLG has a widespread analgesic 
effect in LE, demonstrating increased PPT also at the pain-free ipsilateral wrist. 
The findings from these studies demonstrated that CPM and MIPM share 
similar patterns of response whilst also differing in several aspects. Robust 
multi-segmental increases in PPT measures (wrist and elbow) during and post 
CPT and CLG were seen in both the CPM and MIPM protocols and across all 
studies. Higher levels of CPM and MIPM analgesia were observed at the wrist 
compared to the elbow in Studies 2 and 3. However, the analgesic responses 
were higher at the elbow test site compared to the wrist test site in Study 4. 
This finding is hard to explain and it would need to be clarified with additional 
data. Further, the increase in PPT and thus the analgesic response, was 
significantly greater during CPM than during MIPM (assessed in Study 2). 
CPT is an intense and potentially painful stimulus (Yarnitsky 2015) while the 
CLG mobilisation is pain free (Vicenzino et al. 1999). CPT acts as a stressor that 
suddenly triggers autonomic nervous system responses and leads to release of 
noradrenaline (Silverthorn & Michael 2013). On the other hand, CLG is a 
relaxing stimulus (similar to massage) that increases general well-being 
responses and release of serotonin (5-HT) (Field et al. 2005). This could explain 
the stronger analgesic responses associated with CPM compared to MIPM. 
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Similar patterns of analgesic responses during CPM and MIPM were observed 
in the empathetic interaction study (Study 3) and the aerobic exercise study 
(Study 4). While there was no significant difference between the levels of CPM 
and MIPM analgesia post CPT and CLG mobilisation (assessed in Study 2), 
the pattern of analgesic response reduced rapidly after the CPT stimulus while 
it remained relatively steady after the CLG mobilisation. Therefore, while the 
MIPM analgesia appears to be less than for CPM, its effect is longer lasting 
Despites these differences in the patterns of CPM and MIPM analgesia, both 
CPM and MIPM appear to share similar temporal (i.e. during and after 
CPM/MIPM) and spatial manifestations (i.e. wrist and elbow). This suggests 
that they could be potentially mediated by common neurophysiological 
mechanisms but with some differences in the individual modulatory pathway. 
This requires further exploration. Moreover, these observations are based on 
the immediate analgesic responses measured at defined time points assessed 
during these investigations. Therefore, it is unknown how and in what way 
they will differ over a longer timeframe (i.e. after a single session of CPM or 
MIPM) in people with LE. Further research measuring these analgesic 
responses over a longer follow-up period in this patient population is 
warranted.  
 The analgesic effect of aerobic exercise  
In the aerobic exercise study (Study 4), for the first time in people with LE an 
acute bout of aerobic cycling was shown to produce an analgesic effect 
(increase in PPT) at remote test sites not being activated during the exercise 
(wrist and elbow). This finding indicates that the EIA response is intact in this 
sample of patients with LE. Although it is notable that both exercise intensities 
induced EIA, compared to moderate intensity cycling, high intensity cycling 
produced higher levels of analgesia, indicating a dose response relationship. 
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The remote effect of aerobic exercise indicates that central pain inhibitory 
systems play a role in EIA (Vaegter et al. 2015). These findings were based on 
the immediate influence of a single 15 minute aerobic exercise session at a 
specific intensity. Further research is recommended into the effect of multiple 
aerobic exercise sessions on EIA.  
 The Association between different forms of endogenous 
analgesia  
An important finding in the association study (Study 2) and the aerobic 
exercise study (Study 4) was the significant association in people with LE 
between the natural forms of analgesia under investigation. Study 2 reported 
significant moderate and positive association between CPM and MIPM 
analgesia. This association was measured at the wrist and elbow sites during 
and post CPT (CPM) and CLG mobilisation (MIPM). Previous investigations 
were confined to the association between CPM analgesia and EIA (Lemley, 
Hunter & Bement 2015; Vaegter et al. 2015). Another important finding was 
that the strong positive association between aerobic EIA and CPM, and 
between aerobic EIA and MIPM in Study 4. The association between CPM 
analgesia and EIA was larger in the aerobic exercise study than that described 
by Lemley, Hunter and Bement (2015) and Vaegter et al. (2015). This variation 
may be attributable to differences in methodological factors related to study 
design, testing parameters, and research sample recruited. However, 
additionally Study 4 found a strong association between EIA and MIPM 
analgesia, a new finding that has not been previously reported.  
Previous studies have also reported that CPM analgesia is predictive of EIA 
(Ellingson et al. 2014; Lemley, Hunter & Bement 2015; Stolzman & Bement 
2016), a finding that was replicated in the current study. To our knowledge 
though, the association study (Study 2) is the first study to show that CPM is 
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a significant predictor of MIPM analgesia, and the aerobic study (Study 4) is 
the first to report that EIA is a significant predictor of both CPM and MIPM 
analgesia. These findings provide further evidence that CPT, CLG, and aerobic 
exercise may activate similar pain modulatory mechanisms involving the 
descending inhibitory pathways. Further studies verifying similar findings in 
different patient populations should be carried out.  
Findings from the aerobic exercise study showed that aerobic exercise induced 
an analgesic response at the wrist and elbow, a similar manifestation 
(temporal and spatial) to that reported for CPM and MIPM. These 
observations enable us to hypothesise that these natural forms of EA may be 
mediated by common neurophysiological mechanisms in the central nervous 
system. These findings suggest the potential use of CPM to predict response 
to MIPM in the clinical setting when considering manual therapy as a 
treatment option for musculoskeletal pain. Further long term clinical trial 
studies in this area are recommended. 
 CPM responders and non-responders analysis 
The association study (Study 2) highlighted the importance of individual 
variations in CPM response by demonstrating that participants can be divided 
into two distinct CPM groups: responders and non-responders. The CPM 
responders group exhibited more robust MIPM analgesia compared to the 
CPM-non-responders. This finding further supports the link between CPM 
and MIPM analgesia, suggesting again that they may be controlled by 
common descending inhibitory systems.  
Although the proportion of CPM-non responders in this study was very small 
(11.4%) compared with CPM responders (88.6%), the difference in MIPM 
analgesia between both CPM groups was statistically significant. This 
indicates that responders vs non-responders analysis is a sensitive and robust 
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method (Rankin & Stokes 1998) for assessing the effectiveness of pain 
interventions. The CPM responders and non-responders analysis could be also 
applied to EIA in future studies.    
 Effect of psychological and physical manipulation on CPM 
and MIPM  
This study provided evidence, for the first time, that both CPM and MIPM 
analgesia can be enhanced by both psychological and physical manipulation. 
In Study 3, the enhanced empathetic interaction group experienced 
significantly higher levels of CPM and MIPM analgesia compared with the 
neutral interaction group. This study supports the potential clinical benefit of 
a positive patient-therapist interaction in enhancing analgesia. Further studies 
are required to evaluate whether creating a more positive clinical interaction 
might result in better clinical outcomes from more prolonged periods of 
treatment.  
In Study 4, the high intensity aerobic cycling group exhibited significantly 
higher levels of CPM and MIPM analgesia than the moderate intensity group. 
This study provides further evidence that high intensity aerobic exercise can 
be used as an additive intervention to enhance pain-relieving treatments in 
patients with chronic musculoskeletal pain, and is shown for the first time in 
LE. However, the extent to which these positive effects last is currently 
unknown. Therefore, there is a need to conduct further studies investigating 
the change in these analgesic responses over longer periods.  
Based on these findings, it appears that enhanced empathetic interaction and 
high intensity cycling can both potentiate CPM and MIPM analgesia in a 
similar way. Again, this provides an indication that both CPM and MIPM 
analgesia may be mediated by common mechanisms linked to the descending 
pain modulatory systems.  
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 Summary of limitations 
 LE was used as a clinical model to represent other conditions with 
chronic pain. Owing to the complexity of chronic pain states, the 
generalisability of the findings of the studies in this thesis to other 
chronic pain conditions is limited.  
 Due to the experimental nature of these studies, there may be questions 
about the extent of applicability of the findings to clinical settings.  
 Only short term analgesic responses of CPM and MIPM were measured 
in these studies. Therefore, the pattern of these analgesic responses over 
longer follow-up periods cannot be determined. 
 Although communications with the participants were standardised at 
all times in these studies, the influence of participants’ expectations on 
their analgesic responses and/or instructions could not be ruled out. 
This was particularly relevant to Studies 1 (the reliability study) and 2 
(the association study) where CPM and MIPM analgesia was not 
manipulated by an additional intervention. 
 The association study (Study 2) was a single-arm trial that investigated 
the association between CPM and MIPM analgesia. This design (quasi-
experimental) is associated with threats to internal validity (bias) such 
as lack of randomisation and the potential regression to the mean 
(Harris et al. 2006). However, the study was mainly intended to find the 
association between CPM and MIPM analgesia as a starting point 
before introducing the experimental manipulation in the subsequent 
study (the empathetic interaction study, Study 3). There were efforts 
made to minimise possible sources of bias such as: ensuring adequate 
sample size, using clear-cut inclusion and exclusion criteria, and 
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administering the experimental procedure and data collection in a 
consistent way.  
 Studies 3 and 4 (the empathetic interaction study and the aerobic 
exercise study, respectively) used post-test only control group design. 
So neither group was pretested for CPM or MIPM. While pre-
intervention (baseline) CPM and MIPM assessments would allow for 
better understanding of the differential effects of the intervention 
observed, pre-intervention assessment of CPM and MIPM responses 
could have influenced participants’ analgesic responses during the 
intervention studies (empathetic interaction and aerobic exercise).  
 Study 3 sought to compare between the influence of two types of 
interaction on CPM and MIPM analgesia. Although there was a 
statistical difference in CARE Measure scores between the groups, a 
more distinct difference between the interaction interventions could 
have been achieved by subgrouping people using a cut-off value of the 
CARE score. This was not performed since an appropriate cut-off value 
of the CARE Measure has not been determined.  
 In Study 2 and 3, MIPM always came after CPM (i.e. order effect), it is 
possible that the effects of MIPM were systematically influenced by the 
preceding CPM – it may have enhanced (or limited) the MIPM 
response. However, the sufficient washout period (determined in 
Study 1) followed the CPM protocol should have minimised this effect. 
Further, statistical models also dealt with CPM and MIPM data 
separately. 
 In Study 4, CPM and MIPM protocols were assessed over 2 test days, 
with an interval of 3 days, and randomised to eliminate possible order 
effect. While the CPM after-effect was determined in Study 1, the 
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washout out period after the MIPM or EIA protocols was not 
determined. The duration of the rest period was decided based on 
clinical judgment that 3 days would be the minimum reasonable time 
for an adequate recovery (associated with less chance for dropouts and 
reduced post exercise soreness) before starting the second aerobic 
exercise session. Additionally, this was based on previous studies 
(Moss, Sluka & Wright 2007; Vicenzino et al. 1998b; Vicenzino, Collins 
& Wright 1996) where at least 24 hours was allowed between 
mobilisation conditions.  
 Recommendations for future research 
Taking into consideration the findings presented in this thesis, some important 
areas for future work have been highlighted below: 
 In the light of the positive results achieved in this series of studies (i.e. 
Studies 2, 3, 4) using LE, equivalent clinical trials are necessary to 
evaluate whether a similar influence on CPM and MIPM endogenous 
analgesia could be obtained in different chronic musculoskeletal states.  
 In these studies, short term analgesic responses (PPT) of CPM and 
MIPM were evaluated.  It would be important from a clinical point of 
view to determine what changes would occur in the pattern of analgesic 
responses over longer follow-ups.  
 The current thesis explored the one-hour effects of a single CPM session 
(Study 1). The MIPM effects from a single session could also be 
explored in a similar way in future research. For Study 4, this would 
clearly rule out possible carryover effects from MIPM protocol to CPM 
protocol. 
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 Results from Study 2 suggest that CPM could potentially be a useful 
predictor for MIPM response in the clinical setting. Pre manual therapy 
CPM assessment could also be used to identify responders and non-
responders in advance of treatment. It would be useful of conduct a 
longer term study to determine if CPM testing could accurately identify 
MIPM responders and non-responders. 
 Studies 3 and 4 assessed CPM and MIPM analgesia in response to 
empathetic interaction and aerobic exercise interventions, respectively. 
Future studies could assess pre-interventions CPM and MIPM and then 
allow a period of time before conducting post-interventions CPM and 
MIPM protocols to reduce the effect of testing.  
 In Study 4, the influence of a single session of aerobic exercise on LE 
and CPM and MIPM analgesia was assessed. It would be beneficial to 
investigate the effect of a course of multiple aerobic exercise sessions on 
EIA, CPM and MIPM analgesia. 
 It would also be appropriate to consider undertaking a future study 
using a pharmacological intervention such as duloxetine, a selective 5-
HT and NA reuptake inhibitor (SNRI) (Lyengar et al. 2004) to evaluate 
the influence it has on CPM and MIPM analgesia. An appropriate 
musculoskeletal model for testing would need to be identified where 
there is already some evidence for the effect of duloxetine and at least 
one of the interventions (i.e. CPM and MIPM). Using the same 
methodologies, participants could attend for CPM and MIPM 
assessment protocols before and following a course of duloxetine 
therapy or a control intervention. The patterns of analgesic responses 
to CPM and MIPM could then be analysed to determine whether 
duloxetine could effectively enhance MIPM. 
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 In this thesis, similar variations in the patterns of CPM and MIPM 
analgesia were observed in a series of experimental paradigms to 
support the hypothesis that CPM and MIPM analgesia is mediated by 
descending inhibitory systems. However, due to ethical considerations 
differential control of the system (i.e. involvement of serotonergic and 
adrenergic pathways) cannot be investigated in humans. One area of 
future research is to apply the same methodologies in a 
pharmacological trial using an animal model (e.g. rats). Selective 
serotonergic reuptake inhibitors/agonists and/or noradrenergic 
receptors agonists/antagonists could then be systemically or 
intrathecally injected to investigate/manipulate the DNIC/CPM and 
MIPM analgesic effects in an equivalent way, to determine whether the 
responses are blocked by similar pharmacological interventions. 
 Original contribution to knowledge 
 The reliability and duration of CPM effect in Study 1 provided essential 
data related to the reliability of PPT measurements at the wrist and 
elbow sites, and for the first time, the duration of the meaningful CPM 
effect, and sample size calculations that had a methodological 
significance to the subsequent studies.  
 The association study (Study 2) is the first study to find an intact CPM 
effect in people with LE. 
 Study 2 was also the first study to report a difference in MIPM analgesia 
based on (CPM effect) responders vs non-responders analysis for a 
different form of analgesia.  
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 Study 2 was also the first to report a remote analgesic response (PPT) in 
response to CPM and MIPM over the asymptomatic ipsilateral wrist in 
LE.  
 Study 2 also provided the first evidence of an association between CPM 
and MIPM analgesia in people with musculoskeletal pain and first to 
report the use of CPM to predict MIPM analgesia. 
 The empathetic interaction study (Study 3) was the first study to 
selectively assess and manipulate the therapist (RA)/patient interaction 
to objectively show the positive influence of an enhanced empathetic 
interaction on CPM and MIPM analgesia in participants with LE. 
 The aerobic exercise study (Study 4) was the first study to investigate 
the analgesic effect of aerobic exercise in LE and to show the positive 
multi-segmental aerobic EIA in this clinical group.  
 Study 4 was the first study to investigate and demonstrate an 
association between EIA and MIPM.  
 Study 4 also showed the positive influence of high intensity aerobic 
exercise on CPM and MIPM analgesic responses in participants with 
LE.  
 Study 4 was also the first study to demonstrate that aerobic EIA is 
predictive of both CPM and MIPM analgesia in participants with LE. 
 The studies in this thesis show that analgesia induced by CPT, CLG and 
aerobic exercise exhibits similar patterns of analgesic responses 
suggesting that there is likely to be a considerable overlap between the 
neurophysiological mechanisms mediating each form of EA.  
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 In clinical practice clinicians tend to combine interventions to obtain 
greater positive treatment outcomes. The findings in this thesis support 
the use of this (multimodal) approach to manage clinical pain 
conditions, in that there is evidence for enhanced analgesic responses 
as a result of combining different modalities.  
 Conclusions  
Repeated PPT measures (Chapter 3) showed excellent intra-class correlational 
coefficients (ICCs: 0.991 and 0.986) at two test sites: the wrist and elbow, 
respectively. The CPM pattern of analgesic responses showed that PPT 
returned to baseline measurement after 5 minutes post cold water immersion.  
The association study (Chapter 4) demonstrated an immediate significant 
increase (relative to baseline) in all CPM and MIPM measures of analgesia over 
different time points. PPT measures of CPM and MIPM were significantly, 
moderately and positively associated at the elbow and wrist. CPM analgesia 
was shown to significantly predict MIPM analgesia consistently at both test 
sites. There was also a significant difference in MIPM analgesia between CPM 
responders and non-responders, with higher levels of analgesia measured for 
CPM responders. However, there was no significant difference between both 
CPM groups in the secondary outcome measures of MIPM. That finding is 
likely attributable to the difference in the sample size between responders 
(n=62) and non-responders (n=8). The results of this study suggested that CPM 
and MIPM may activate similar neurophysiological mechanisms in the 
descending inhibitory system.  
The RCT manipulating the RA/participant interaction (Chapter 5) found that 
all participants experienced an immediate significant increase in CPM and 
MIPM analgesia (including PFG and ULNDT-RN). However, higher levels of 
CPM and MIPM analgesia were demonstrated at the wrist and elbow sites 
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(excluding PFG and ULNDT-RN) for those participants who were in the 
enhanced empathetic interaction group. The study concluded that a single 
session of enhanced empathetic interaction significantly potentiated the CPM 
and MIPM analgesia (in a similar way). This suggests that when CPM and 
MIPM analgesic effects are combined with enhanced empathetic interaction 
they produce an increased analgesic effect. These results may indicate that 
both forms of analgesia induced by CPM and MIPM are potentially accessing 
the same central pain control systems in the descending pathways.    
The final RCT manipulating the intensity of aerobic exercise showed that both 
aerobic exercise groups (i.e. the high and moderate intensity) demonstrated an 
immediate significant increase in EIA, CPM and MIPM analgesia at both test 
sites. However, significantly higher levels of analgesia (i.e. EIA, CPM and 
MIPM analgesia, excluding PFG) were reported for the high intensity aerobic 
exercise group. EIA analgesia was significantly and positively associated with 
MIPM and CPM analgesia. EIA was found to be a significant predictor of CPM 
and MIPM analgesia. The results of this study indicate that a single bout of 
high intensity exercise (similarly) enhanced the CPM and MIPM analgesic 
responses. It also suggests a common link between the neurophysiological 
mechanisms in the descending system mediating the initial analgesic effect of 
aerobic exercise, CPT and CLG mobilisation. 
This series of experimental studies provide further evidence that CPM and 
MIPM produce natural forms of EA. They appeared to have comparable 
analgesic responses as demonstrated in these investigations. They also 
appeared to be similarly influenced (enhanced) by psychological (enhanced 
empathetic) factors and physical interventions (aerobic exercise). These 
observations (combined with the available research evidence) suggest that 
CPM and MIPM may share similar underlying neurophysiological 
mechanisms in the central descending pain inhibitory systems.  Further 
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research should be carried out to investigate this possibility in suitable animal 
models.  
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Background: Conditioned Pain Modulation (CPM) refers to a reduction in pain perception of 
a painful stimulus applied to one body part in response to application of a distant noxious 
stimulus. Recent research evidence suggests that CPM activates endogenous pain inhibitory 
systems to produce a natural form of analgesia. We sought to determine if a psychological 
intervention based on an empathetic interaction and an enhanced expectation of analgesic 
effect might have a positive influence on the degree of CPM that individuals with a 
musculoskeletal pain problem might experience.  
 
Purpose: The main purpose of this study was to evaluate the impact of an enhanced research 
assistant/research participant interaction on CPM analgesic responses in a patient population 
with tennis elbow.  
 
Methods: 66 participants with tennis elbow from Western Australia were recruited for the 
study. They were initially assigned into two groups, the enhanced interaction (n=33) and 
normal interaction groups (n=33). The enhanced /normal interactions were all under the control 
of a professional role play actor, playing the part of a research assistant. The actor was trained 
to provide a very empathetic and positive interaction with the research participants (enhanced 
interaction) or a very neutral business like interaction (neutral interaction). Participants’ ratings 
of the interaction were determined using the Consultation and Relational Empathy (CARE) 
Measure. At the start, the research assistant spent 15min interacting with the participants. 
Immediately after the interaction, a blinded assessor (ICC (3,4)=0.99) measured pressure pain 
threshold (PPT) at the elbow and wrist of the symptomatic side before, during and after 
immersing the other arm in a bath of cold water (10°C) to evoke the CPM response. Linear 
mixed models were used to evaluate differences in CPM response between the interaction 
groups, controlling for the CARE measure and baseline PPT. 
 
Results: There was a significant difference in the CARE scores (p<0.001) between the 
interaction groups. There was also a significant increase in PPT for all participants during CPM 
(p<0.001) and immediately post CPM (p<0.001), with higher level of analgesia observed for 
the enhanced empathetic interaction group during (p<0.001) and post CPM (0.002) at the 
elbow and wrist compared to the neutral group. A similar pattern of change in PPT was 
demonstrated at both measurement sites (wrist and elbow) during and immediately post CPM.
 
Conclusion: The current study showed that an empathetic interaction and an enhanced 
expectation of analgesia positively influence CPM pain responses in people with tennis elbow. 
Further research is recommended into the effect of a longer term of psychological intervention 
on CPM analgesia.    
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